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 I 
Abstract 
 
 
During lytic infection with a number of pathogenic viruses, host cells have been 
found to exhibit loss of mRNA culminating in loss of cellular proteins, a 
phenomenon termed host shutoff. In γ-herpesviruses, the precise mechanism by 
which host shutoff takes place is yet to be fully determined. Initially, host shutoff in 
Kaposi’s sarcoma-associated herpesvirus (KSHV) was associated with the viral DNA 
exonuclease SOX (shutoff and exonuclease), which was followed by the 
identification of host shutoff in Epstein Barr virus (EBV) linked to the SOX 
homologue BGLF5. Murine γ-herpesvirus-68 (MHV-68) is a γ-herpesvirus that 
infects murid rodents including laboratory mice, with extensive viral genome 
homology to KSHV and EBV.  MHV-68 was also found to induce host shutoff via 
the SOX homologue ORF37. The similarities between MHV-68 and the human γ-
herpesviruses make the mouse virus an ideal model for studying host shutoff and 
consequences of host shutoff in disease pathogenesis. In this study, MHV-68 was 
used to investigate the role of ORF37 in MHV-68 infection in vitro and in vivo and 
to examine possible mechanisms of mRNA degradation mediated by ORF37. A stop 
codon mutant of MHV-68 (ORF37Stop) and its corresponding revertant 
(ORF37StopRev) were engineered.  ORF37Stop virus exhibited highly restrictive 
phenotype in immunocompetent cells.  In contrast, lack of ORF37 was tolerated in 
cells lacking a functional intereferon- α/β receptor (IFNαβRKO). These in vitro 
observations were replicated, to some extent, in vivo with the mutant virus 
establishing lytic infection in the lungs of IFNαβRKO mice. Interestingly, host 
shutoff was found to proceed even in the absence of ORF37, but only where 
functional type I IFN-mediated responses were lacking. A poly(A) tail assay was 
used to investigate the possibility of mRNA degradation at the 3’ mRNA.  In contrast 
 II 
to a previously published study, the results suggest that cellular poly(A) tails do not 
appear to be elongated as a result of MHV-68 lytic infection.   
 
Data generated during this project have identified a novel function by which ORF37-
mediated host shutoff causes mRNA degradation and that a primary role of this viral 
protein is to overcome the type I interferon-receptor-mediated responses.  The 
observation that host shutoff can proceed in the absence of ORF37 in cells unable to 
respond to type I IFNs highlight two important possibilities: other viral proteins may 
mediate host shutoff; and type I IFN effector mechanisms are a key player in host 
shutoff. These novel observations together with lack of a mechanism by which 
ORF37 mediates mRNA degradation warrant further studies in this field.   
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Chapter One 
 Introduction 
 
1.1 Herpesviruses 
Herpesviruses are enveloped double-stranded DNA viruses of eukaryotes. They are 
highly disseminated in nature, having been isolated from a diverse range of species, 
from mammals to oysters (Knipe 2007). Most animal species will yield at least one 
herpesvirus, however, the most studied group includes viruses which infect amniotes, 
such as mammals, birds and reptiles (Knipe 2007; Wang 2007). One of the key 
features of infection with these viruses is their ability to remain latent within certain 
cell types in their hosts. During this time the viral genome forms closed circular 
molecules, termed episomes, with only a small subset of viral genes being expressed 
(Knipe 2007).  
1.1.1 Classification of herpesviruses 
In recent years the International Committee on Taxonomy of Viruses (ICTV) has 
carried out a major review of how herpesviruses are classified. These changes have 
come in the form of the introduction of the Herpesvirales order which encompasses 
three herpesvirus families, namely the Herpesviridae, Alloherpesviridae and the 
Malacoherpesviridae. These three families cover a diverse range of host species: the 
Herpesviridae include mammal, bird and reptile hosts; the Alloherpesviridae are 
associated with fish and amphibians and; the Malacoherpesviridae have been found 
to infect bivalves (Davison et al. 2009). This thesis will focus on Herpesviridae, 
which contain three subfamilies namely the Alphaherpesvirinae, the 
Betaherpesvirinae and the Gammaherpesvirinae (Figure 1.1). Historically, 
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membership of these three subfamilies was based on biological properties of these 
viruses, such as tissue tropism; however, more recently genome sequence 
information has been used in their classification.  Nevertheless, the initial 
classification (based on cell tropism/disease) has proved relatively consistent with 
more recent genomic profiling (McGeoch et al. 2006).  
 
Alphaherpesvirinae: The alpha-herpesvirus (-herpesvirus) subfamily contains 
neurotropic viruses, with the majority of latent infections found in sensory ganglia. 
The prototypic human -herpesvirus is herpes simplex virus (HSV1), however this 
group also contains the human viruses herpes simplex virus 2 (HSV2) and Varicella 
zoster virus (VZV) (Knipe 2007; Liu 2007). 
 
Betaherpesvirinae: Members of the beta-herpesvirus (-herpesvirus) subfamily have 
been found in a number of cell and tissue types, such as secretory glands and 
lymphoreticular cells. Human viruses in this group include human cytomegalovirus 
(HCMV) and human herpesviruses 6 and 7 (HHV6 and HHV7 respectively) (Knipe 
2007; Liu 2007). 
 
Gammaherpesvirinae: Gammaherpesvirus (-herpesvirus) subfamily consists of 
lymphotropic viruses, infecting mainly B and T lymphocytes. The -herpesvirus 
subfamily can be further divided into two genera: Lymphocryptoviruses; and 
Rhadinoviruses. The two human viruses of medical importance within this subfamily 
include the Epstein Barr virus (EBV or HHV4) a lymphocryptovirus, and Kaposi’s 
sarcoma-associated herpesvirus (referred to as KSHV or HHV-8), which is a 
rhadinovirus, (Knipe 2007; Liu 2007). A hallmark of -herpesviruses is that infection 
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with these viruses is highly species-specific therefore limiting their study to their 
natural hosts. Due to this species-specificity, the murine gammaherpesvirus 68 
(MHV-68 also referred to as MHV4, MuHV-4 and HV-68) has often been used to 
study γ-herpesviruses pathobiology (reviewed by Nash et al. 2001; Blackman and 
Flano 2002).  
α
β
γ
(HCMV)
(HSV-1)
(EBV)
(KSHV)
(VZV)
 
 
Figure 1.1 Phylogenetic tree showing the evolutionary relationships within the 
herpesvirus family. The herpesvirus family can be divided into three subfamilies; α, 
β- and γ-herpesviruses. In the figure some known human herpesviruses are 
highlighted within each subfamily: HSV-1 and VZV are α-herpesviruses, HCMV 
belongs to the β-herpesvirus subfamily, while EBV and KSHV have been assigned 
into the γ-herpesvirus subfamily (Wang 2007). 
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1.1.2 Herpesvirus virion structure 
Membership of order Herpesvirales is classically based on virion architecture 
(Figure 1.2). The basic herpesvirus structure consists of a core containing linear 
double-stranded (ds) DNA in the form of a torus, between 124-230 kilo base pairs 
(kbp). This is surrounded by an icosahedral capsid of approximately 125nm in 
diameter, containing 162 capsomeres (Knipe 2007). Surrounding the capsid is the 
tegument, a proteinaceous compartment unique to herpesviruses. The tegument 
proteins have multiple roles in the viral life cycle, such as assembly and egress of 
herpesvirus particles (reviewed by Guo et al. 2010). Furthermore tegument proteins 
can stimulate expression of viral immediate early (IE) genes and can also modulate 
the host cellular environment during initial infection through inhibition of host 
signalling pathways and host shutoff of cellular protein synthesis (Knipe 2007; Guo 
et al. 2010). Although originally believed to be an amorphous structure, the tegument 
has now been found to be built up through protein-protein interactions that form an 
organised structure (reviewed by Sathish et al. 2012). The use of electron 
cryomicroscopy has led to further insights into virion structure as 3D images have 
been produced for members of the α-, β- and γ-herpesviruses, which have highlighted 
both similarities and differences between tegument structures (Chen et al. 1999; 
Zhou et al. 1999; Dai et al. 2008). Dai et al. also used a process of cryo-electron 
tomography, which identified two tegument layers; one (inner) attached to the capsid 
and the other (outer) tegument layer, which is flexible and conforms to the shape of 
the envelope (Dai et al. 2008). Although the presence of inner and outer tegument 
layers appears to be conserved across the herpesvirus family the pattern of tegument 
proteins which interact with the capsid is different for different members of this 
family (Chen et al. 1999; Zhou et al. 1999; Dai et al. 2008). Encapsulating the 
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tegument is a cell-derived lipid bilayer envelope, which has a number of viral-
encoded glycoprotein spikes on its surface (Knipe 2007). Upon infection of the cell 
the capsid uncoats in the cell cytoplasm and the viral DNA enters the host nucleus 
where viral genes are transcribed and translated (Liu 2007). The process of virion 
assembly is highly conserved within the herpesvirus family.  Initially a procapsid is 
formed, which contains internal scaffolding proteins.  Upon maturation into a 
nucleocapsid, the internal scaffolding is replaced with the viral genomic DNA (Liu 
2007). During the assembly process viral proteins are present which recognise and 
cleave at conserved sequences on the DNA, which signal the genomic termini 
allowing the correct packaging of the DNA into the capsid (Knipe 2007).  
 
 
 
 
 
Figure 1.2 Herpesvirus structure. Diagram depicting herpesvirion structure, which 
comprises; the viral genome, capsid, inner and outer tegument and the envelope. 
Information from (Knipe 2007; Dai et al. 2008). 
 
Icosohedral capsid 
Genome 
Envelope 
Glycoprotein spikes 
Outer 
Tegument 
Inner 
Tegument 
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1.1.3 Virus entry and traffic to the nucleus 
Herpesvirus entry into cells is a complex process that requires the interactions of 
viral glycoproteins with cell surface receptors. A combination of different viral 
glycoproteins and cellular receptors more than likely determines the virus tropism.  
There are two main stages of entry:  first is attachment, during which the virus is 
tethered to the cell; second is fusion, which can occur either via direct fusion of the 
plasma membrane or endocytosis (Figure 1.3A) (reviewed by Krummenacher et al. 
2007; Connolly et al. 2011).  
 
The entry of EBV into B cells is via endocytosis, however, entry into epithelial cells 
does not require endocytosis, occurring instead via fusion at the cell surface, both of 
which occur in a pH-independant manner (Miller and Hutt-Fletcher 1992). In 
contrast, KSHV enters both fibroblasts and endothelial cells via endocytosis, both of 
which occur in a low pH-dependant manner (Akula et al. 2003; Greene and Gao 
2009). Similar to KSHV, MHV-68 also uses the process of endocytosis to enter cells 
(Gill et al. 2006). Although a variety of herpesvirus glycoproteins are involved in 
virion entry, there are three fusion glycoproteins (gB and the heterodimer gH/gL), 
which are conserved and are often referred to as the core fusion machinery (Table 
1.1). Initial contact between herpesvirus glycoproteins and the cell surface is usually 
via heparan sulphate (Table 1.1). However this association is not essential for virus 
infection and viral glycoproteins are also not essential for viral entry, but the 
association does increase the efficacy of viral entry by allowing viral glycoproteins 
to locate the correct entry receptor. One notable exception is EBV, which does not 
bind heparan sulphate, but instead uses binding and entry receptors found on very 
few cell types and mainly B cells. These findings are consistent with the fact that 
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KSHV for example can infect a number of different cell types, whereas EBV has a 
much more limited host range (specifically in relation to B-cell targets) (reviewed by 
Spear and Longnecker 2003). 
 
Once the fusion glycoproteins have attached to cell receptors this triggers a 
rearrangement of the host cytoskeleton. One of the components of the cytoskeleton 
are microtubules, comprising of α and β-tubulin heterodimers. The stiff, cylindrical 
microtubules are polar, allowing the positive (plus) end to grow and shrink rapidly 
while the negative (minus) end is tethered to the organising centre. Directional 
transport along the microtubules is governed by two motors; the plus-end kinesin 
motors involved in transport to the cell periphery and the minus-end dynein motor 
involved in movement from the periphery to the cell centre (reviewed by Lyman and 
Enquist 2009). After attachment and fusion have taken place the capsid is released 
into the cytosol leaving behind the glycoproteins and the outer tegument at the 
plasma membrane (Maurer et al. 2008). The partially tegumented capsid is then 
transported to the nucleus via the interaction of both capsid and inner tegument 
proteins with the minus-end directed dynein motor and dynactin protein complex 
(Sodeik et al. 1997; Dohner et al. 2002). During infection with KSHV the dynein 
motor is also used to transport the viral DNA to the nucleus. Furthermore KSHV has 
also been found to induce Rho GTPases, which lead to stabilisation of microtubules 
thus promoting delivery of viral capsids to the nucleus (Naranatt et al. 2005).  The 
capsid then docks at the nuclear pore where the viral DNA is released into the 
nucleoplasm hence completing the process of uncoating (reviewed by (Mettenleiter 
et al. 2009). 
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1.1.4 Trafficking of viral genomic DNA and replication in the nucleus  
During herpesvirus infection, the processes of transcription, DNA replication, 
assembly of new capsids, and viral DNA packaging take place in the nucleus 
(reviewed by Mettenleiter 2002).  Once inside the nucleus, the parental viral 
genomes become associated with nuclear domain 10; ND10 (also known as PML-
nuclear bodies) and the initial site of transcription is usually adjacent to these 
domains. ND10 is associated mainly with three cellular proteins; PML, Sp100 and 
hDaxx, which form a subnuclear structure that acts as a cellular organising centre. A 
number of roles for ND10 have been suggested one of which is antiviral defence, as 
PML and Sp100 are interferon (IFN)- inducible. Members of the herpesvirus family 
have evolved different mechanisms to overcome the antiviral effect of ND10. The 
first to be discovered was in infection with HSV-1, which triggers proteosomal 
degradation of PML causing rapid destruction of the subnuclear structure.  Similarly, 
MHV-68 induces proteosomal degradation leading to disassembly of the subnuclear 
structure reducing the antiviral activity of ND10 (reviewed by Tavalai and 
Stamminger 2009). It has also been suggested that apart from diminishing the 
antiviral activity of ND10, herpesviruses may localise at sites close to ND10 as it 
may be beneficial to viral replication due to cellular proteins involved in cell growth, 
gene expression, and DNA recombination being within this location (Wilkinson and 
Weller 2003). The viral linear DNA then becomes circularised (episome) and is 
replicated via a rolling circle mechanism producing linear concatemers of tandemly 
repeated viral genomes. The newly replicated viral DNA is then cleaved at 
conservered sequences, that define genomic termini, into monomeric molecules that 
are then packaged into capsids (encapsidation) (Figure 1.3B) (Knipe 2007).  
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Table 1.1 Interaction between human herpesvirus and MHV-68 glycoproteins 
and cellular receptors.  
Herpesvirus Glycoprotein Function Cellular receptors 
 
 
HSV-1 
gB 
gC 
gD 
gH/gL 
Fusion 
Attachment 
Attachment/fusion 
Fusion 
HSPG, CD209, MAG, PILRα 
HSPG 
Nectin 1 & 2,  HVEM, 3-O-S-HS 
Integrins 
 
HSV-2 
 
gB 
gC 
gD 
Fusion 
Attachment 
Attachment/fusion 
HSPG, PILRα 
HSPG 
Nectin 1 
 
VZV 
gB 
gC 
Fusion 
Attachment 
HSPG 
HSPG 
 
CMV 
gB 
gH/gL/gO 
Attachment/fusion 
Fusion 
HSPG, TLR, EGFR, Integrins 
Integrins 
HHV-6 gH/gL/gQ1/gQ2 Attachment/fusion CD46 
HHV-7 gB Attachment/fusion HSPG, CD4 
 
 
EBV 
 
 
BMRF2 
gp42 
gp350/220 
gB 
gH/gL 
Attachment 
Attachment/fusion 
Attachment 
Fusion 
Attachment/fusion 
Integrins 
MHC-II 
CD21 
Unknown                                               
Integrins 
 
KSHV 
gB 
K8.1 
gH/gL 
Attachment/fusion 
Attachment/fusion 
Attachment/fusion 
HSPG, Integrins 
HSPG 
Integrins, HSPG, EphA2 
 
MHV-68 
gH/gL 
gB 
gp150 
Attachment/fusion 
Attachment/fusion 
Attachment/fusion 
HSPG 
HSPG 
HSPG 
*HSPG -heparan sulphate peptidoglycans, HVEM – Herpesvirus entry mediator, 3-OS-HS – 3-O-
sulfated heparan sulphate, TLR – Toll like receptor, EGFR – Epidermal growth factor receptor, MHC-II 
– Major histocompatibility complex II, MAG- myelin associated glycoprotein, EphA2 – ephrin receptor 
tyrosine kinase A2. (Stevenson and Efstathiou 2005; Gillet et al. 2006; Krummenacher et al. 
2007; Gillet et al. 2008; Connolly et al. 2011; Hahn et al. 2012). 
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1.1.5 Virus assembly and egress from the cytoplasm  
The next stage is the export of the virus from the nucleus into the cytoplasm and then 
egress out of the cell. There are three possible pathways to explain how the 
herpesvirus particles move through the cell and become enveloped (Figure 1.3C). 
The first is the single envelopment pathway. After accumulation of tegument 
proteins in the nucleus and an envelope from the inner nuclear membrane, the virion 
travels along secretory pathways leading to interactions with membranes such as the 
Golgi apparatus. In this pathway the virion maintains its original tegument and 
envelope and has its glycoproteins matured by the Golgi apparatus. The virions are 
then released out of the cell via fusion of the vesicle to the cell plasma membrane 
(reviewed by Campadelli-Fiume 2007). The second pathway and the one that has 
gained the most support in recent years is the de-envelopment-re-envelopment 
pathway (reviewed by Campadelli-Fiume 2007; Guo et al. 2010; Johnson and Baines 
2011). In this pathway the first stage is envelopment, which is the same as the first 
pathway, with the virion gaining an envelope from the inner nuclear membrane, 
however in this pathway de-envelopment takes place at the outer nuclear membrane, 
releasing the nucleocapsid into the cytoplasm. These nucleocapsids then gain their 
tegument in the cytoplasm and are re-enveloped by the Golgi apparatus. This gives 
rise to an enveloped virion encased in a cytoplasmic vesicle. The key difference is 
that the virion acquires its tegument in the cytoplasm rather than the nucleus. The 
virions are then released in the same manner as described in pathway  
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Figure 1.3 Herpesvirus entry, genome replication and virion egress from cells.  
A) Herpesvirus particles enter into cells via fusion with the plasma membrane or 
endocytosis, which in turn causes remodeling of the cytoskeleton. Viral capsids are 
then transported to the nucleus along microtubules using dynein motors. B) In the 
nucleus, linear viral DNA is circularized and replicates via a rolling circle 
mechanism followed by packaging into capsids. C) Virion egress from cell which 
may happen using one of three possible pathways: 1. Single-envelopment pathway; 
2. Nuclear pore pathway; or 3. De-envelopment-re-envelopment pathway. 
Information compiled from (Campadelli-Fiume 2007; Knipe 2007; Lyman and 
Enquist 2009; Connolly et al. 2011). 
A 
B 
C 
CYTOPLASM 
CYTOPLASM 
NUCLEUS 
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one (reviewed by Campadelli-Fiume 2007). The third possible pathway involves the 
transport of non-enveloped capsids to the cytoplasm via enlarged nuclear pores, 
which are subsequently modified into a mature form in the Golgi or early endosomes 
(Knipe 2007).  
 
The viral envelope is believed to originate from the trans-Golgi network (reviewed 
by Mettenleiter et al. 2009), although fluorescence immunolabelling has suggested 
that endosomes may also play a role in envelope supply (Turcotte et al. 2005; Das et 
al. 2007). During the processes of nuclear egress and viral envelopment the virion 
must also acquire its tegument, a process which has proved difficult to characterise, 
although interactions between viral capsid, tegument and glycoproteins have been 
described (reviewed by Mettenleiter et al. 2009). One example of this is the 
interaction between the HSV-1 tegument protein VP22 and the envelope 
glycoproteins gM and gE (Stylianou et al. 2009).  
 
The last stage in the lytic replication cycle is the release of virions, which involves 
the transport of vesicles containing enveloped virions to the plasma membrane and 
the subsequent exocytosis by fusion of vesicles to the plasma membrane. The 
proteins involved in herpesvirus egress are yet to be deciphered (reviewed by 
Mettenleiter et al. 2009). However the cellular endosomal sorting complexes 
required for transport (ESCRT) complexes may be involved as they have been found 
to play an important role in the viral budding of several enveloped viruses (reviewed 
by Bieniasz 2006) and in particular HIV-1 (von Schwedler et al. 2003). Work carried 
out on HSV-1 has found a possible link to ESCRT pathways and cytoplasmic 
 13 
 
envelopment, as inhibition of the activity of the Vps4 enzyme required for ESCRT 
function caused a reduction in infectious HSV-1 (Crump et al. 2007).  
 
1.1.6 Herpesvirus lytic and latent infection cycles 
A key feature of herpesvirus infections is that the infection invariably leads to two 
outcomes with respect to the virus life cycle: lytic and latent replication. During a 
herpesvirus infection amplification of the virus is achieved during the lytic stage, 
when virus genome is replicated to high levels and infectious progeny virions are 
released from infected cells. The virus may then enter into a latent (persistent) stage 
during which time a smaller subset of viral genes are expressed, however the virus 
retains the ability to lytically reactivate and produce progeny virions (reviewed by 
Penkert and Kalejta 2011). During in vitro α- and β-herpesvirus infections the 
majority of cells infected contain lytic virus particles, with only a small group of 
cells supporting the latent infection. This differs in γ-herpesvirus infection, as these 
viruses favour latent infection, with only a small subset of cells being lytically 
infected at any given time (reviewed by Ackermann 2006). The cell type in which 
different herpesviruses can become latent is highly specific, with α-herpesviruses 
favouring neurons, the β-herpesviruses different subsets of hematopoietic cells and 
the γ-herpeviruses establishing latency predominantly in B lymphocytes. The ability 
of herpesviruses to enter into a latent cycle during infection allows them to persist for 
the lifetime of host organisms whilst retaining the capability to re-activate (reviewed 
by Penkert and Kalejta 2011). 
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1.2 Gammaherpesviruses 
1.2.1 Kaposi’s sarcoma-associated herpesvirus 
Kaposi’s sarcoma-associated herpesvirus (KSHV), also referred to as HHV8 was 
first described by Chang et al in 1994, after they identified γ-herpesvirus-like DNA 
sequences in tissues from Kaposi’s sarcoma neoplasms (Chang et al. 1994). However 
the classic or endemic Kaposi’s disease was first described back in 1872 by Moritz 
Kaposi (Hungarian dermatologist b. 1837) (Sternbach and Varon 1995). Endemic KS 
is found mostly in elderly Mediterranean or African men and generally affects the 
skin. In later years two more forms of KS were discovered: one was a variant of the 
endemic disease identified in young children; the second form was AIDs-related KS, 
seen in immunodeficient HIV sufferers. KS differs from classic forms of cancer, as 
lesions comprise of multifocal elongated (spindle) endothelial cells. The different 
forms of KS share similar histology; however the AIDS-related form is the most 
aggressive and can also cause lesions in the lungs and gastrointestinal tract, which 
can then lead to further complications (reviewed by Ganem 2006). A year after the 
link between KS and KSHV had been established, KSHV was also linked to two 
more lymphoproliferative diseases: primary effusion lymphoma (PEL); and 
multicentric Castleman’s disease (MCD) (reviewed by Viejo-Borbolla and Schulz 
2003).  
 
1.2.2 Epstein Barr virus 
Epstein Barr virus (EBV), also referred to as  HHV4,  was the first human tumor 
virus to be discovered and since then has been implicated in a number of B-cell 
lymphoproliferative disorders, such as Burkitt’s lymphoma, Hodgkin’s lymphoma, 
nasopharyngeal carcinoma, and lymphomas in immunocompromised individuals 
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(reviewed by Carbone et al. 2008). Infection of immunocompetent hosts with EBV 
via an oral transmission route is generally asymptomatic, however if infection occurs 
during adolescence it can cause infectious mononucleosis (IM). It is thought that IM 
infection involves mucosal B cells, but there is evidence that it is also associated with 
the oropharyngeal epithelium (reviewed by Thorley-Lawson 2001; Young and 
Rickinson 2004). 
 
1.2.3 Murine gammaherpesvirus-68 
Due to the high species-specificity of the human gammaherpesviruses (Knipe 2007), 
murine gammaherpesvirus -68 (γ-herpesvirus-68, MHV-68, also referred to as 
γHV68, MuHV4, and MHV4) is often used as an amenable mouse model to study γ-
herpesvirus pathobiology.  MHV68 was originally isolated from bank voles (Myodes 
glareolus) and yellow-necked field mice (Apodemus flavicollis) captured in Slovakia 
(Blaskovic et al. 1980; Nash et al. 2001) and have been found to be endemic in wood 
mice (Apodemus sylvaticus) in some parts of the UK (Blasdell et al. 2003). 
Sequencing of the MHV-68 genome has revealed that it encodes for approximately 
80 gene products, at least 63 of which are homologous to KSHV genes. Comparison 
of the MHV-68 genome with other γ-herpesviruses has indicated that it is arranged 
into large co-linear gene blocks interspersed with virus–specific Open Reading 
Frames (ORFs) (Virgin et al. 1997). It is believed that virus-specific ORFs provide 
an advantage for virus infection in each respective host. For example MHV-68 
encodes for the unique gene M2, which through M2-null virus infections in mice, has 
been found to play an important role in establishment and reactivation from latency 
(Jacoby et al. 2002; Herskowitz et al. 2005). With extensive genome homology to 
KSHV and EBV (Virgin et al. 1997), along with the relative ease of constructing 
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MHV-68 gene deletion mutants (Adler et al. 2000; Adler et al. 2003; Song et al. 
2005) MHV68 has proved an important experimental model to study aspects of γ-
herpesvirus pathobiology, not readily feasible in their respective hosts, for example, 
de novo infections and use of host knockouts.  
 
The route of MHV-68 infection is not clear, although in vivo imaging of mice 
infected either orally, intranasally or intraperitoneally has suggested that the most 
likely route of infection is the intranasal route (Milho et al. 2009). Interestingly, in 
contrast to EBV which is transmitted via saliva (reviewed by Thorley-Lawson 2001) 
oral MHV-68 was very poorly infectious and so it may be that in mice MHV-68 
favours a nasal entry route as sense of smell is an important part of a murine social 
life (Milho et al. 2009). After intranasal infection of mice, replication of MHV-68 
occurs mainly in the lung epithelium, where the primary pathology observed is 
pneumonia with a proportion of mice developing clinical disease. This acute 
infection is then followed by life-long latent virus persistence in lymphoid tissues. 
Intranasal MHV-68 infection also leads to a disease state similar to infectious 
mononucleosis seen in human γ-herpesvirus infections.  Moreover, similar to human 
infections, MHV-68 causes lymphoma formation during persistent infection in vivo 
(Figure 1.4) (Sunil-Chandra et al. 1992). The biological similarities, such as tropism 
of MHV-68 for predominantly splenic B lymphocytes (other cells may also become 
infected e.g. cells of the monocyte/macrophage lineage) and lymphoproliferative 
disease, together with a mouse being an easily manipulated small animal make, 
MHV-68 a powerful experimental system for the study of human γ-herpesviruses 
(reviewed by Blackman and Flano 2002).   
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Figure 1.4 Infection path of MHV-68 in mice via the respiratory route. After 
primary lytic infection in the lungs, the virus traffics to the lymphoid tissues 
including the spleen where MHV-68 then establishes latency mainly in B cells. The 
productive infection lasts for around 10 days in the lung tissues before it is cleared by 
the immune system. Just before the productive infection is resolved in the lungs, 
MHV-68 moves to the spleen where it enters its latent phase in B lymphocytes. 
Infective center assays are used to detect latent infection, the results of which have 
shown that MHV-68 reaches a peak in spleens two to three days post-infection 
before declining and reaching a stable level. Latency can then be maintained 
indefinitely in the mouse (Information from Sunil-Chandra et al. 1992; Stewart et al. 
1998a; Stewart et al. 1998b; Nash et al. 2001).   
 
 
 
Splenic phase 
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1.2.4 Gammaherpesvirus lytic and latent infection cycles 
The site of latency for EBV is in memory B cells. Three viral lytic proteins have 
been found to be important in establishment of EBV latency: BALF1; BHRF1 and 
BZLF1. Once latency has been established, EBV expresses nine latency-associated 
proteins, six nuclear proteins (EBNA 1, 2, 3A, 3B, 3C and LP) and three latency-
associated membrane proteins (LMP 1, 2A and 2B). There are also three different 
states of latency in EBV infection based on the subset of viral proteins being 
synthesised.  In all three latency states, EBNA-1 plays a key role in viral genome 
maintenance, DNA replication and cell division, while the other viral proteins 
contribute to the transformation and immortalisation of infected B cells. In addition 
to these viral proteins, non-coding viral RNAs are also detected in infected cells 
during latency, known as EBERs (EBV-encoded RNAs) and BARTs (BAMH1-A 
rightward transcripts). EBERs and BARTs are involved in PKR-associated apoptosis 
and LMP modulation, respectively. One of the key EBV proteins is the Z protein; 
bZip transactivator (Zta) encoded by BZLF1.  Zta, plays a part in establishment of 
latency and in reactivation of the virus (reviewed by Ackermann 2006; Penkert and 
Kalejta 2011).   
 
Similar to EBV infection, latency in KSHV appears to be the default pathway 
established in the B cell compartment. In immunocompromised individuals, KSHV 
DNA is found in a variety of cell types e.g. T cells, monocytes, and endothelial cells, 
although viral genomes are most frequently harboured by peripheral B lymphocytes 
(Longnecker and Neipel 2007).  In vitro, KSHV can infect a variety of adherent cells 
and readily establishes latency.  However, unlike EBV, KSHV does not trigger B cell 
transformation in vitro (reviewed by Speck and Ganem 2010). During latency only a 
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few viral genes are expressed. A major latency locus encodes for latency associated 
nuclear antigen (LANA), v-cyclin, v-FLIP and kaposins A, B and C (reviewed by 
Speck and Ganem 2010).  However, differences in latency-associated gene 
expression patterns have been observed in other diseases caused by KSHV; as a 
second locus vIRF3 (LANA-2) is expressed in PEL and MCD, but not in KS (Rivas 
et al. 2001). Recently a third latency-associated locus has been identified: K1, which 
mimics B-cell receptor signalling similar to the effect of LMP2 during EBV latency 
(Lee et al. 2005; Chandriani and Ganem 2010). The viral protein, vFLIP is a potent 
activator of cellular NF-κB, which leads to stabilisation of latency (reviewed by 
Speck and Ganem 2010).  Interestingly, NF-κB activation is also prominent in EBV 
latency in which LMP1 has been shown to be a strong constitutive activator of NF-
κB (Adler et al. 2002).  As well as encoding the Kaposin proteins the Kaposin locus 
also encodes for a series of viral microRNAs (miRNAs), which may play an 
important role in latency (reviewed by Speck and Ganem 2010). For example the 
miRNA miRK9* appears to regulate the stability of latency by preventing the 
triggering of inappropriate lytic reactivation (Bellare and Ganem 2009). LANA has 
been found to have a number of activities one of which is regulation of transcription, 
which may lead to negative regulation of lytic gene transcription. The other gene 
encoded by the major latency locus is v-cyclin, which appears to induce replicative 
stress, although much is still to be learnt about this gene (reviewed by Speck and 
Ganem 2010). 
 
Induction of the lytic cycle is linked to one viral gene that encodes a key 
transcription factor, known as the Replication and Transcription Activator (RTA). 
Although RTA is the key lytic switch other viral proteins, such as K-bZIP help to 
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regulate the switch from latent into lytic cycle. Induction of the lytic cycle leads to 
the temporal expression of virtually the entire viral genome, DNA replication and 
production of progeny virions (reviewed by Viejo-Borbolla and Schulz 2003; Ganem 
2006). 
 
In contrast to KSHV and EBV, the default pathway for MHV-68 infection in vitro is 
lytic replication. This has meant that it has been harder to study the genes involved in 
MHV-68 latency, however a number of genes have been linked to latency in 
particular LANA and v-cyclin. The murine homologue of LANA (mLANA) appears 
to share a great deal of biochemical functionality with the KSHV LANA gene. 
However, in contrast, work on the v-cyclin gene has highlighted some biochemical 
differences between KSHV and MHV-68, as they appear to bind different factors 
(reviewed by Speck and Ganem 2010). One key similarity between the two human γ-
herpesviruses and MHV-68 is the importance of NF-κB in stabilising latency (Krug 
et al. 2007). MHV-68 also encodes for a number of unique genes not conserved in 
the other γ-herpesviruses that can have effects on latency and reactivation (e.g. M1 
and M2) (reviewed in Speck and Ganem 2010). Similarly to KSHV and EBV, MHV-
68 reactivation is controlled by RTA (encoded for by ORF50), which can disrupt 
latency and activate lytic replication (Wu et al. 2000). 
 
1.3. Innate immune responses to viruses 
The innate immune responses are the first line of defence against viral infections, 
which lead to the cell entering an antiviral state.  The first stage is the recognition of 
virus-associated molecules, such as genomic DNA, RNA or outer structural proteins, 
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which are recognised by host pattern recognition receptors (PRRs). Viral recognition 
by PRRs leads to the induction of a variety of cellular proteins, in particular
type I interferons (IFNs). The most common types of PRRs are Toll-like receptors 
(TLRs), which recognise pathogen-associated molecular patterns (PAMPs) such as 
viral or bacterial components. So far 13 human TLRs have been identified, six of 
which have been linked to viral recognitions; TLR2 and TLR4 recognise viral 
structural proteins or glycoproteins, TLR3 recognises dsRNA, TLR7 and TLR8 
recognise ssRNA and TLR9 senses cytidine-phosphate-guanosine (CpG) DNA 
motifs during viral replication (reviewed by Kawai and Akira 2006).  
 
TLRs are composed of a leucine-rich extracellular domain involved in PAMP 
recognition, a transmembrane domain and a cytoplasmic tail which contains a Toll-
interleukin-1 receptor (TIR) homology domain, required for signalling (reviewed by 
Kawai and Akira 2006; Boo and Yang 2010). Upon recognition of PAMPs, TLRs 
recruit a set of TIR containing adaptors including MyD88, TIRAP, TRIF and TRAM. 
Most TLR signalling pathways are MyD88-dependant, with the exception of TLR3. 
MyD88 forms a complex with members of the IL-1 receptor-kinase (IRAK) family 
and TRAF6. In contrast TLR3 signals via its interaction with TRIF. The signalling 
pathways that the TLRs induce lead to the activation of a number of cellular 
transcription factors, including interferon regulatory factor 3 (IRF3), IRF7, NF-κB 
and ATF2-c-jun. In turn,  these lead to the induction of type I IFNs and whilst IRF3 
and IRF7 play a key role in this induction, NF-κB and ATF2-c-jun regulate genes 
involved in inflammation and interact with IRF3 and IRF7 to enhance type I IFN 
induction (reviewed by Kawai and Akira 2006). In more recent years work has been 
carried out to identify other DNA sensors apart from TLR9 that can trigger innate 
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immune responses. As a result, a number of DNA sensors have been identified some 
of which have been linked to recognition of DNA viruses (reviewed by Sharma and 
Fitzgerald 2011). In particular the DExD/H box helicases (DHX36 and DHX9) bind 
to CpG-DNA in plasmacytoid dendritic cells (pDCs), which in turn binds to the Toll-
interleukin receptor domain on MyD88, leading to activation of IRF7 and NF-κB 
(Kim et al. 2010). Another receptor which acts as an important part of the immune 
response to DNA viruses is IFI16, which upon binding DNA activates IFN-β 
production (Unterholzner et al. 2010). 
 
1.3.1 Interferon response to viral infections 
The IFN family encompasses three groups, namely Type I, II and III. Type I IFNs 
encompass a large group of molecules, classified into IFNs-α, -β, -δ, -κ, -ε, -τ, -ω, 
however only IFN-α and -β are involved in control of viral infection. Type II IFNs 
produce IFN-γ in response to recognition of viral infection by T-lymphocytes and 
natural killer (NK) cells. Type III IFNs produce a number of cytokines in direct 
response to viral infection following similar pathways to type I IFNs and elicit 
similar responses, however type III receptor exhibits limited tissue distribution and 
so appears not to play an essential role in host survival (reviewed by Goodbourn et 
al. 2000; Randall and Goodbourn 2008). Once the type I IFNs (α/β) have been 
induced they both bind to a common receptor, IFNAR, composed of two subunits 
IFNAR1 and IFNAR2.  The cytoplasmic domains of IFNAR1 and IFNAR2 are 
associated with the Janus tyrosine kinases; Tyk2 and Jak1, respectively; IFNAR2 is 
also associated with the Signal Transducer and Activator of transcription (STAT) 
molecule (STAT2). Binding of the type I IFNs with the IFNAR leads to a cascade of 
phophorylation events that result in a STAT1/STAT2 heterodimer translocating to 
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the nucleus where it associates with a monomer of IRF9 to form the Interferon-
stimulated gene factor 3 ISGF3 heterotrimer. ISGF3 then binds to an IFN-stimulated 
response element (ISRE), which is present in the promoters of most IFN-responsive 
genes, which in turn leads to up-regulation of genes involved in creating the antiviral 
state. Activation of the type I IFN pathway upregulates a number of genes involved 
in the antiviral state, several of which have been extensively studied (Table 1.2). The 
antiviral state induce by type I IFNs is effective against a number of viral infections, 
however, viruses have evolved mechanisms to circumvent the IFN system (reviewed 
by Brierley and Fish 2002; Randall and Goodbourn 2008; Boo and Yang 2010).  
 
1.3.2 Innate immune avoidance by herpesviruses 
In order to successfully infect their host, viruses must first overcome the host innate 
immune responses and different viruses have evolved different mechanisms to do so 
(reviewed by Randall and Goodbourn 2008). In herpesvirus infections, the most 
effective evasion strategy is the ability of these viruses to enter a latent state where 
only a minimal number of viral genes are expressed. This in turn reduces the number 
of antigens presented to the host immune surveillance system for example cytotoxic 
T cells. However during lytic infection or re-activation, the majority of viral genes 
are expressed and the virus becomes vulnerable to innate immune responses and it is 
during this time that the virus will employ active evasion strategies (reviewed by 
Rezaee et al. 2006).  
 
Herpesviruses use different mechanisms to interrupt the antiviral state (reviewed by 
Randall and Goodbourn 2008). In particular HSV-1 can disrupt protein kinase R 
(PKR) activity through two mechanisms; through the direct binding of HSV-1 Us11 
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to PKR, which blocks the phosphorylation of the α subunit of the eukaryotic 
translational initiation factor 2 (eIF2α) (Cassady et al. 1998); and via the indirect 
binding of HSV-1 ICP34.5 with the cellular protein phosphatase 1α, which in turn 
dephosphorylates eIF2α (He et al. 1997). PKR targets eIF2α, as eIF2-GTP forms a 
complex with initiator tRNA
met
, which scans mRNA for AUG codons, hence 
phosphorylation of eIF2α prevents eIF2-GDP being recycled to eIF2-GTP by the 
GDP-GTP exchange factor eIF2B. The consequence of this is a decrease in 
tRNA
met
/eIF2-GTP, which in turn decreases translation initiation of viral and cellular 
mRNA (reviewed by Thompson and Sarnow 2000). Other HSV-1 proteins have dual 
mechanisms for innate immune avoidance, such as ICP0, which can induce 
degradation of PML and Sp100 via its E3 ligase activity (reviewed by Randall and 
Goodbourn 2008). Secondly, ICP0 recruits IRF3 and its transcriptional co-activators; 
CBP and p300 to nuclear foci, which lead to inactivation and accelerated degradation 
of IRF3, a key component of type I IFN system (Melroe et al. 2007). 
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Table 1.2 Type I IFN induced genes and their role in activating the antiviral 
state of an infected cell.  
Gene Mode of action 
Protein kinase R (PKR) PKR is an enzyme that upon activation phosphorylates 
eukaryotic initiation factor 2α (eIF2α). This prevents recycling of 
translation initiation factors, which in turn blocks protein 
synthesis and can lead to autophagy. PKR has also been linked to 
apoptosis. 
2’-5’ Oligoadenylate 
synthetase (OAS) 
Activation of OAS causes polymerisation of ATP into 2’-5’ 
oligoadenylates, which bind and activate RNase L. RNase L 
degrades cellular and viral RNA inhibiting protein synthesis. 
OAS/RNase L has also been associated with apoptosis. 
Mx proteins Mx proteins belong to a family of GTPases, related to dynamin. 
They recognise nucleocapsid structures and stop them from 
entering the nucleus. This control viral replication by inhibiting 
nuclear export and hence blocks further assembly. 
Interferon-stimulated 
genes (ISGs) 
A number of genes become upregulated in response to interferon 
and these have been named ISGs along with their molecular 
mass e.g. ISG54 is a 54kDa protein. Much is still to be learnt 
about this family, although ISG15 has been reported to inhibit 
degradation of IRF3 by viral components. 
p200 family The p200 proteins affect cell cycle progression, the best 
characterised is p202. This protein binds to members of the E2F 
transcription family stopping DNA binding leading to loss of 
transcription of genes important for cell cycle progression. 
Promyelocytic 
leukaemia (PML) 
nuclear bodies 
Contain IFN-inducible proteins such as PML and Sp100, which 
appear to play a role in restricting viral replication by regulating 
chromatin structure and promoter accessibility. 
Viperin (cig5) Disrupts lipid rafts on plasma membranes, which are important 
in budding of some viruses. It achieves this through binding and 
inhibiting an enzyme involved in lipid biosynthesis. 
Information compiled from (Brierley and Fish 2002; Randall and Goodbourn 2008; 
Boo and Yang 2010). 
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1.3.3 Immune evasion strategies employed by γ-herpesviruses 
The γ-herpesviruses have evolved a number of mechanisms to evade both the innate 
and adaptive host immune responses. The main adaptive immune evasion strategy 
seen in KSHV, EBV and MHV-68 is the avoidance of the T cell response. MHV-68 
achieves this through the down-regulation of MHC class I molecules via the viral K3 
gene, a mechanism that is also seen with KSHV homologues K3 and K5 (Stevenson 
et al. 2000). In contrast EBV produces an IL10 homologue (vIL10), which down-
regulates MHC class II molecules suppressing the Th1 immune response (reviewed 
by Goodbourn et al. 2000).  
 
1.3.3.1 Innate immune evasion strategies employed by γ-herpesviruses 
Type I IFNs are the first antiviral defence mechanisms against most viruses including 
herpesviruses.  As a result, herpesviruses have evolved a number of immune evasion 
strategies against type I IFN effector mechanisms (Table 1.3).  As table 1.3 
highlights, the complexity of the host innate immune response is equalled by a range 
of immune evasion strategies employed by γ-herpesviruses.  
 
One interesting group of immunomodulatory proteins expressed in KSHV are the 
four vIRFs (vIRF1-4), which share some homology with the cellular IRFs (reviewed 
by Areste and Blackbourn 2009). Of the four proteins only vIRF1-3 have been 
functionally characterised with little known about vIRF4, however vIRF1-3 have 
been implicated in immune evasion strategies (reviewed by Lee et al. 2009). vIRF1 
was the first member of the viral IRF family to be described (Moore et al. 1996) and 
has since been found to negatively regulate IFN signalling (reviewed by Rezaee et al. 
2006). vIRF1 achieves this through an association with the cellular p300 protein, 
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which in turn prevents IRF3-mediated activation of IFN-α (reviewed by Lee et al. 
2009). Similar to vIRF1, vIRF2 has been found to inhibit expression of the IFN-
inducible genes; IRF3 and IRF1, but not IRF7, however vIRF2 probably does it 
through a different mechanism than the one employed by vIRF1 (Fuld et al. 2006). 
In contrast to vIRF1 and vIRF2 that mostly target IRF3-mediated signalling, vIRF3 
interacts with IRF7, which leads to inhibition of IRF7’s DNA-binding activity, which 
in turn inhibits IFN-α production (reviewed by Lee et al. 2009). Taken together the 
vIRF proteins play an important role in down-regulation of the IFN pathway. 
 
In MHV-68, ORF36, a protein kinase, was found to also play a role in IFN immune 
evasion during screening of mutant viruses. MHV-68 ORF36 was shown to bind to 
activated IRF3, blocking IRF3’s interaction with co-transcriptional activators, which 
in turn inhibited the recruitment of RNA polymerase II to the IFN-β promoter. This 
anti-IFN function was found to be conserved in the ORF36 homologues in EBV 
(BGLF4) and in KSHV (ORF36). The results from the in vivo study using mutant 
ORF36 virus found that a much greater IFN response was seen during infection with 
the mutant virus, which lead to a compromised infection in the lungs and spleens of 
mice (Hwang et al. 2009). The highly complex nature of the host immune response 
and the γ-herpesvirus evasion strategies means that there is still much to learn in this 
area, however the use of MHV-68 as a model may help to gain insights into key 
evasion strategies in vivo.  
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Table 1.3 Immunomodulatory proteins involved in evasion of type I IFN 
immune response to human γ-herpesviruses and MHV-68. 
Herpesvirus Immunomodulatory 
protein 
Function 
EBV BARF1 BARF1 is a soluble receptor for colony stimulating 
factor 1 (CSF1), which can block function of CSF1, 
which in turn interferes with secretion of antiviral 
factors like IFN-α. 
 EBNA-2 Blocks IFN signal transduction although the 
mechanism is unknown. 
 EBER-1 and 2                                                                      EBER RNA binds to dsRNA binding site on 
PKR acts as an inhibitor and so fails to activate 
PKR. 
 BS-MLF1 Acts as a dsRNA-binding protein to sequester any 
dsRNA produced as a viral by-product and reducing 
PAMPs. 
 BGLF4 Inhibits activation of IFN-β in a dose-dependent 
manner. 
KSHV Viral IRFs Four protein (vIRFs 1-4) function as cellular IRF 
homologues interfering with their functions, 
especially IRF3 and 7. 
 ORF45 Is an IE protein that binds to inhibitory domain of 
IRF7, blocking its function. 
 RTA Binds to IRF7 inducing proteosomal degradation and 
also mediates the degradation of TRIF via the 
ubiquitin-proteosome pathway. 
 ORF36 Inhibits activation of IFN-β in a dose-dependent 
manner. 
 K-bZIP Targets IRF3 binds to IFN-β promoter, resulting in 
defective transcription of IFN-β. 
 RIF Targets multiple components of IFN signalling 
pathway, which inhibits generation and accumulation 
of ISGF3 impeding transcription of ISGs. 
 vIL6 vIL6 inhibits binding of the ISRE promoter to 
ISGF3, suppressing the IFN response. 
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MHV-68 ORF36 Binds to IRF3 inhibiting its interaction with CBP, 
which suppresses the recruitment of Pol II to the 
IFN-β promoter. 
 ORF45 Represses activation of IRF7 and IFN-αβ ISG 
transcription. 
 ORF54 Degrades IFNAR1 protein, which interferes with 
type I IFN response. 
Information compiled from (Goodbourn et al. 2000; Snow and Martinez 2007; 
Randall and Goodbourn 2008; Barton et al. 2011; Leang et al. 2011; Sathish and 
Yuan 2011) 
 
Another immune evasion strategy that can be employed by viruses is the interference 
of viral proteins with cellular gene transcription, mRNA processing, export or protein 
synthesis within the cell. This process, known as host shutoff, can be linked to a 
number of cellular processes although it is believed that one of the main reasons for 
the virus to cause global inhibition of cellular gene expression is to avert the IFN 
response (reviewed by Randall and Goodbourn 2008). 
 
1.4 Eukaryotic RNA synthesis 
In eukaryotic cells, mRNA biosynthesis is a multistage process that begins with 
transcription in the nucleus, the product of which is then transported to the cytoplasm 
for translation to take place. Transcription is a process by which DNA is copied into 
RNA with the potential to be translated into protein (Lewin 2004). Biochemical and 
genetic analysis of various model organisms has identified eukaryotic gene 
transcription as an intricate biochemical process that is tightly regulated at many 
levels with a number of protein factors responsible for its control (Lemon 2000) 
(Figures 1.5 &1.6).  
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The complexity of the gene expression process means that it must be tightly 
regulated. The first problem that the transcription machinery encounters is that the 
DNA template is embedded in the chromatin structure. The chromatin structure 
consists of histone and non-histone proteins that compact the large genome allowing 
it to fit into confines of the nucleus. However, a number of chromatin-remodelling 
complexes, such as ATP-dependant remodelers and histone modifying enzymes are 
recruited which in turn facilitate gene expression (reviewed by Svejstrup 2004; 
Shandilya and Roberts 2012). Transcription of genes is performed by three main 
enzymes associated with different sets of genes: RNA polymerase I (Pol I) which 
transcribes ribosomal RNA (rRNA); RNA Pol II which transcribes protein-coding 
genes from messenger RNA (mRNA) and RNA Pol III which transcribes transfer 
RNA (tRNA) genes (reviewed by Engelhardt 2006). The transcription of mRNA 
requires Pol II to bind to promoters of genes, via transcription factors forming a 
transcription complex (reviewed by Deng 2007). Eukaryotic promoters generally 
contain either a sequence called the TATA box around 25-35 bp upstream from the 
start site of transcription or an initiator element located around the transcription start 
site. Lack of such elements within a sequence will result in reduced transcription 
efficiency (Turner 2000). Transcription may also be increased by the presence of an 
enhancer element, a sequence linked to a promoter independent of orientation and 
position (reviewed by Szutorisz 2005). The TATA sequence is recognised by the 
TATA-binding protein (TBP), which binds to the DNA along with its associated 
factors, for example, TFIID. Binding of the TBP to the promoter distorts the TATA 
sequence recruiting other general transcription factors (e.g. TFIIA), these factors 
along with RNA Pol II form a complex that is competent for transcription. Once the 
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RNA Pol II has cleared the promoter sequence it begins the process of transcription 
of pre-mRNA (reviewed by Svejstrup 2004; Shandilya and Roberts 2012). 
 
Once RNA Pol II has started making the transcript, before the chain is 20-30 nt long, 
the 5’ end is capped by the enzyme mRNA guanyltransferase, which adds a 7 -
methylguanosine residue (m
7
G). The addition of the cap stabilises the transcript by 
forming a barrier to 5’-exonucleases and also plays a role in splicing, nuclear 
transport and translation. As well as a cap a poly(A) tail is added at the 3’ end of the 
pre-mRNA. The addition of the poly(A) tail is dependent on sequences in the DNA, 
which make up the polyadenylation site. A number of protein factors recognise the 
sequence elements and form a complex on the pre-mRNA, one of these factor, 
poly(A) polymerase (PAP) adds A residues to the 3’ end of the pre-mRNA forming 
the tail. Similarly to the cap, the poly(A) tail is thought to stabilise the mRNA as it 
binds poly(A)-binding protein, preventing 3’ exonucleases from removing the tail 
(Turner 2000). Once the pre-mRNA has been transcribed it undergoes a process 
known as splicing (directed by uracil rich small nuclear RNAs or snRNAs) to 
remove non-coding regions (introns) to produce continuous protein-coding regions 
comprising of exons (Turner 2000) (Figure 1.5).  The reliance of eukaryotic mRNA 
processing on splicing may seem a disadvantage. However, splicing leads to 
proteomic complexity, as sequences can be interpreted as intronic or exonic 
depending on cell type or environmental conditions and it allows the generation of 
multiple mRNAs from a single transcript (reviewed by Mendes Soares and Valcarcel 
2006).  
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During mRNA synthesis, proteins associate with the RNA molecules, forming 
complexes known as messenger ribonucleoproteins (mRNPs). The composition of 
these mRNPs is dynamic, allowing different proteins that are required for different 
steps of gene expression to bind to the mRNA facilitating its progression through to 
translation. One of the key functions of these proteins is to facilitate the transport of 
the mRNA through nuclear pore complexes (NPCs) into the cytoplasm (reviewed by 
Folkmann et al. 2011). Initially movement of the mRNPs occurs via diffusion 
through areas of the nucleus not occupied by chromatin to the nuclear surface 
(Zachar et al. 1993). Export of tRNA, rRNA, miRNA and small nuclear RNA 
(snRNA) rely on a family of nuclear transport receptors known as importin-β or 
karyopherins and are regulated by Ran GTPase. These receptors recognise nuclear 
localisation and nuclear export signals on RNA, which signal the export and 
transport of the RNA either into the nucleus or out of the nucleus into the cytoplasm. 
In contrast, mRNA export uses a transport receptor that is not related to the 
karyopherins and does not require Ran GTPase (reviewed by Kohler and Hurt 2007).  
 
A number of proteins are linked to export of mRNA; one of the main protein 
complexes is THO, which is involved in transcription elongation and also associates 
with REF and UAP56 proteins, which together form the transcription-export 
complex (TREX). The REF export adaptor then recruits the TAP-p15 mRNA export 
factor. The TAP-p15 complexes have the ability to associate with nuclear mRNA, 
shuttle and interact with NPC components (reviewed by Erkmann and Kutay 2004). 
Work carried out in yeast has suggested that the carrier complex Mex67:Mtr2 (TAP-
p15 in metazoans) interacts with FG-nucleoporins that line the NPC, which in turn 
moves the mRNP through the NPC via Brownian motion (Stewart 2007). The mRNP 
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is remodelled by the DEAD box protein Dbp5 (DDX19 in vertebrates), which is 
activated by Gle1 and IP6 at the cytoplasmic face of the NPC. This process releases 
transport factors and nuclear mRNA binding proteins allowing them to be recycled 
and it also stops the mRNP from re-entering the nucleus (reviewed by Folkmann et 
al. 2011). The complexity of mRNA export means that surveillance can take place 
which ensures that only export-competent mRNPs are transported. In contrast to 
tRNA, which is transported to the cytoplasm via the exportin-t pathway, which does 
not discriminate between intron-containing and spliced tRNAs (Arts et al. 1998). 
Studies in yeast examining mRNA export have identified myosin-like Mlp1 and 
Mlp2 proteins as key components of the surveillance process at the NPCs. The Mlps 
have been found to interact with mRNPs and retain improperly assembled mRNPs in 
the nucleus (reviewed by Cole and Scarcelli 2006) 
 
Once the mRNA has entered the cytoplasm translation can occur.  This process 
involves the sequence being read in triplets to give a series of amino acids that make 
the corresponding protein (Lewin 2004) (Figure 1.6). Translation can be broken 
down into three stages; initiation, elongation and termination. The first stage of 
initiation refers to the assembly of a ribosome at the AUG start codon on the mRNA. 
The next stage of elongation is the codon-dependent assembly of the polypeptide. 
The final stage is termination and this is the release of the protein when the ribosome 
has reached the termination codon. All three stages rely on a number of proteins 
referred to as eukaryotic  
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Figure 1.5 Eukaryotic transcription of mRNA from a DNA template. Chromatin 
remodeling enzymes open up the chromatin structure allowing transcription to take 
place. The first step of transcription is the recognition of the TATA sequence by the 
TBP, which in turn recruits transcription factors along with RNA Pol II. Pol II starts 
making the pre-mRNA transcript and a 5’ cap is added. Once the mRNA has been 
transcribed a poly(A) tail is added to the 3’ end. A number of snRNPs then bind to 
the pre-mRNA forming a spliceosome, which remove intron sequences. The introns 
are removed in a lariat configuration leaving just the coding exons forming the 
mRNA (Information from Svejstrup 2004; Mendes Soares and Valcarcel 2006; 
Shandilya and Roberts 2012). 
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Figure 1.6 Translation of eukaryotic mRNA into a protein. A number of 
eukaryotic initiation factors (eIFs) along with methionyl-transfer RNA (Met-tRNA) 
bind to the 40S ribosomal subunit forming a 43S pre-initiation complex. A cap-
binding complex, which consists of eIF4G, 4E and 4A bind to the 5’ cap structure, 
eIF4G also binds to poly(A) binding protein (PABP), which bridges the 5’ and 3’ 
ends of the mRNA. It is thought that the circularisation of mRNA promote the 
binding of the 43S complex to the mRNA, which then scans the mRNA for the AUG 
start codon. The eIFs then dissociate and the 60S ribosomal subunit is recruited 
forming an 80S ribosome, which activates translation elongation. The ribosome 
moves along the mRNA with each coded tRNA binding to the mRNA forming a 
protein sequence attached by peptide bonds. This process continues until a stop 
codon is reached leaving the newly synthesized protein (Information from Klann and 
Dever 2004). 
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initiation factors (eIF), elongation factors (eEF) and release factors (eRF) (reviewed 
by (Klann and Dever 2004). 
 
1.4.1 mRNA turnover in eukaryotic cells 
An important part of gene expression is mRNA turnover, as it sets the basal level of 
gene expression, is a site of regulatory response, and plays an important role in 
antiviral defenses (reviewed by Coller and Parker 2004; Lewin 2004). Once the 
mRNA has been transcribed it is transported to the cytoplasm for translation to occur 
and it is here that the mRNA is subject to regulatory processes that may lead to 
repression of translation or mRNA degradation. The factors required for mRNA 
surveillance and degradation co-localise in cytoplasmic processing bodies known as 
P bodies. It is in the P bodies that most of the mRNA decay takes place (reviewed by 
Newbury 2006; Eulalio et al. 2007). A significant body of the work on mRNA 
degradation pathways has been carried out in model organisms such as yeast and 
fungi. There are two general mechanisms for degradation of mRNA: (i) 
deadenylation dependant pathways (either 5’-3’ or 3’-5’); and (ii) endonucleolytic 
digestion (reviewed by Coller 2004) (Figure 1.7).  
 
Degradation of the bulk of mRNA takes place under the control of deadenylation-
dependant pathways, which begin with the shortening of poly(A) tails at the 3’ end of 
the mRNA via deadenylases (reviewed by Eulalio et al. 2007). Deadenylases are 
Mg
2+
-dependant exoribonucleases that hydrolyse RNA in a 3’-5’ direction, resulting 
in the release of 5’-AMP. Poly(A) tails are the main substrate for deadenylases and 
once the tail is removed other degradative enzymes initiate degradation of the mRNA 
(reviewed by Goldstrohm and Wickens 2008). Following deadenylation the complete 
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degradation of mRNA by the 5’-3’ RNA decay pathway requires the removal of the 
cap structure by decapping enzymes. A decapping complex known as Dcp1-Dcp2 
has been identified in yeast to catalyse mRNA cap hydrolysis, which releases 
m
7
GDP and monophosphated mRNA (Gu and Lima 2005). This Dcp1-Dcp2 
decapping complex is thought to play a similar role in decay mechanisms in all 
eukaryotes (reviewed by Coller and Parker 2004). However, there are some 
differences. In yeast Dcp1 has been found to associate directly with Dcp2, whereas in 
mammalian cells it is thought Dcp1 forms a larger complex including EDC3 and Ge-
1 (reviewed by Eulalio et al. 2007). Removal of the cap structure opens up the 
mRNA to degradation by Xrn1, a 5’-3’ exoribonuclease, which preferentially 
degrades substrates containing a 5’ monophosphated end (reviewed by Coller and 
Parker 2004; Eulalio et al. 2007). 
 
 The 3’-5’ mRNA decay pathway is reliant on an exoribonuclease complex known as 
the exosome. The exosome is a large protein complex consisting of multiple 3’-5’ 
exonucleases, which form a ring structure that can encircle RNA. This structure 
gives the exosome flexibility, as different exonucleases may be specific for different 
RNA sequences. The ability of the exosome to degrade RNA is reliant on a helicase 
complex Ski2p-Ski3p-Ski8p, which unwinds the RNA structure helping RNA entry 
into the exosome for digestion (reviewed by Newbury 2006). Following the 
exosome-mediated 3’-5’ mRNA decay the scavenger decapping enzyme, DcpS 
catalyses residual cap hydrolysis (Gu and Lima 2005).  
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Figure 1.7 Eukaryotic mRNA decay pathways. The two main mRNA decay 
pathways first require that the 3’ poly(A) tail is removed via deadenylases. Once this 
has occurred the mRNA is either decapped by DCP1 and 2 enzymes before 5’-3’ 
degradation takes place via Xrn1 or the mRNA is degraded by the exosome in 
conjunction with the Ski complex. Alternative pathways include cleavage of the 
mRNA by endonucleases, which then allow the mRNA to be degraded by the mRNA 
machinery and nonsense-mediated decay (NMD). The NMD pathway is initiated by 
the premature termination of the ribosome due to a nonsense codon, which recruits 
the surveillance complex (UP1-3 and SMGs) to the mRNA. The surveillance 
complex then recruits the general mRNA decay machinery for degradation 
(Information from Coller and Parker 2004; Eulalio et al. 2007; Goldstrohm and 
Wickens 2008). 
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Decay of mRNA can also take place prior to deadenylation with endonucleolytic 
cleavage and there appears to be a variety of different endonucleases that have 
different cleavage specificities (reviewed by Coller and Parker 2004). One example 
of endonucleolytic cleavage is RNA mediated gene silencing (RNAi), which 
functions to protect the genome from viruses and transposons as well as controlling 
gene expression of some mRNAs. The process of RNAi involves the recognition of a 
dsRNA sequence by an endonuclease known as Dicer, which cleaves dsRNA into 
21-22 nt siRNAs (small interfering RNAs). The siRNAs are incorporated into a 
complex called the RNA-induced silencing complex (RISC), which will also contain 
at least one Argonaute protein. Argonaute proteins adopt an RNase H-like fold that 
cleaves the mRNA at sites complementary to the siRNAs. Following endonucleolytic 
cleavage the mRNA fragments are degraded by the general mRNA decay machinery 
(reviewed by Coller and Parker 2004; Newbury 2006; Eulalio et al. 2007). 
 
Eukaryotes have also evolved specialised quality control mechanisms to ensure that 
only fully processed error free mRNA is translated. Nonsense-mediated decay 
(NMD) is a crucial mRNA quality control mechanism which includes pathways that 
degrade transcripts with premature translation termination codons known as 
nonsense codons (reviewed by Coller and Parker 2004; Eulalio et al. 2007). The 
premature termination of translation triggers the NMD pathway, which leads to the 
formation of UPF1-3 complex on the mRNA along with NMD effectors SMG1 and 
SMG5-7. The UPF1 protein is an RNA helicase, which is regulated by 
phosphorylation and dephosphorylation events, which in turn requires additional 
complex factors. Once the complex has assembled on the mRNA it recruits enzymes 
from the normal mRNA decay machinery to degrade it (reviewed by Eulalio et al. 
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2007). Another specialised pathway referred to as nonstop decay degrades mRNA 
which does not have a stop codon; the mRNA is targeted to the cytoplasmic exosome 
by a specific adapter protein, Ski7p, which is thought to interact with the stalled 
ribosome (reviewed by Coller 2004). 
 
1.5. Viral manipulation of host transcription machinery 
Different viruses are able to down-regulate or inhibit cellular gene expression within 
their host with a subsequent reduction in cellular protein pool, a phenomena which is 
known as host shutoff. The mechanism causing this host shutoff can be virus-
specific, with different viruses targeting different stages in mRNA biosynthesis 
(reviewed by Aranda and Maule 1998) (Table 1.4). The mechanisms employed by 
different viruses can be very similar or vary greatly, as viruses may only produce one 
protein linked to host shutoff, that can have multiple effects, whereas other viruses 
appear to target one key area of the host transcription or translation machinery (Table 
1.4). The host shutoff identified during viral infections allows the virus to usurp the 
cellular machinery, which in turn enhances viral replication and may also 
compromise the synthesis of proteins required for the host to mount its antiviral 
defence (reviewed in Pe'ery and Mathews 2000). 
 
1.5.1 Host shutoff identified in RNA viruses 
The inhibition of host gene expression in RNA viruses has been well studied 
(reviewed by Lyles 2000; Bushell and Sarnow 2002). One of the most studied 
families of RNA viruses that has been found to cause host shutoff is the 
Picornaviridae and in particular the prototype picornavirus; poliovirus (reviewed by 
Lyles 2000). Polioviruses have been found to employ two mechanisms of host 
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shutoff: disruption of transcription; or disruption of translation using two viral 
proteases; 3C
PRO
 and 2A
PRO
 (reviewed by Aranda and Maule 1998; Lyles 2000). The 
two proteases share some functional similarity as they can both cleave Poly(A) 
binding protein (PABP) (Joachims et al. 1999) and can also both cleave the TBP 
(Yalamanchili et al. 1996; Yalamanchili et al. 1997). However they cleave TBP at 
different sites and only 3C
PRO
 is able to inhibit Pol II transcription (Yalamanchili et 
al. 1997). These findings indicate that the main role of 2APRO in host shutoff is not to 
interfere with transcription, but to inhibit translation.  As well as its ability to cleave 
PABP, 2A
PRO
 has been found to cleave the translation initiation factors eIF4G 
inhibiting translation of capped mRNAs (Krausslich et al. 1987).  
 
Poliovirus is an RNA virus that replicates in the cytoplasm and does not require the 
host transcription machinery meaning that the action of 3C
PRO
 hinders the host, but 
not the viral replication. This is also true of the mechanism of 2A
PRO 
as cleavage of 
eIF4G separates the domain responsible for association with the cap-binding subunit 
eIF4E inhibiting the translation of capped mRNAs, but as poliovirus mRNAs are 
uncapped this does not affect viral mRNA translation (reviewed by Lyles 2000). The 
obvious benefits of host shutoff in poliovirus infection can be seen throughout the 
Picornoviridae family as similar mechanisms are employed to inhibit host gene 
expression. Examples of this include the cleavage of eIF4G seen in coxsackievirus 
and rhinovirus (Lamphear et al. 1993) and the cleavage of PABP by coxsackievirus 
B3 2A protease (Joachims et al. 1999). However, some differences are seen in the 
Picornaviridae family, such as in encephalomyocarditis virus (EMCV), which does 
not cleave eIF4G, but instead activates eIF4E binding proteins (4E-BPs) that 
sequester eIF4E from the eIF4F complex. This process is also seen in poliovirus, but 
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takes place following other shutoff mechanisms, whereas it coincides with EMCV 
shutoff (Gingras et al. 1996; Bushell and Sarnow 2002).  
 
1.5.2 Host shutoff identified in DNA viruses 
Adenovirus C is a DNA virus which, like poliovirus, employs two modes of action to 
mediate host shutoff. However, unlike poliovirus, adenovirus c produces proteins 
that block nuclear transport of cellular mRNA (Pilder et al. 1986), whilst the other 
protein causes displacement of a MAPK kinase from eIF4G impairing eIF4F activity 
(Cuesta et al. 2000).  The advantage of a transport block during adenovirus infection 
is that E1B-55K and E4 proteins produce a selective block to nucleocytoplasmic 
transport so that cellular mRNAs do not enter the cytoplasm, but viral mRNAs do 
(reviewed by Aranda and Maule 1998). The advantage to adenovirus in impairing 
cap-dependant translation is less obvious since adenovirus mRNAs are capped, like 
cellular mRNAs. However a process known as ribosome shunting has been identified 
in adenovirus infections (Yueh and Schneider 1996). All adenovirus mRNAs derived 
from the major late promoter contain a 5’ non-coding region known as the tripartite 
leader. The tripartite leader promotes export of mRNAs to the cytoplasm and also 
directs ribosome shunting. The process of ribosome shunting involves the loading of 
40S subunits to the 5’ end of mRNA, the 40S subunit is then translocated to the 
downstream initiation codon via shunting elements. Ribosome shunting decreases the 
dependence of mRNA on eIF4F during initiation, which in turn facilitates the 
translation of adenovirus mRNA (reviewed by Schneider 2000). 
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Table 1.4 Viruses and host shutoff. 
Virus Protein Mode of Action Reference 
Poliovirus 3C 
 
 
 
 
 
2A 
Protease cleaves TBP stopping it 
from   binding to the TATA box, 
inhibiting Pol II transcription. Also 
cleaves PABP removing the C-
terminal domain (CTD) inhibiting 
poly(A)-dependant translation. 
Protease indirectly cleaves the 
eIF4G (p220) subunit of eIF4F 
inactivating cap-dependant 
translation. Also cleaves PABP. 
(Clark et al. 1993; 
Yalamanchili et al. 
1996; Joachims et al. 
1999; Kuyumcu-
Martinez et al. 
2004b) 
(Etchison et al. 1982; 
Krausslich et al. 
1987; Joachims et al. 
1999) 
Adenovirus C E1B-55K 
& E4 
 
100K 
Block transport and accumulation 
of cellular mRNA, but facilitate the 
same processes for viral mRNA. 
Displaces MAPK kinase (Mnk1) 
from eIF4G, which leads to 
dephosphorylation of eIF4E, 
impairing eIF4F activity and 
inhibiting translation. 
(Halbert et al. 1985; 
Pilder et al. 1986) 
 
(Cuesta et al. 2000) 
Influenza A NS1A Binds to the cleavage and 
polyadenylation specificity factor 
(CPSF), inhibiting 3’ processing 
and export. Also binds to U6 
snRNA, inhibiting splicing and 
spliceosome formation. 
 
(Qiu et al. 1995; 
Nemeroff et al. 
1998) 
Calcivirus 3CL 3C-like protease cleaves PABP  (Kuyumcu-Martinez 
et al. 2004a) 
Rotavirus NSP3 Interacts with eIF4G, displacing 
PABP from eIF4F. Also NSP3 
interaction with eIF4G along with 
rotavirus X protein associated with 
NSP3 (RoXaN) redirects 
cytoplasmic PABP to nucleus. 
 
(Piron et al. 1998; 
Harb et al. 2008) 
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Vesicular Stomatitis 
Virus 
M Interferes with transport 
mechanisms dependant on Ran 
GTPase and its associated factors 
inhibiting transport. Also binds 
mRNA export factor Rae1 and 
targets nucleoporin Nup98 
inhibiting nuclear export. M protein 
also inhibits transcription from Pol 
I and Pol II dependant promoters. 
(Her et al. 1997; 
Ahmed and Lyles 
1998; von Kobbe et 
al. 2000; Faria et al. 
2005) 
Mouse hepatitis 
corona virus 
? Increases phophorylation of 
eIF2α leads to formation of 
stress granules (P-bodies) 
causing mRNA decay. 
(Raaben et al. 2007) 
Rift valley fever virus  NSs Interacts with p44 and XPB 
components of TFIIH sequestering 
them into nuclear filamentous 
structures preventing assembly of 
TFIIH subunits. 
(Le May et al. 2004) 
SARS corona virus Nsp1 Binds to 40S ribosomal subunits 
inactivating translational activity 
and inducing modification of 5’ 
capped mRNA leading to 
endonucleolytic cleavage. 
(Kamitani et al. 
2009; Huang et al. 
2011) 
HIV PR Protease cleaves eIF4G and PABP 
blocking cap-and poly(A)-
dependant translation. 
(Ventoso et al. 2001; 
Alvarez et al. 2006; 
Castello et al. 2009) 
Sindbis virus nsP2 Transcriptional shutoff. (Garmashova et al. 
2006) 
Semliki Forest Virus ? Increased phosphorylation of eIF2α 
leading to formation of stress 
granules. 
(McInerney et al. 
2005) 
Encephalomyocardit
is virus 
4E-BPs Sequesters eIF4E from eIF4F 
complex. 
(Gingras et al. 1996) 
Vaccinia virus POLADs Polyadenylated small non-
translating RNA sequences 
(POLADS) sequester PABP.  
(Su and Bablanian 
1990) 
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1.5.3 Host shutoff mediated by herpesviruses 
Host shutoff was first identified in α-herpesviruses HSV-1 and HSV-2 as far back as 
1965 (Roizman et al. 1965) and since then much work has been carried out to 
understand the underlying mechanisms of HSV-mediated host shutoff. Much of this 
work has focused on herpes simplex virus type 1 (HSV-1) which causes host shutoff 
through two distinct inhibitory pathways (reviewed by Smiley 2004b). One pathway 
influences host mRNA maturation, through, the product of the viral ICP27 gene, 
which causes the major components of the spliceosome, the snRNP’s to be 
redistributed, inhibiting splicing of cellular mRNA (Phelan 1993; Hardwicke and 
Sandri-Goldin 1994). ICP27 achieves this through interaction with a group of 
proteins linked to the regulation of splicing known as SR proteins. In particular 
ICP27 interacts with SR protein kinase 1 (SRPK1), which triggers aberrant SR 
phosphorylation impairing their ability to function in spliceosome assembly 
(Sciabica et al. 2003). This action is beneficial to the virus as HSV-1 carries very few 
genes with introns, hence a disruption to the splicesome allows for preferential 
maturation of viral transcripts (reviewed by Aranda and Maule 1998). However 
ICP27 is a multifunctional protein linked to a number of processes during virus 
infection, including transcriptional activation and mRNA export (reviewed by 
Sandri-Goldin 2011). The role of ICP27 as a transcriptional activator is linked to Pol 
II, as ICP27 has been found to bind to the C-terminal domain of Pol II, which 
recruits Pol II to viral replication sites (Dai-Ju et al. 2006). In terms of mRNA 
export, ICP27 binds to intronless RNAs and facilitates their export via cellular export 
machinery (reviewed by Sandri-Goldin 2011). The functions of ICP27 allow for the 
preferential processing of viral mRNAs over the cellular mRNAs. In other 
herpesviruses, positional homologues of ICP27 have been found in all sequenced 
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mammalian herpesviruses and have been shown to play a role in the lytic cycle of 
these viruses, there is, however, some divergence between these viral proteins 
(reviewed by Sandri-Goldin 2011). For example ICP27 has been found to stimulate 
the transcription of viral genes through recruitment of cellular RNA Pol II, a 
phenotype which has not been identified in ICP27 homologues (reviewed by Sandri-
Goldin 2011). However KSHV ICP27 homologue (ORF57) has been found to 
interact with the transcriptional activator ORF50 to promote vial lytic gene 
expression (Malik et al. 2004). 
 
The other pathway associated with HSV-1-mediated host shutoff is linked to mRNA 
stability, as the product of gene UL41 encodes a bona fide virion host shutoff (vhs) 
protein, which functions as an RNase (Zelus 1996; Everly et al. 2002). The action of 
vhs protein is not restricted to HSV-1 as it has also been found to cause host shutoff 
in other members of the α-herpesvirus family, such as pseudorabies and varicella-
zoster virus, however the activity of vhs protein in these viruses is not as extensive as 
that seen in HSV-1 (Sato et al. 2002; Lin et al. 2004) (Table 1.5). Interestingly, in the 
case of equine herpesvirus (EHV) although in cotransfection reporter assays vhs 
activity is observed no vhs-induced cellular mRNA degradation can be detected 
during viral EHV-1 infection even though the vhs homologue is transcribed and 
translated in cells.  This has led to the speculation that host shutoff may not be seen 
during infection due to the smaller amount of vhs associated with viral particles or 
modulation from another viral factor, which may mask vhs activity (Feng et al. 
1996).  
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The vhs protein degrades only mRNA, leaving other cytoplasmic RNA intact and it 
appears to do this through an interaction with the translation initiation machinery. 
The vhs protein has been found to interact with components of the eIF4F translation 
complex; eIF4H, eIF4B and eIF4AII (an isoform of eIF4A) and has been linked to 
the 5’ capped region of mRNA (Doepker et al. 2004; Feng et al. 2005). These results 
are in accordance with a previous study which used RNase protection assays to 
compare 5’ and 3’ decay rates of a selected mRNA. Their results indicated that in 
wild type HSV-1 infection, the 5’ end of the transcript was degraded quicker than the 
3’ end. In contrast upon infection with a vhs mutant virus the 5’ and 3’ decay rates of 
the transcript were very similar (Karr and Read 1999). However, there is also 
evidence that 3’-5’ decay is taking place in a vhs-dependent manner linked to cellular 
mRNA sequences in stress-inducible genes (Taddeo et al. 2003; Esclatine et al. 
2004a). Esclatine et al used Northern blotting techniques along with RT-PCR, which 
used primers targeted to 5’ and 3’ sequences along either AU-rich element (ARE) or 
non-ARE-containing mRNAs. Using these techniques they discovered that certain 
cellular mRNAs containing AREs were deadenylated before endonucleolytic 
cleavage within the ARE occurred in a vhs-dependent process, deadenylation was 
not seen in mRNAs with no AREs. They also found that the 5’ cleavage products 
remained in the cytoplasm for many hours in the infected cell (Esclatine et al. 
2004a). Taken together, these results suggest that in the absence of AREs, vhs will 
bind to the cap-binding proteins and initiate degradation in a 5’-3’ manner. However, 
in the presence of ARE-containing stress response mRNAs, vhs initiates 
deadenylation and cleavage of the transcripts. The lingering 5’ cleavage products 
may then be accounted for by the limited number of 5’ degradation enzymes, which 
are being utilised by vhs on non-ARE containing mRNAs. 
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Homologues of vhs have been identified in all of the α-herpesviruses, but not in  β- 
nor in γ-herpesviruses, suggesting an important role for vhs in α-herpesvirus 
infections, which is also highlighted in its crucial role in virulence and pathogenicity 
(reviewed by Smiley 2004). The degradation of cellular mRNA by vhs leads to a 
downregulation of proteins required for the innate and adaptive immune responses. 
The use of mutant vhs viruses and immune knockout cell lines and mice has led to a 
greater understanding of the role of vhs in immune evasion and pathogenesis. For 
example, infection of IFNαβRKO mice with wild type HSV-2 and HSV-2 vhs 
mutant viruses has indicated that vhs interferes with the IFN-αβ response, as 
replication and virulence of the vhs-deficient virus was restored to wild type levels in 
IFNαβRKO mice (Murphy et al. 2003), a phenotype that has also been identified in 
fibroblast cell lines from these mice (Duerst and Morrison 2004). In addition HSV-1 
vhs has been shown to suppress cytokine production and reduce IFN-αβ activity 
(Suzutani et al. 2000). In terms of adaptive immunity, vhs (in combination with 
ICP47) blocks antigen presentation by MHC class I (Tigges et al. 1996) and also 
reduces levels of MHC class II (Trgovcich et al. 2002). Furthermore the vhs protein 
has also been found to block the activation of dendritic cells, which in turn may 
reduce efficient antigen presentation and reduced/delayed induction of cellular 
immune responses (Samady et al. 2003).  
 
The dual host shutoff mechanism employed by HSV-1 is complex, but is structured 
in this way to give the most benefit to the virus. The vhs protein is packaged within 
the virion and it is taken into the infected cell allowing host shutoff to take place 
during the first stages immediately post infection (reviewed by Aranda and Maule 
1998). However, at later times after infection the virion transactivator VP16 along 
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with VP22 act to neutralise the effects of vhs (Lam et al. 1996; Taddeo et al. 2007). 
This is then followed by the second host shutoff pathway linked to the immediate 
early (IE) gene, ICP27. Therefore the disruption to splicing occurs after the 
expression of the IE genes, which include three of the four intron-containing genes 
encoded by HSV-1. This allows ICP27 to disrupt cellular but not viral mRNA 
splicing (reviewed by Aranda and Maule 1998). Interestingly a more recent study has 
found that ICP27 and vhs interact with each other. They suggest that this may occur 
when ICP27 is bound to PABP during shuttling of mRNA late in infection, which 
then binds vhs in the cap structure preventing it from cleaving transported mRNAs. 
This interaction may function to stop the RNase action of vhs protein not previously 
neutralised by VP16 and VP22 (Taddeo et al. 2010). 
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Table 1.5 Herpesviral proteins associated with host shutoff. 
Herpesvirus Gene Protein Function Reference 
HSV-1 ICP27 
 
UL41 
ICP27 
 
vhs 
Redistribution of snRNPs 
disrupts splicing machinery. 
Acts as an RNase causing non-
specific mRNA degradation. 
(Phelan et al. 1993) 
 
(Read and Frenkel 
1983; Zelus et al. 
1996) 
HSV-2 ICP27 
 
UL41 
ICP27 
 
vhs 
Redistribution of snRNPs 
disrupts splicing machinery. 
Acts as an RNase causing non-
specific mRNA degradation. 
(reviewed by 
(Sandri-Goldin 2011) 
(Schek and 
Bachenheimer 1985; 
Zelus et al. 1996) 
Pseudorabies UL41 vhs Acts as an RNase causing 
mRNA degradation. 
(Lin et al. 2004) 
Varicella-zoster 
virus  
ORF17 ORF17 Homologue of vhs induces 
cleavage of mRNA similar to 
HSV vhs, but to a much lesser 
extent. 
(Sato et al. 2002) 
Bovine 
herpesvirus 
UL41 vhs Strong mRNA degrading 
activity. 
(Hinkley et al. 2000) 
KSHV ORF37 SOX mRNA degradation. (Glaunsinger and 
Ganem 2004b) 
EBV BGLF5 BGLF5 mRNA degradation. (Rowe et al. 2007b) 
MHV-68 ORF37 mSOX mRNA degradation. (Covarrubias et al. 
2009) 
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1.5.4 Host shutoff in γ-herpesviruses 
Host shutoff in γ-herpesviruses was first documented in MHV68 using microarray 
technology (Ebrahimi et al. 2003). This observation was then followed by that of 
host shutoff in cells undergoing lytic KSHV infection (Glaunsinger and Ganem 
2004b). The mediator of this shutoff was shown to be the product of viral gene 
ORF37, which encodes a viral DNA alkaline exonuclease (AE).  Because of the dual 
exonuclease and host shutoff activities of ORF37, the protein was re-named SOX 
(ShutOff and Exonuclease) (Glaunsinger and Ganem 2004b). This discovery was 
followed by identification of host shutoff activity in EBV-infected cells mediated by 
the EBV gene BGLF5 product with a high degree of homology to KSHV SOX 
(Rowe 2007). More recently the host shutoff in MHV-68 was also shown to be 
linked to the protein product of MHV-68 ORF37 gene (Covarrubias et al. 2009). All 
three host shutoff proteins KSHV SOX, MHV-68 ORF37 and EBV BGLF5 are 
herpesvirus alkaline exonucleases (AE) (Glaunsinger and Ganem 2004b; Rowe 2007; 
Covarrubias et al. 2009), encoded by a gene conserved across the herpesvirus family 
(Sheaffer 1997) and in particular the γ-herpesvirus family (Figure 1.8). However, the 
product of this gene has so far only been linked to mRNA turnover within the γ-
herpesvirus family (Glaunsinger and Ganem 2004b; Rowe 2007; Covarrubias et al. 
2009). As mentioned earlier, host shutoff has been seen in members of the α-
herpesvirus family through vhs protein, which is packaged into the virions (reviewed 
by Smiley 2004) (Table 1.5). However KSHV does not encode a homologue of vhs 
and it is also unlikely that there is an RNA degradative function brought in with the 
virion as RNA turnover does not begin until the lytic cycle is induced (Glaunsinger 
and Ganem 2004b). The homologue of SOX protein AE functions as a DNase and is  
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OHV2            -------MDFLHKATLLEQTITLDIEDQVKKLSTYTFSNFIRCPEVQQAIGDGTIQRDMP 53 
alcel           -------MDFLHKATLLEQTLNMEIGEQVKKLATYTFSNFIRCPEVQQAIASGEIRNDMP 53 
HHV-8           MEATPTPADLFSEDYLVDTLDGLTVDDQQAVLASLSFSKFLKHAKVRDWCAQAKIQPSMP 60 
HVS             -------MDLFSEESPINEIGNMDMSDQQTQLCSSSFSHFLKHPKVQHFISTYSELVKMP 53 
MHV-68          MEGS-IILDFFEKDDLLEVLGNMARENQLESLATLNFSAFIRSPQVQELLATSKTSVRIS 59 
EBV             ------------------MADVDELEDPMEEMTSYTFARFLRSPETEAFVRNLDRPPQMP 42 
                                          :    : : .*: *:: .:..           :. 
 
OHV2            HFRFVYIFYLFRKIHTFIGDSEVLDVYTQAMGS--ECASTAKLPDVVRACVAMKPPLKAK 111 
alcel           HLRFVYIFYLFKKIQDFIGDTEVFGIYEKVMGV--ERANSAKLVDVVQACTEMRPHIQAQ 111 
HHV-8           ALRMAYNYFLFSKVGEFIGSEDVCNFFVDRVFG---GVRLLDVASVYAACSQMNAHQRHH 117 
HVS             TIRYVYFYYLFKKIGGFIGNEKIGTYFSKNVCNNIAAKGVPKLADVYKACEKMNLRQQSE 113 
MHV-68          DMRLTYYYFLFLRLNEYIGNTAIMGVFKDMMHL----TDNSEVSAVYAACRDVTPDIKYA 115 
EBV             AMRFVYLYCLCKQIQEFSGETGFCDFVSSLVQEN-DSKDGPSLKSIYWGLQEATDEQRTV 101 
                 :* .* : *  ::  : *.  .     . :          .:  :  .        : 
 
OHV2            ICEHIERLTRGQSDNVLWEVLRDGVISSSKLLKFVKQQTPDSKIFHPIPIQKDHYVASPV 171 
alcel           ICEHIERLTRGQGENVLWEVLRDGVISSSKLLKFVKQQTPDSKIFNPIPIQKNHYVASPV 171 
HHV-8           ICCLVERATSSQSLNPVWDALRDGIISSSKFHWAVKQQNTSKKIFSPWPITNNHFVAGPL 177 
HVS             ICLLIEEVTRGQYLNSLWDALRDGTISSSKFYWATKKQNSTKKIFEPWPIKNDYYVAGPL 173 
MHV-68          VCQRIEALTRGQQDNELWDILRDGMISSSKFQWAVKQHSINKKLFNPQPIKVNHYFAGPL 175 
EBV             LCSYVESMTRGQSENLMWDILRNGIISSSKLLSTIK--NGPTKVFEPAPISTNHYFGGPV 159 
                :*  :*  * .*  * :*: **:* *****:    *  .  .*:* * **  :::...*: 
 
OHV2            AFGVRNESTVKTLVSELVLEENVKCITDFGFMLSPNDGIFGVSLDMCANACLTSDNIVQF 231 
alcel           AFGVRNETVVKKLISELVVEEGIGCVTEFGFMLSPNDGIFGVSLDMCTNASMSDHNTVEF 231 
HHV-8           AFGLRCEEVVKTLLATLLH-PDETNCLDYGFMQSPQNGIFGVSLDFAANVKTDTEGRLQF 236 
HVS             AFGLRCEEVIKTVLNELICTPKQASCFDCGFMQSPLDGIFGVSLDYCTNVETNKDNLLVF 233 
MHV-68          AFGIRCEQTVKKILSELIH-PNLPRFHDCGFLPSAIDGIFGVSLDTAFNVFTDSSGLVHF 234 
EBV             AFGLRCEDTVKDIVCKLIC-GDASANRQFGFMISPTDGIFGVSLDLCVNVESQGD-FILF 217 
                ***:* * .:* ::  *:         : **: *. :******** . *.       : * 
 
OHV2            EATTHIYEIKCRYKYLFAKCDYDPIYNYYLALYNAPGRQPLIDFIQAIQKPAVEYVPRGR 291 
alcel           TSTTTIYEIKCRYKYLFSKCDYDPIYQAYQKLYNSPGRQELIDFIQSIQKPTVEYVSRGR 291 
HHV-8           DPNCKVYEIKCRFKYTFAKMECDPIYAAYQRLYEAPGKLALKDFFYSISKPAVEYVGLGK 296 
HVS             HPDTEVYEIKSRFKYLFDKSECDTLYKKYKELYSNPCVKTLIKFIFSVSRPAIEFVPSGR 293 
MHV-68          EPDSIVYEIKSRYKYQFSKSEFDGLAKKYLDLYKNPCEATFIKFINCISRPAVEYVPHGK 294 
EBV             TDRSCIYEIKCRFKYLFSKSEFDPIYPSYTALYKRPCKRSFIRFINSIARPTVEYVPDGR 277 
                     :****.*:** * * : * :   *  **. *    :  *: .: :*::*:*  *: 
 
OHV2            LPTQNDYLLSFDKCWDFGPPRRKRRLVSGHKVTEQCMKYNCYTESKVLVLTDPALTSGKI 351 
alcel           LPTQNDYLLSFDRSWDFGPPKRKRKLTSGHKITEQCMKYNCYTESKVIILTDPALTSGKI 351 
HHV-8           LPSESDYLVAYDQEWEACP-RKKRKLTPLHNLIRECILHNSTTESDVYVLTDPQDTRGQI 355 
HVS             LPSESDYLLAYDEEWNLRP-TKKRKLNASHEMIKKCIEYNSYAGSQIYILSDPAENNGQI 352 
MHV-68          LPSESDYLITHSMNWKTSN-KRKRKITDSHICLKKCLLHNMYQQSTVYILSDPSETSGKI 353 
EBV             LPSEGDYLLTQDEAWNLKD-VRKRKLGPGHDLVADSLAANRGVESMLYVMTDPSENAGRI 336 
                **::.***:: .  *.     :**::   *    ..:  *    * : :::**  . *:* 
  
OHV2            EVKNSFFVDIYINPRHAYYHQCMLQYKIVTNYVQLS-RDHSCRHTRPSVFLVSAFFRKRN 410 
alcel           EVKGSFFVDIYINPRHAYYHQCMLQYKIVTNYVQLT-KGDSCKHTHPGVFLVSAFFRKRN 410 
HHV-8           SIKARFKANLFVNVRHSYFYQVLLQSSIVEEYIGLD-SGI-PRLGSPKYYIATGFFRKRG 413 
HVS             TVKTKFKAGIFMNPRHTYFYQVALQHRVVQSYIGLS-ESP-RSLGTQKNFIVSSFFRKRH 410 
MHV-68          TIKASFPIDVFVNPAHNYFYQVALQNMVVQDYIEFG-QGVYKRLGHQKNFIASGFFRKRH 412 
EBV             GIKDRVPVNIFINPRHNYFYQVLLQYKIVGDYVRHSGGGKPGRDCSPRVNIVTAFFRKRS 396 
                 :*  .  .:::*  * *::*  **  :* .*:     .           :.:.***** 
 
OHV2            SADFPKTYIKTERGFLDCSVEIPVLLIITPVFIPHEPLVETLEQAIGFWQTAVEEEFCHT 470 
alcel           SADFPKTYIKTERSFVDASVEIPVLLIITPVFVPHGPLVDTLEQAIKFWQVAVKEEFNHW 470 
HHV-8           YQDPVNCTIGGD--ALDPHVEIPTLLIVTPVYFPRGAKHRLLHQAANFWSRSAKDTFPYI 471 
HVS             FSDPPVCYIGKK--QLEKTVEIPVFIIITPVYIPRSALLETISQAVNFWEESAKEAFTEY 468 
MHV-68          FSDPAVCSIGNCG-KLDTTDEIPVALIITPVRIPSTVLHEYLKKAIDFWNQCAEANFDHI 471 
EBV             PLDPATCTLGSDL-LLDASVEIPVAVLVTPVVLPDSVIRKTLSTAAGSWKAYADNTFDTA 455 
                  *     :      ::   ***. :::*** .*       :  *   *.  ..  * 
 
OHV2            PWAPTSLSAVGDITP 485 
alcel           PWAPTSLSAVGDVTP 485 
HHV-8           KWDFSYLSANVPHSP 486 
HVS             PWAPCALFANGDLTP 483 
MHV-68          PWGQLSDVARKPITP 486 
EBV             PWVPSGLFADDESTP 470 
 
Figure 1.8 Highly conserved ORF37 homologues in γ-herpesviruses. Comparison 
of amino acid sequence of ORF37 protein from ovine herpesvirus, alcelaphine 
herpesvirus, KSHV, herpesvirus saimiri, MHV-68 and EBV. 
 
 53 
 
normally involved in the packaging of the viral DNA (Martinez 1996; Goldstein and 
Weller 1998). 
 
Based on sequence structures herpesvirus AE has been suggested to belong to the 
PD-(DE)XK deoxyribonuclease superfamily having a distant evolutionary 
relationship to the prokaryotic bacteriophage λ-exonuclease (Bujnicki and 
Rychlewski 2001). Herpesvirus AE exhibits 5’-3’ exonuclease activity, which is 
dependent on the divalent cations Mg
2+
 or Mn
2+
, although endonuclease activity has 
also been identified, but to a much lesser extent (Hoffmann and Cheng 1978; 
Hoffmann and Cheng 1979; Bronstein and Weber 1996; Sheaffer et al. 1997). 
Although SOX possesses in vitro DNase activity similar to that of HSV-1 AE, this 
does not explain its ability to influence host mRNA metabolism (Glaunsinger et al. 
2005). 
 
The obvious model for RNA turnover within cells would be that ORF37 and its 
homologues possess RNase as well as DNase activity. However, in vitro studies 
aimed at detecting direct RNase activity by ORF37 and its homologues have been 
unsuccessful (Glaunsinger and Ganem 2004b; Rowe et al. 2007). This has led to the 
hypothesis that SOX protein could possess latent or cryptic RNase activity requiring 
cellular cofactors for activation. Alternatively SOX protein may have no RNase 
activity at all and function instead to activate host mRNA degradation pathways 
(Figure 1.7), such as deadenylation or it may inactivate host factors that normally 
protect transcripts from degradation (Glaunsinger 2004). Recently the crystal 
structures of KSHV ORF37 and EBV BGLF5 have been elucidated, which 
confirmed that SOX and BGLF5 are members of the PD-(D/E)XK superfamily and 
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that they preferably act as 5’-3’ exonucleases rather than 3’-5’ exonucleases or 
endonucleases (Buisson et al. 2009; Dahlroth et al. 2009). Interestingly, both SOX 
and BGLF5 have also been found to possess RNase activity, but only in the presence 
of high levels of metal ions (Buisson et al. 2009; Bagneris et al. 2011). Taken 
together with the finding that SOX has a low affinity for binding RNA it appears that 
other factors may be involved in mRNA degradation. Furthermore, upon mutation of 
key residues that have been found to attenuate or abolish host shutoff, RNase activity 
was still seen suggesting that the RNase activity identified could not completely 
explain mRNA degradation (Bagneris et al. 2011). All of which points to ORF37 
requiring other factors to cause mRNA degradation. 
 
As previously discussed during HSV-1 infection, ICP27 plays an important role in 
host shutoff and working in conjunction with the viral vhs protein (reviewed by 
Smiley 2004). Similar to ICP27, the EBV homologue, SM plays a number of roles in 
regulating gene expression, such as acting as a nuclear export factor and facilitating 
export of intronless EBV mRNAs (reviewed by Swaminathan 2005). Similarly to 
ICP27, the SM protein may also play a role in host shutoff, as it has been found to 
inhibit expression of spliced mRNA transcripts (Ruvolo et al. 1998). Furthermore 
microarray analysis of the effect of SM in EBV-negative B lymphocytes has shown 
that the majority of cellular mRNAs were downregulated (Ruvolo et al. 2003). Taken 
together these results suggest a globally repressive effect on cellular splicing that is 
similar to ICP27. However how SM causes this repressive effect has not been 
elucidated and this along with the different roles that SM plays in gene expression 
means that no direct link has been made to host shutoff (reviewed by Swaminathan 
2005). Alternatively it may be that SM is important for the switch from latency to 
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lytic infection, as EBV latent genes are spliced, hence its expression after 
reactivation may decrease latent gene mRNAs (Ruvolo et al. 1998). In contrast, the 
KSHV homologue of ICP27, ORF57, does not suppress the expression of most 
intron-containing genes and associates with components of the spliceosome to 
promote viral RNA splicing, which is beneficial to KSHV, as KSHV has over 30 
intron-containing genes (reviewed by Majerciak and Zheng 2009). 
 
A role of ORF37/BGLF5, would appear to be as an immune evasion mechanism. 
This link was first suggested for BGLF5, which was found to block synthesis of 
HLA class I and II molecules (Rowe et al. 2007). The effect of EBV BGLF5 and 
KSHV ORF37 on the down-regulation of HLA class I molecules was found to be 
enough to impair the recognition of lytic cycle antigens by virus-specific CD8
+ 
T 
cells (Zuo et al. 2008). There is a suggestion, however, that ORF37 host shutoff in 
KSHV is rather a blunt immune evasion strategy, as roughly one-quarter of KSHV 
genes encode cellular homologues or unique proteins with immunomodulatory roles. 
Lytic cycle immunomodulatory viral proteins, such as K15, K1 and vGPCR 
influence host cell survival through paracrine activity or through subversion of cell 
signalling pathways, which appear to be more sophisticated immune evasion 
strategies than host shutoff (reviewed by Rezaee et al. 2006). For example K15 has 
been found to block B- cell receptor signal transduction modulating lymphocyte 
signalling (Choi et al. 2000). Furthermore microarray experiments showed that K15 
induces expression of multiple cytokines and chemokines, which play an important 
role in KSHV pathogenesis (Brinkmann et al. 2007).  
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Another interesting aspect of ORF37 host shutoff is cellular genes that escape 
shutoff. Much of the work looking at host shutoff escapees has focused on KSHV 
(Glaunsinger and Ganem 2004a; Chandriani and Ganem 2007; Clyde and 
Glaunsinger 2011) and more recently MHV-68 (Clyde and Glaunsinger 2011). 
Microarray experiments have indicated that over 75% of transcripts are significantly 
downregulated, approximately 20% decline less than two-fold, but 2% of cellular 
transcripts are significantly up-regulated, suggesting that there is a gradient of 
susceptibility (Chandriani and Ganem 2007). One of the most notable transcripts to 
be up-regulated is IL-6, a multi-functional cytokine which has effects on a wide 
range of cell types, particularly those involved in the innate and adaptive immunity. 
Over-expression of IL-6 has been identified in a number of proliferative diseases 
including MCD and PEL (Glaunsinger and Ganem 2004a; Rezaee et al. 2006). As 
previously discussed, although HSV mRNA degradation appears to be non-selective 
(reviewed by Smiley 2004), other studies have found evidence of selective 
degradation of mRNA during HSV infection based on the presence or absence of 
ARE sequences within the mRNA (Esclatine et al. 2004a). However, further studies 
found that vhs may induce rapid degradation of some mRNAs whilst stabilising or 
delaying degradation of other mRNAs and that this process is not completely reliant 
on the presence of AREs (Esclatine et al. 2004b). Interestingly, IL-6 has also found 
to be upregulated upon HSV-1 infection, which may highlight its importance in 
herpesvirus infection (Kanangat et al. 1996). In contrast to HSV-1 infection, 
Chandriani and Ganem suggested that AREs may be important for stabilisation of 
transcripts, as a statistically significant number of cellular mRNAs that did not 
succumb to virus-induced degradation contained two or more AREs in their 3’ UTR. 
Conversely many escapees did not have AREs and some mRNAs that did have AREs 
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were downregulated (Chandriani and Ganem 2007). A later study that used next 
generation sequencing techniques did not find that the presence of an ARE sequence 
led to stabilisation of mRNA (Clyde and Glaunsinger 2011). It may be that the 
enrichment of mRNAs containing AREs is regulated by another viral protein such as 
kaposin B, which activates the MK2/p38 signalling pathway that inhibits ARE-
mRNA decay (McCormick and Ganem 2005). One factor that did appear to 
determine which mRNAs were degraded was transcript abundance, as a strong 
correlation was seen between abundance and downregulation and furthermore 
overexpression of certain genes made them more susceptible to shutoff (Clyde and 
Glaunsinger 2011). However this theory is also imperfect as overexpression of some 
genes did not make them susceptible to SOX, including IL-6 (Chandriani and Ganem 
2007; Clyde and Glaunsinger 2011). Taken together these results suggest that 
multiple mechanisms may influence SOX-mediated mRNA degradation and more 
work still needs to be executed to further elucidated how SOX is causing mRNA 
decay. 
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1.6 Aims 
Host shutoff during lytic infection with γ-herpesviruses has been linked to the highly 
conserved herpesviral DNA exonucleases: ORF37/SOX in KSHV and MHV-68 and 
BGLF5 in EBV. The post-transcriptional loss of cellular mRNA may play an 
important role in modulating the host immune responses to these viruses, 
establishment of latency and disease progression. Thus, further understanding of how 
host shutoff is mediated in γ-herpesviruses undoubtedly will lead to insights into how 
these viruses evade immune responses, establish latency, and reactivate from latency 
as well as disease pathogenesis.   To achieve these aims, an MHV-68 ORF37 mutant 
virus was constructed to study the role of ORF37 during virus lytic cycle and its role 
in host shutoff in vitro and in vivo and in different cellular environments.  Attempts 
were also made to decipher how ORF37 actually mediates mRNA degradation by 
investigating bulk poly(A) tail length distribution. 
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Chapter Two 
Materials and Methods 
 
2.1 Molecular biology kits, reagents, chemicals and buffers 
All molecular biology kits and reagents as well as chemicals used in this study are 
listed along with the manufacturer and catalogue number in Appendix B. The 
preparation of buffers and biological reagents are outlined in Appendix C. 
 
2.2 Tissue Culture 
2.2.1 Murine cell lines  
Table 2.1 Cell lines utilized in this project 
Cell line Description 
NIH3T3 Highly contact inhibited murine fibroblast cells developed from NIH 
Swiss embryo cultures, transformed with SV40 (Jainchill et al. 1969) – 
ATCC: CRL 1658 
MEF IFNα/βRKO Mouse embryonic fibroblasts derived from mice with an inactivated 
type I IFN receptor through homologous recombination (Muller et al. 
1994). 
MEF IFNαβR+/+ Mouse embryonic fibroblasts with an intact type I IFN receptor. 
 
2.2.2 Growth and maintenance of cell lines 
The mouse fibroblast cell lines NIH 3T3 and α/β-receptor knockout cells were grown 
in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% (w/w) 
bovine serum, 400µM L-Glutamine, 1U/ml penicillin, 2.5µg/ml Fungizone-
amphotericin B and 1µg/ml streptomycin and incubated at 37ºC under a 5% CO2 
atmosphere. Cells were passaged using 0.05% trypsin along with the chelating agent 
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Versene-EDTA, cells were spun at 100 x g for 5 minutes before reconstitution in 
complete media. 
 
2.3 Growth of viruses 
2.3.1 MHV-68 viruses 
Three viruses were used in the study namely MHV-68, ORF37Stop and 
ORF37StopRev. The stop mutants of MHV-68 ORF37 were generated in 
collaboration with Dr Bernadette Dutia (Edinburgh University) by manipulating an 
MHV-68 genomic clone containing nucleotides (nt) 49951–59889 (Efstathiou et al. 
1990). A 17 bp DNA sequence containing three stop codons and a diagnostic HpaI 
site (DeLuca and Schaffer 1987) was inserted at nt 54157 into a PCR product 
spanning the Hpy99I site at nt 53949 and the SacI site at nt 54270.  This product was 
cloned and sequenced and then inserted into the genomic clone. The mutated 
genomic clones were then ligated into the shuttle vector pST76_SR. The resultant 
plasmids were transformed into Escherichia coli DH10B containing the MHV-68 
bacterial artificial chromosome (BAC) pHA3 (Adler et al. 2000). Recombinant BAC 
clones were produced as described (Figure 2.1) (Messerle et al. 1997; Adler et al. 
2000), screened by PCR using primers spanning the region 53949-54270 followed by 
HpaI digestion to identify mutated colonies.  A revertant virus of MHV-68 
ORF37Stop (termed ORF37StopRev) was made by transformation of bacteria 
containing mutant BAC with a shuttle vector containing the wild type genomic clone 
and selected by PCR in the same way. Virus stocks were produced by transfection of 
BAC DNA into mouse cells lacking type I interferon receptor and BAC sequences 
excised from the reconstituted virus by passage through cells expressing Cre 
recombinase (Stevenson et al. 2002).   
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Figure 2.1 Construction of MHV-68 BAC viruses. The BAC cloned genome was 
generated in eukaryotic cells by homologous recombination of MHV-68 DNA with a 
recombination plasmid. Viral DNA and the linearised recombination plasmid were 
co-transfected into eukaryotic cells to generate a recombinant virus. Circular DNA of 
the recombinant virus genome was then isolated from cells and electroporated into 
the E. coli strain DH10B. In a first step, the shuttle plasmid carrying the desired 
mutation plus flanking homologies (black boxes) is transformed into DH10B. 
Through homologous recombination via one of the two homologies, the shuttle 
plasmid is completely integrated into the viral BAC genome, leading to a cointegrate. 
Bacteria containing the cointegrate were selected by incubation at 43
o
C plus both 
antibiotics. Bacteria harbouring a resolved cointegrate (either wildtype (WT) or 
mutant (Mut)) are selected at 30
o
C using the negative selection marker SacB together 
with the antibiotic whose resistance gene is encoded on the BAC (adapted from 
Adler et al. 2003). 
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2.3.2 Virus stock preparation 
Virus was added to a 5ml volume of α/β-receptor knockout cells at a cell density of 
10
7
/ml
 
to give an MOI of 0.001. Cells were then incubated at 37
o
C with agitation for 
1 hour. After the incubation period another 5ml of media was added to the cells. The 
infected cells were then split between 10x T175 flasks (1ml infected cells per flask) 
along with another of 50ml of fresh media per flask. The flasks were then incubated 
for 4-5 days and monitored for cytopathic effect (CPE). Cells were then harvested 
using a cell scraper and pipetted into 200ml centrifuge bottles and centrifuged at 
3000rpm for 20 minutes at 4ºC. Supernate was discarded and the pellets were re-
suspended in 3ml sterile PBS, and kept at -80ºC. 
 
Prior to homogenization, virus stocks were thawed, poured into a 15ml dounce 
homogenizer and homogenized with 5x10 strokes with one minute to cool down in 
between each 10 strokes by placing the homogenizer on ice. The suspension was 
then poured into a 50ml tube and spun at 3000rpm, for 20 minutes at 4ºC.  The 
supernate was then poured into a 50ml Falcon tube and kept on ice. Pellet was re-
suspended in 1ml of sterile PBS and transferred back to homogenizer and 
homogenized pellet as before.  Supernate was collected by spinning as before.  The 
two supernates were then pooled into one tube, aliquoted into cryovials and kept at  
-80ºC. 
 
2.3.3 Lytic virus titration 
Dilutions of the virus prep were made by adding 100µl of virus prep to 0.9 ml media, 
which was subsequently mixed to give a 1/10 dilution. 100µl of the 1/10 dilution was 
then added to another bijoux containing 0.9 ml of medium, this process was repeated 
to give five serial dilutions. Then 4µl of each dilution was taken and placed into 4ml 
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media, to give final dilutions of 10
-9
, 10
-8
, 10
-7
, 10
-6
, and 10
-5
. 200µl (1x10
6
) of 
IFNα/βRKO cells were then added to each tube, mixed and placed in at 37ºC, with 
vigorous shaking for one hour. Two ml of each virus dilution was pipetted into tissue 
culture petri dishes containing 3ml media (so that each dilution was in duplicate), 
which were then left in a 37ºC incubator for approximately four days. The media was 
then removed and cells were covered with approximately 3ml formalin, which were 
the left for at least an hour to fix the cells. The formalin was then removed and cells 
were stained with 0.1% toluidine blue for roughly 40 minutes, washed and left to dry. 
Then the plaques were counted for each dilution using a microscope. 
 
2.3.4 One-step growth curve 
Six-well plates were seeded with 5x10
5
 cells and left to grow in 37ºC incubator 
overnight. Cells were then inoculated with either, mutant (ORF37Stop), revertant 
(ORF37StopRev) or WT (MHV68) virus at an MOI of 5. Cells were incubated for 
one hour to allow adsorption of virus into cells. Media containing the inocula were 
removed; cells were then rinsed three times with DMEM without bovine serum, 
followed by incubation in complete medium. At various time-points cells were 
removed using a cell scraper.   
 
Viral particles were released from cells by three cycles of freeze-thaw (37
o
C 
followed by incubation on dry ice for 30 minutes). Each virus sample was serially 
diluted, to give dilutions ranging from 10
-1
 to 10
-5
. Virus titration was then carried 
out as described in section 2.3.3. 
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2.4 Isolation of protein and RNA from virus-infected cells  
2.4.1 Virus infection for protein and RNA isolation 
The correct amount of virus, to give an MOI of 5, was added to 3.8 ml of medium in 
bijoux. Into each bijou 1.5x10
6
 cells were added, they were then incubated at 37
o
C 
with constant agitation for one hour.  The content of each bijou was then placed in a 
T25 flask and placed in 37ºC
 
incubator until harvest time. 
2.4.2 Protein isolation 
To harvest total protein from cell cultures, growth medium was removed and 
replaced with one ml cold PBS to rinse cells.  After two rinses, one ml cold PBS was 
added to cells and cells were scraped off the culture vessel using a disposable cell 
scraper. The cells were then transferred to a microfuge tube and spun at 6000rpm for 
2 minutes. The supernate was removed and 50µl of cold lysis buffer (2.5ml cell 
extraction buffer (Invitrogen), 25µl phenylmethanesulfonylfluoride (PMSF) and 
125µl protease inhibitor cocktail) was added to cell pellet. It was then placed on ice 
for 30 minutes, with vortexing every 10 minutes and stored at -20ºC. 
2.4.3 RNA isolation 
For intact monolayers the growth medium was removed and 700µl of lysis buffer 
(1ml RLT buffer (Qiagen) plus 10µl β-mercaptoethanol) was added. In the case 
where cell monolayers had become detached from the culture vessel due to virus 
infection, cells were harvested in growth medium in a universal tube and spun at 
100x g for 5 minutes to collect the cells. The supernate was then removed.  Cells 
were lysed by adding lysis buffer to the cell pellet. The lysates were then placed in 
Qiashredders and spun at 13,000rpm for 2 minutes. The samples were then 
transferred to microfuge tubes and stored at -70ºC. 
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2.5 Transient transfection assays 
2.5.1 Bacterial growth cultures 
Bacteria cultures were routinely plated in Luria Bertani agar (LA) and Luria Bertani 
broth (LB), supplemented with specific antibiotics. Agar plates were prepared with 
1% LB (w/v) (Sigma-Aldrich), 1.5% agar (w/v) (Sigma-Aldrich) and 0.5% NaCl 
(w/v) in Millipore water. LB media was prepared with 2% LB (w/v) and 0.5% NaCl 
(w/v) in millipore water. The ingredients were mixed using a magnetic stirrer until 
dissolved and the liquid was clear and the broth/agar was divided into Duran glass 
bottles and autoclaved.   
 
2.5.2 Reconstitution of plasmids from glycerol stocks 
Previously constructed plasmids had been stored as glycerol stocks and kept at -
80ºC. To grow up bacteria containing the plasmid of interest the tubes were removed 
from the freezer and placed on dry ice. Using a heated loop (allowed to cool slightly) 
the top of the glycerol stock was scraped off and streaked onto the first quadrant of 
an LB agar plate. The loop was re-heated and the following three quadrants were 
streaked to give single colonies. The plates were then placed in a 37ºC and left 
overnight. 
 
2.5.3 Transformation of bacterial competent cells  
The XL-10 Gold supercompetent cells (Agilent) were used in transformation 
reactions. One hundred microlitres of thawed competent cells were transferred to 
pre-chilled 50 ml falcon tubes and incubated on ice for 10 minutes. Fifty nanograms 
of plasmid DNA in a total volume of 10 µl was then added to competent cells, mixed 
gently and incubated on ice for a further 30 minutes. The cells were heat-shocked in 
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a water bath set at 42°C for 45 seconds followed by immediate incubation on ice for 
2 minutes. Pre-warmed LB (900 µl) with no antibiotics was added to the cells 
followed by incubation at 37 °C, for one hour shaking at 220rpm.  The mixture was 
then plated on LA, supplemented with the specific antibiotic. The plates were 
incubated overnight, at 37°C. 
 
2.5.4 Bacterial growth for plasmid preparations 
The media supplements ampicillin (100 mg/ml) and kanamycin (50 mg/ml) were 
stored as stock solutions.  Starter cultures were prepared by inoculating 3ml LB in a 
universal containing 100 µg/ml of the appropriate antibiotic with a single colony 
from a freshly streaked selective plate. The starter cultures were then incubated at 
37ºC for roughly 8 hours, shaking at 250rpm. Once the starter cultures were ready 
(turbid media) 200µl of the starter cultures were transferred to a 250ml flask 
containing 100ml LB plus 100ug/ml of appropriate antibiotic, the flasks were placed 
in a shaker at 220rpm in a 37 ºC incubator. 
 
2.5.5 Endofree maxi plasmid preparations 
All plasmid preparations were carried out using Qiagen Endofree Maxi Prep kits 
(Qiagen), following the manufacturer’s instructions. In brief: RNase was added to 
Buffer P1. Bacterial cells were pelleted by centrifugation  at 6000xg, for 15 minutes 
at 4°C in a 250ml centrifuge bottle and then resuspended in 10ml Buffer P1 and 
transferred to a 50ml tube. 10ml of Buffer P2 was added and mixed thoroughly by 
inverting the tube 6 times, then left at room temperature for 5 minutes. 10ml of pre-
chilled Buffer P3 was added and mixed immediately and thoroughly by inverting the 
tube 6 times. The samples were then applied to the Qiafilter cartridge and incubated 
at room temperature for 10 minutes, the plunger was then inserted into the cartridge, 
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filtering the lysate into a 50ml tube. To the lysate 2.5ml buffer ER was added and 
mixed via inverting the tube 10 times. This was then incubated on ice for 30 minutes. 
The filtered lysate was then applied to a Qiagen-tip, after it had entered the resin it 
was washed 2 times with 30ml buffer QBT. The flow-through was then discarded 
and the tip was placed into a clean 50ml tube. 15ml Buffer QN was used to elute the 
DNA. The DNA was then precipitated by adding 10.5ml isopropanol and spinning at 
5000xg for 1 hour. The supernate was decanted off and the pellet washed in 5ml of 
70% ethanol and spun as above. The supernate was again decanted off and the pellet 
was left to air-dry and then subsequently re-suspended in 100µl sigma water. The 
optical density (O.D) was measured on the NanoDrop (ND-1000) to check both 
quantity and purity of plasmid preparations. Vector maps of plasmids used in this 
study are located in appendix A. 
 
2.5.6 Restriction enzyme digestion 
Plasmid preps were digested with EcoR I (Roche), a restriction endonuclease which 
cuts double stranded DNA at 5'-G^AATTC-3' producing cohesive 5’ ends. 1µg of 
plasmid DNA was digested with 1µl EcoR I in the presence of 2.5µl 10X SuRE/Cut 
Buffer H along with water to give a final volume of 25µl. The mixture was then 
incubated at 37°C for 1 hour. The uncut and cut plasmid DNA was then visualised 
using gel electrophoresis to check the size of the plasmid and to indicate the presence 
of contaminating genomic DNA. 
2.5.7 Transient transfection assay 
Cells were trypsinised and then counted using a haemocytometer. Following this the 
cells were diluted to give a cell density of 1.5x10
5
cells/ml and 1ml of the cell 
dilution was seeded into each well of Nunc 6-well plates. Cells were then incubated 
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overnight at 37°C under 5% CO2 atmosphere in complete growth media. The 
following day cells in each well were transfected with 4µl of appropriate plasmid 
(1µg/µl) in 625µl Opti-MEM added to 8µl Lipofectamine 2000 in 242µl OptiMEM 
the mixture was then incubated at room temperature for 20 minutes before 500µl was 
added to each well. During each transfection experiment one of the wells was 
transfected with pEGFP-NI so that the transfection efficiency could be monitored via 
visulation of GFP in transfected cells. The cells were incubated for 6 hours at 37ºC 
under a 5% CO2 atmosphere. After 6 hours the medium was taken out of each well 
and cells were washed with 1ml Opti-MEM before 3ml Opti-MEM with 10% bovine 
serum was added to the well and the plate was placed back into incubator. At 24 
hours post-transfection medium was changed to 3ml complete medium. The cells 
were then harvested at different time points using the methods described in sections 
2.4.2 and 2.4.3. 
 
2.6 Diagnostic PCR to check virus stocks  
Diagnostic PCR reactions were carried out in 50µl volumes. Each reaction contained 
0.5U of Platinum Taq DNA Polymerase (Invitrogen), 200nM of each oligonucleotide 
primer, 1x PCR buffer (20 mM Tris HCl, 50 mM KCl), 1.5mM MgCl2 and 200µM 
Nucleotides (dATP, dCTP, dGTP and dTTP). All the primers were supplied by 
Sigma-Genosys or MWG-Eurofin and stored as stock solutions at 100µM at -20°C. 
A master PCR mix was prepared with above concentrations and 44µl of the master 
mix was aliquoted into 0.2ml microfuge tubes to which one µl of virus stock (or 
water in case of negative controls) was added along with one µl of 10mg/ml 
proteinase K (10µg).  This was then heated at 65°C for 10 minutes before the enzyme 
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was inactivated by heating at 95°C for 5 minutes. Taq polymerase was then diluted 1 
in 5 in 1x PCR buffer and 5 µl of the diluted Taq was added to the PCR master mix. 
The PCR was run using the standard PCR amplification program, which consisted of 
an initial denaturation step at 95°C for 5 min, followed by 35 cycles of denaturation 
at 94°C for 1 min, annealing at a suitable annealing temperature, which in this case is 
60°C for 1 min, and primer extension at 72°C for 1 min. Plus a final extension step 
of 5 min at 72°C. The Opticon 2 thermal cycler (BioRad) PCR machine was used for 
amplifications. 
 
 
Table 2.2 Oligonucleotide primers used for diagnostic PCR and Southern blot 
probe. 
Primer name  Primer sequence 
Amplicon 
size  
(bp) 
 
Annealing 
temperature 
(°C) 
 
ORF37StopFA GACATCGACGGAGGAAGCAG 
340* 
 
461 
 
897 
60 
 
60 
 
53.2-59.4 
ORF37StopRB 
ORF37F652 
ORF37R55,221 
5’b-actin 
3’b-actin 
GTCTTTGATGTTGCC AGGAG 
CTGGACACTGCT TTCAATGTG 
GTAGTTGTGTGCAGGATTCAC 
ACCCTAAGGCCAACCGTGAA 
AAACAAAGCCATGCCAATGT 
 
* If fragment contains 17bp insertion would expect a fragment size of 357bp 
 
2.6.1 Validation of viral diagnostic PCR through restriction enzyme digestion 
Following diagnostic PCR protocol, PCR products from MHV68, ORF37Stop and 
ORF37StopRev were digested with HpaI (Roche), a restriction endonuclease which 
cuts double stranded DNA at 5'-GTT^AAC-3' producing blunt ends. 15 µl of PCR 
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product  was digested with 1µl HpaI in the presence of 2.5 µl 10X SuRE/Cut Buffer 
A  and 6.5µl of water the mixture was then incubated at 37°C for 2 hours. 
 
2.7 Preparation of cDNA for reverse transcription (RT)-PCR amplification 
RNA extraction was performed using the RNeasy mini kit (Qiagen) along with the 
Qiagen RNase-free DNase kit following the manufacturer’s instructions, in brief:  
RNA samples isolated from cells were defrosted and 1 volume of 70% ethanol was 
added and mixed well by pipetting. 700μl of the sample was added to an RNeasy 
spin column placed in a 2ml collection tube. Tubes were centrifuged for 15 seconds 
at 8000 x g (10,000 rpm) and the flow-through was discarded. Buffer RW1 (350 μl) 
was added to the RNeasy spin column and was centrifuged for 15 seconds. 
Following each centrifugation step the flow-through was discarded and unless 
otherwise stated all centrifugation steps were at 8000 x g (10,000 rpm). Then 10μl 
DNase I stock solution was added to 70µl Buffer RDD, which was subsequently 
pipette directly onto the RNeasy spin column membrane, and place on the benchtop 
(20–30°C) for 15 minutes. The spin column was then washed by adding 350μl Buffer 
RW1 and centrifuging for 15 seconds.  Then 500μl buffer RPE was added to the 
RNeasy spin column and centrifuged for 15 seconds to wash the spin column. The 
column was then washed a second time in the same way as above, but this time the 
sample was spun for 2 minutes, to ensure that no ethanol is left in RNA sample. The 
RNeasy spin column was then placed in a 1.5ml microfuge tube and 50μl Sigma 
water was added directly to the spin column membrane, and centrifuged for 1 minute 
to elute the RNA. RNA concentration was measured using the Nanodrop (ND-1000) 
spectrophotometer.  
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cDNA was then synthesised using the following protocol. Initially, a mixture was 
made that consisted of 2µg of RNA, 1µl random primers (250ng), 2µl dNTPs (5mM) 
made up to 13µl with Sigma water. The reaction mixture was heated at 65
o
C for 5 
minutes and snap-cooled on ice for 5 minutes before a brief spin. To the mixture, 
four µl of first strand synthesis buffer was added along with two µl 0.1M DTT.  The 
contents were gently mixed and incubated at 42
o
C for two minutes. To the mixture 
one l of SuperScript II was added and mixed by repeated pipetting before it was 
incubated at room temperature (25
o
C) for 10 minutes. The contents were then 
incubated at 42
o
C for two hours before it was inactivated by heating at 70
o
C for 15 
minutes. The temperature was then decreased to 37
o
C for 10 minutes. After the 
contents had been spun briefly one l of RNAse H was added, and incubated at 37oC 
for 20 minutes. For each RNA preparation, a control reaction lacking the reverse 
transcriptase was also prepared.   
 
2.7.1 Quantitative PCR (qPCR) 
Quantitative PCR reactions were carried out in 20µl volumes. Each reaction 
contained 1 U of Platinum Taq DNA Polymerase, 500 nM of each oligonucleotide 
primer, 1x PCR buffer (20 mM Tris HCl, 50 mM KCl), 2.5 mM MgCl2 and 200 µM 
nucleotides (dATP, dCTP, dGTP and dTTP), and one µl of cDNA. In addition, one 
µl of 10x SYBR green, one µl 3% Triton X-100 (v/v) and 0.4µg of BSA were also 
added to each reaction. All the primers used are listed in table 2.2 and were supplied 
by Sigma-Genosys or MWG-Eurofin and stored in a stock solution of 100µM at -
20°C. 
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The qPCR amplification program consisted of an initial denaturation step at 95°C for 
10 seconds, annealing at a gene-specific annealing temperature for 20 seconds, and 
primer extension at 72°C for 15 seconds. A final step of one second at 75°C was 
introduced to melt off any possible primer dimer formations before fluorescence 
readings were taken. To ensure only the fluorescence signal from the intended 
product was detected for cycle threshold (ct) calculations, melting curve analysis was 
performed at the end of each PCR reaction by melting the PCR products from 65°C 
to 95°C, with 0.2°C increments, with each temperature held for one second. The 
Opticon 2 thermal cycler (Bio-Rad) PCR machine was used for amplifications. 
 
Where possible, absolute quantification of PCR products were performed by 
constructing standard curves using templates listed in table 2.4. The standards were 
serially diluted to give copy numbers ranging from 1x10
11
 to 1x10
5
 and PCR 
amplified in the same way as described above. Where absolute quantification was not 
feasible, the Pfaffl equation was used (Pfaffl 2001), which gives a ratio that takes 
into account both the efficiency and Ct value of the reaction:  
 
           (Etarget) ∆Ct target (control-treated) 
              (Eref) ∆Ct ref (control-treated) 
 
 
2.7.2 Oligonucleotide primers and templates for qPCR 
Oligonucleotide primers used for qPCR assays are shown in Table 2.3 and templates 
used for qPCR standard curves are listed in Table 2.4. 
 
Ratio = 
 73 
 
Table 2.3 Oligonucleotide primer forward and reverse sequences and the 
optimum range of annealing temperatures. 
 
 
Gene Primer name Primer sequence 
 
Annealing 
temperature 
(°C) 
 
 c-fosRT5’ GTCCGGTTCCTTCTATGCAG 
59.4-61.4 c-fos c-fosRT3’ GGTGACCACGGGAGTACACA 
 cyclophilinRT5’ GGATTTGGCTATAAGGGTTC 
55.3-61.4 cyclophilin cyclophilinRT3’ CTGCCGCCAGTGCCATTATG 
 5’RTeEf_Tu GTCACACAGCCCACATAGCA 
59.4 eEf_Tu 3’RTeEf_Tu CGCCAGACTTCAGGAACTTG 
 5’RT18SrRNA CATTGGAGGGCAAGTCTGGT 
59.4 18s rRNA 3’RT18SrRNA CCCAAGATCCAACTACGAGC 
 5’b-actin ACCCTAAGGCCAACCGTGAA 
53.2-59.4 β-actin 3’b-actin AAACAAAGCCATGCCAATGT 
 
 
Table 2.4 Gene templates used for producing qPCR standard curves. 
 
 
Gene 
Template sequence 
 
c-fos 
GTCCGGTTCCTTCTATGCAGCAGACTGGGAGCCTCTGCA
CAGCAATTCCTTGGGGATGGGGCCCATGGTCACAGAGCT
GGAGCCCCTGTGTACTCCCGTGGTCACC 
   cyclophilin GGATTTGGCTATAAGGGTTCCTCCTTTAGAATTATTCCAG
GATTCATGTGCCAGGGTGGTGACTTTACACGCCATATTG
GCACTGGCGGCAG 
      eEf_Tu GTCACACAGCCCACATAGCATGCAAGTTTGCTGAGCTTA
AAGAAAAGATCCATCGTCGTTCTGGTAAGAAGCTGGAA
GATGGCCCCAAGTTCCTGAAGTCTGGCG 
  
 
18s rRNA 
CATTGGAGGGCAAGTCTGGTGCCAGCAGCCGCGGTAATT
CCAGCTCCAATAGCGTATATTAAAGTTGCTGCAGTTAAA
AAGCTCGTAGTTGGATCTTGGG 
 
 
 
 74 
 
2.8 Diagnostic PCR for plamid preps 
All reaction were carried out in 20µl volumes using the same reaction mixture as the 
one stated in section 2.6, but without the addition of SYBR green, triton X-100 or 
BSA. The primers used are listed in table 2.2 and reactions were amplified using the 
same parameters stated in section 2.6. 
 
2.9 Agarose gel electrophoresis 
PCR products were resolved on 2% (w/v) agarose gels in 1X TAE Buffer. A size 
marker (Generuler DNA Ladder mix) was used on every gel throughout the project. 
Five µl of 10mg/ml ethidium bromide was added to 100 ml of agarose prior to 
pouring the gel. Unless stated otherwise, 10 µl of sample were mixed with 2µl of 6x 
loading dye (Fermentas) and the mixture was loaded into the wells of the gel. 
Plasmid DNA was run on 1% (w/v) agarose gel in the same way as described above. 
The gels were viewed under UV transillumination at a wavelength of 302 nm and 
images recorded using GeneSnap software (Syngene). 
 
2.10 Sequencing  
Sequencing was provided by Cogenics. Samples were prepared according to 
specifications provided by Cogenics, labelled with the respective codes and sent 
together with respective forward and reverse primers to Cogenics. Sequencing output 
was aligned using the BioEdit programme to compare sequences and check for 
insertion sequences. 
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2.11 Southern Blot 
2.11.1 Isolation of viral genomic DNA for Southern blot hybridization 
An appropriate amount of virus stock to give approximately 5x10
7
 pfu was added to 
a 38.5ml Beckman Ultracentrifuge tube, which was filled with media and were then 
spun in the Beckman Ultracentrifuge, SW28 rotor at 20,000 x g (11,000rpm) for two 
hours at 4
o
C to pellet the virions. Media was removed and 400 µl of lysis buffer was 
added to the pellet, which was then incubated at 53
o
C overnight. DNA was extracted 
with an equal volume of phenol/chloroform. Mixed gently by inversion of tube and 
then incubated at room temperature for 10 minutes followed by centrifugation at 
13,000rpm for 10 minutes, then the top (aqueous) layer was carefully pipetted off. 
The phenol/chloroform extraction was then repeated two further times. Then DNA 
was extracted from the aqueous phase with an equal volume of chloroform and 
mixed gently by inversion of the tube. The samples were then incubated at room 
temperature for 10 minutes and centrifuged for 10 minutes at 13,000rpm and 
subsequently the top layer was removed. To the remaining DNA pellet 1/3 volume of 
ammonium acetate (7.5M) was added followed by two volumes of 96% ethanol, 
which was then mixed gently and left at -20
o
C overnight. The following day the 
solution was spun at 13,000rpm for 10 minutes. Then carefully decanted off the 
waste supernate leaving the DNA pellet, to which 100µl of 70% ethanol was added 
to wash the pellet. After a further centrifugation at 13,000rpm for 15 minutes the 
supernate was removed and the pellet was left to air-dry for 10 minutes. DNA was 
re-suspended in 50µl of pure sterile water. 
 
Restriction enzyme digests were carried out on viral genomic DNA in a similar way 
described in section 2.6.1.1. Digests were carried out in 40µl reactions, which 
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contained approximately 1U of the restriction enzyme HpaI (Roche), and 1µg of 
DNA. Reactions were incubated at 37
o
C overnight. 
 
2.11.2 Southern blotting 
Samples were dry-loaded and run on a 0.8% (w/v) gel in 1 x Tris/acetate/EDTA 
(TAE) buffer and run at 80V for 10 minutes. The gel was then completely submerged 
with running buffer and run at 60V for 4 hours. The gel was then washed in 
denaturing solution with gentle agitation for 30 minutes. This was followed by 2 x 30 
minute washes in neutralisation solution. The transfer apparatus consisted of an 
electrophoresis tank partially filled with 10X SSC, with a long strip of 3MM filter 
paper trimmed to fit the width of the gel.  One sheet of nylon membrane was then 
briefly soaked in ddH2O and then in 2X SSC solution.  The gel was rinsed in ddH20 
and placed on the tank. The nylon membrane was then placed onto the gel.  The 
3MM papers (same size as membrane) were then soaked and drained each in 2X SSC 
and placed on the membrane.   Then a stack of paper towels were placed onto the 
membrane/filter stack along with a weight to facilitate transfer and left overnight. 
The following day the membrane was placed between two 3MM filter papers and 
oven-baked for 30 minutes at 120
o
Cbefore being left to air dry at room temperature 
for 30 minutes. 
 
2.11.3 Radio-labelling of DNA probes 
A PCR product corresponding to 340bp fragment of ORF37 was used to generate 
radiolabelled probes.  The 340bp fragment was amplified from MHV-68 WT virus 
stock using primers ORF37StopFA and ORF37StopRB listed in table 2.2 using the 
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PCR protocol detailed in section 2.6.1. The PCR product was then resolved on a 1% 
TAE low-melting point gel (microsieve). The DNA band corresponding to 340bp 
was cut out and DNA extracted using the Qiaquick Gel extraction kit (Qiagen) 
following the manufacturer’s instructions. The purified PCR product was eluted in 
sterile water and the concentration was determined using the Nanodrop (ND-1000) 
spectrophotometer. Approximately 49ng of purified amplified DNA was made up to 
a volume of 45µl in Tris/EDTA (TE) buffer, which was subsequently denatured by 
heating at 100
o
C for 2 minutes then placed immediately on ice. The denatured DNA 
was then added to Ready-to-go DNA labeling beads (Amersham) along with 5µl     
α-32P dCTP (Perkin-Elmer), which was mixed by gentle pipetting. This was then 
incubated for 20 minutes at 37
o
C. Prior to use, the probe was denatured at 100
o
C for 
2 minutes and then placed on ice.  The probe was used within one week of synthesis.  
 
2.11.4 Hybridisation and detection of nucleic acids 
The blot was placed in a Techne hybridization tube along with 10 ml of pre-warmed 
(68
o
C) Ultrahyb solution and incubated for 30 minutes at 42
o
C in the hybridization 
incubator. Approximately, 15µl of probe was then added to the hybridization tube 
and left to hybridise overnight at 42
o
C. The hybridization mix was decanted and the 
blot was washed 2x5 minutes with wash buffer 1 at 42
o
C. This was followed by 2x15 
minute washes with wash buffer 2 at 42
o
C. The blot was then removed from the 
hybridization tube, covered with cling film and placed in a cassette with a 
PhosphorImager screen, which was left overnight and then scanned the following 
day. The PhosphorImager system is a quantitative imaging device, which is 15-250-
fold more sensitive than x-ray when used to detect 
32
P (Johnston et al. 1990).  
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2.12 Protein Assay 
Total protein quantification of each sample was determined through the Bradford 
assay. Either immunoglobulin G or bovine serum albumin were used as standards (1 
mg/ml to 31.25 µg/ml), prepared in 20µl of water. Each sample was subjected to two 
serial 2-fold dilutions, in 20µl of water. Samples were vortexed and spun down in 
between dilutions. Each of the samples and standards were added to 1ml of Bradford 
reagent, briefly vortexed and incubated at room temperature for 5 minutes. 
Absorbance of samples was measured in triplicate at 595 nm; the average of each 
standard was determined and used to plot a calibration curve. Samples absorbance 
was averaged and total protein concentration calculated using the calibration curve. 
A new calibration curve was determined for each assay. 
 
2.13 Western blotting 
2.13.1 SDS-PAGE 
Glass plates were cleaned with ethanol and Biorad western blotting apparatus was 
assembled following manufacturer guidelines. Resolving gel was made, which 
consisted of a 10% (w/v) acrylamide concentration, to resolve proteins between 20-
80kDa. After each component was added the glass universal was inverted gently to 
mix. Gel mix was added to each plate set, leaving sufficient room for the stacking 
gel, the gel was then overlayed with 100% ethanol and left to set. A 5% stacking gel 
was then made, again after adding each component the glass universal was inverted 
to mix. Once the resolving gel had set the plates were inverted to remove ethanol and 
then the stacking gel was pipetted on-top of resolving gel. The combs were inserted 
and the gel was left to set. 
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Once the gel had set the combs were removed and the wells were rinsed out with RO 
water. The gel was then mounted in the electrophoresis cell (gel facing inwards). The 
wells were then filled up with 1xSDS-PAGE running buffer and then 20-40µg of 
protein for each sample was added per well. The SDS-PAGE (1x) running buffer was 
poured into the inner buffer compartment covering the wells and then the rest of the 
running buffer was poured into the outer compartment. The gel was then run at 
40mA (200V) at a constant current for 30-40 minutes until the dye front migrated off 
the end of the gel. Apparatus was dismantled and the glass plates were gently prised 
apart using the plastic wedge. Then using the sharp end of the wedge the stacking gel 
was removed from the main gel. 
 
2.13.2 Sample preparation 
An equal volume of 2x sample buffer (Appendix C) was added to each protein 
sample to give a final 1x concentration of sample buffer. The sample was then heated 
at 95°C for 4 minutes and then spun for 30 seconds to pellet any debris or insoluble 
precipitate. 
 
2.13.3 Protein transfer to membranes 
The Hybond-P membrane was cut to the size and pre-wetted in RO water. The 
membrane was then equilibrated in transfer buffer for 15 minutes. Then the gel was 
soaked in the above mentioned transfer buffer for 15 minutes along with 4 pieces of 
thin filter paper to pre-wet. Two sheets of filter paper were placed on the anode of 
the Bio-Rad Transblot semi-dry transfer cell and the membrane was placed on the 
top. The gel was placed on top of the membrane and then sandwiched between two 
more pieces of filter paper. The cathode was then placed on top of the stack and the 
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latches engaged. Once the plastic safety cover was on the transfer cell was plugged 
into the power supply and transfer took place at 10V for one hour. Efficiency of 
transfer was assessed by staining the transferred gel in Coomassie blue. 
 
2.13.4 Colourmetric detection of blotted proteins 
Following transfer, the membrane was rinsed in 20ml of TBS (1 x Tris-Buffered 
Saline) for 2 minutes and then blocked in 10 ml of blocking buffer for one hour at 
room temperature or overnight at 4ºC.   The membrane was then incubated in the 
first antibody, which was either rabbit anti-βactin (Abcam), rabbit anti-myc or mouse 
anti-penta His (Qiagen) in 10ml antibody dilution buffer at room temperature for one 
hour with gentle agitation. The membrane was then washed 3 x 5 minutes with wash 
buffer. The second biotinylated antibody, goat anti-rabbit (Vector labs) or rabbit anti-
mouse (Sigma) was then added to the membrane and left at room temperature for one 
hour with gentle agitation. Approximately 15 minutes before the end of incubation 
with the second antibody, the ABC Vectastain solution (Vector labs)  was prepared: 
to 10ml of 1 x PBS, 2 drops of solution A were added followed by 2 drops of 
solution B the solution was mixed by inverting the tube a few times. The membrane 
was then washed in 1x PBS (3 x 5 minutes). The ABC complex was added to the blot 
and agitated for 30 minutes before it was rinsed in PBS (3 x 5 minutes). The 
membrane was then incubated in 100mM Tris-HCL pH 9.5 for 10 minutes with 
agitation. The BCIP/NBT solution (Vector labs) was then made 5 minutes before 
use, the solution was mixed well following the addition of each reagent: to 5ml 
100mM Tris-HCL pH 9.5, 2 drops of reagent 1, 2 drops of reagent 2, 2 drops of 
reagent 3 and 1 drop of levamisole were added. The NBT substrate mix was added to 
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the membrane with constant agitation and the colour development was monitored. 
The substrate solution was decanted and water added to the blot to stop the reaction.  
 
2.13.5 Enhanced chemiluminescence (ECL) detection of blotted proteins 
After transfer from gels, the ECL (nitrocellulose) membrane was rinsed in TBS (1 x 
Tris-Buffered Saline) for 2 minutes and then blocked in 10ml of blocking buffer for 
one hour at room temperature or overnight at 4ºC.  The membrane was then 
incubated in the first antibody, which was either rabbit anti-βactin (Abcam) or mouse 
anti-penta His (Qiagen) in 10ml antibody dilution buffer at room temperature for one 
hour with gentle agitation. The membrane was then washed 3x 5 minutes with wash 
buffer. The second HRP-conjugated antibody, ECL anti-rabbit (GE Heathcare) or 
anti-mouse HRP-linked was then added to the membrane and left at room 
temperature for one hour with gentle agitation. The membrane was then washed as 
stated above and the Immobilon Western chemiluminescent HRP substrate 
(Millipore) was prepared just prior to use, by mixing equal volumes of the two 
reagents in a universal. Excess wash buffer was drained from the membrane and then 
3ml of the ECL reagent was applied, covering the membrane, which was then left for 
5 minutes. After draining excess ECL reagent from membrane, it was placed on a 
glass plate and wrapped in cling film. The blot was then placed in an X-ray film 
cassette and in the dark room Amersham hyperfilm-ECL (GE Healthcare) was placed 
onto blot and exposed for between 30 seconds and 10 minutes, then placed in 
developer. After approximately 30 seconds the film was rinsed in running water for 
one minute and then into fixer for 5 minutes and again rinsed in running water and 
finally hung to dry. 
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2.14 In vivo infection 
2.14.1 Infection 
Groups of αβRKO female mice were inoculated intranasally with 4 x 105 pfu MHV-
68, ORF37Stop or ORF37StopRev virus. Approximately 40µl of virus was 
administered intranasally to lightly anaesthetized (halothane anaesthesia) mice. After 
three days and six days post-infection mice were euthanised following Schedule 1 
procedures using CO2.  Lungs, spleens and mediastinal lymph nodes (MLN’s) were 
harvested and kept at -80 ºC (Dutia et al. 1999). 
 
2.14.2 Harvesting and homogenisation of organs for virus titration 
Using a sterile disposable blade, one of the lobes of the lung was removed and placed 
into a cryovial for further work. The rest of the lung was left to thaw completely on 
ice. Once thawed the lung tissue was placed into a glass homogenizer. Tissues were 
homogenised with 10 strokes in the homogeniser and then allowed to cool down for 
2 minutes on ice.  This process was repeated until no large tissue fragments could be 
seen by the naked eye. The debris was allowed to settle in the homogenizer.  Using a 
long neck glass Pasteur pipette, the clear supernate was removed placed in a 
cryovials and kept at -80ºC. 
 
2.14.3 Titration of virus isolated from organs 
Lung homogenates were freezed-thawed twice to disrupt any remaining intact cells 
and to facilitate the release of virus particles.  This entailed samples being placed on 
dry ice for 10 minutes, before thawing in a 37
o
C water bath for 2 minutes.  This cycle 
was repeated once more and the tubes were then spun at 3000rpm for 5 minutes. The 
virus preparation was then serially diluted by adding 440l of the supernate to 4 ml 
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of medium, giving a 1 in 10 dilution. 440l was then taken and placed in a tube 
containing 4 ml of medium to give a 1 in 100 dilution. This process was repeated up 
to the 10 
-6
 dilution.  440l was removed fromthe last dilution and discarded.  To 
each dilution, 200l of cells (1 x106) was added and tubes were placed on a shaker 
(300rpm) at 37
o
C for one hour.  From each bijou tube, two ml was removed and 
added to a 60 mm Petri dishes.  Each preparation resulted in two Petri dishes 
(duplicated plates). Each Petri dish was topped up with three ml of fresh medium to 
bring up the total volume in each dish to 5ml. A control was set up which consisted 
of two petri dishes with cells only.  Dishes were left in the incubator for four days, 
fixed with formaline and then stained with 0.1% toluidine blue.  Finally, plaques 
were counted and the pfu/ml calculated. 
 
2.15 mRNA Poly (A) tail Assay 
2.15.1 Labelling of poly (A) tails  
Poly (A) tail labelling was carried out using a reaction master mix which consisted of 
l 5X Poly (A) buffer, l Poly (A) enzyme (<100 units), 1l [-32P]dATP 
(10Ci) made up to a total volume of 10µl with sigma water.  The master mix was 
added to 10 l of RNA (5g), mixed by pipetting and then incubated at 37 oC for one 
hour. Following the incubation period 30l of water was added to bring up the 
volume to 50l. Then 50l of phenol/chloroform was added, mixed by vortexing and 
spun for 5 minutes at room temperature.  The upper aqueous phase was transferred 
into a new tube and 50l of chloroform was added, mixed by vortexing and 
microfuge spun for 5 minutes at room temperature, the upper aqeuous phase was 
then removed. Ethanol precipitation was then carried out using 0.3 volume of NaAc 
(3M, pH 5) and 2.5x volume of 100% ethanol. The mixture was inverted several 
 84 
 
times and incubated at -20
o
C overnight. The following day, samples were spun for 15 
minutes at RT and the supernate was removed. The pellet was rinsed in 100l of 
70% ethanol and spun for 5 minutes at room temperature. After removing the 
alcohol, pellets were allowed to air dry for 15 minutes before being re-suspended in 
20 l of Sigma water. 
 
To make sure equal amunts of labelled RNA were used in subseqauent steps, 
labelling efficiency was measured by a scintillation counter. For this, two l of each 
sample of labelled RNA was added to two ml of scintillation liquid and counted. 
From the counts, the volume giving one million counts was determined for the next 
step. One million cpm counts of each RNA sample were then added to the RNA 
digestion master mix (two l 10X RNaseA/T1 buffer, four l of yeast tRNA (5 
g/l), two l of RNaseA/T1) in a total volume of 20µl.  The reaction mix was 
placed on ice until further use.   
 
The samples were incubated at 30
o
C for 30 minutes. The RNA digestion was stopped 
using a stop solution (appendix C), which was added to the RNA and incubated at 
37
o
C for 30 minutes. Following this step the samples were ethanol precipitated and 
pellets dried as above.  Dried pellets were re-suspended in five l of water.  Samples 
were kept at -20C until ready to run on acrylamide/urea gel. 
 
2.15.2 Preparation of denaturing gels to resolve poly(A) tails 
Labelled poly(A) RNA was separated on 10% polyacrylamide/urea gels using a Bio-
Rad Sequi-Gen GT sequencing apparatus. Initially the glass plate were cleaned using 
water and ethanol, the bottom plate was then wiped with Sigmacoat silicon (Sigma) 
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and left for 5 minutes, following which the plate was cleaned with ethanol. The gel 
apparatus was then assembled and a shark-tooth comb was placed in between the the 
glass plates. The 10% gel mixture (appendix C) was prepared and then added to the 
glass plates using a syringe, ensuring that there were no bubbles in the gel. The gel 
was then left to set for a couple of hours wrapped in cling fim overnight. 
 
2.15.3 Running of poly (A) tail gels and visualisation of bands 
Once the gel had set the Bio-Rad Sequi-Gen GT sequencing apparatus was 
assembled with 0.5x TBE as the running buffer. The gel was pre-heated to 
approximately 40
o
C. Then one µl gel loading buffer (Ambion) was then added to 
each labelled RNA sample before loading into the gel. Gels were then run at 2000v 
for one to two hours (depending on separation). Gels were removed from glass plates 
using 3MM filter paper and dried at 80
o
C for one hour. Once the gel had dried it was 
placed against a PhosphorImager reactive screen and left overnight. The screens 
were then scanned using the PhosphorImager and data were analyzed with the 
ImageQuant. 
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Chapter Three 
Characterising the growth of an ORF37Stop mutant MHV68 
 
3.1 Introduction 
Recent evidence has demonstrated a central role for the ORF37 gene product in 
mediating loss of cellular transcripts in KSHV and MHV-68 infections and for the 
EBV homologue BGLF5 (Glaunsinger and Ganem 2004b; Rowe et al. 2007; 
Covarrubias et al. 2009). The first study to address the question of how host shutoff 
within the -herpesvirus family may be mediated was demonstrated in KSHV-
infected cell lines by Glaunsinger and Ganem in 2004, using a GFP screening 
method. This entailed transfection of a GFP expressing cell line with each of the 
selected viral genes.  Cells were sorted by flow cytometry to identify viral gene(s) 
whose expression caused reduced or loss of GFP expression. This screening 
approach demonstrated that a single viral gene product caused a significant loss of 
GFP.  This gene product was encoded by KSHV ORF37 (Glaunsinger and Ganem 
2004b).  This was followed by similar observations in MHV68 (Covarrubias et al. 
2009) and EBV (Rowe et al. 2007).  
 
Over the last few years, much work has been undertaken to characterise the RF 
gene product, however, progress has been impeded by the inability of producing 
viable ORF37 mutant viruses, which proved difficult to grow and yield infectious 
virus progeny (Covarrubias et al. 2009; Feederle et al. 2009). The EBV mutant virus 
∆BGLF5, was produced using homologous recombination to substitute part of the 
BGLF5 gene with a gene which encodes for kanamycin resistance. It was observed 
that this virus did not replicate efficiently and quantitative assays looking at the viral 
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genome levels showed a 17 to 21-fold decrease in viral genome copies present in 
cells infected with the mutant EBV virus (Feederle et al. 2009). In another study, a 
deletion mutant of MHV-68 ORF37 was constructed using allelic exchange 
(Covarrubias et al. 2009). Similar to the EBV study, the MHV-68 ORF37 mutant 
virus was also unable to yield infectious progeny (Covarrubias et al. 2009). More 
recently, Richner et al. have produced another MHV-68 ORF37 mutant virus R443I, 
which has a single amino acid substitution, within a domain which they believe to be 
linked to host shutoff (Richner et al 2011).  They found that on a murine fibroblast 
cell line, R443I was able to replicate to similar levels as MHV-68 and their marker 
rescue virus. They suggest that the reason for the mutant being able to replicate is 
due to the DNase function of ORF37 still being intact and so allowing the normal 
viral DNA packaging to take place. However some cellular mRNA degradation was 
still seen with this mutant virus, which may be due to incomplete inactivation of the 
host shutoff function (Richner et al. 2011). The different approaches used to produce 
ORF37 mutant viruses (Covarrubias et al. 2009; Feederle et al. 2009; Richner et al. 
2011) along with the possible problems associated with them indicates (Richner et al. 
2011) the need for further study of ORF37 mutant viruses to further elucidate its 
importance during infection. 
 
3.2 Experimental design 
The experimental approach undertaken in this chapter was aimed at investigating the 
growth characteristics of an engineered MHV-68 ORF37 mutant (ORF37Stop) and 
its corresponding revertant, ORF37StopRev in vitro and in vivo. This strategy 
involved the infection of the mutant, revertant and WT viruses on cell lines aswell as 
infection in mice. Growth characteristics were investigated using plaque assays to 
 88 
 
ascertain if the mutant virus would follow a similar infection path to the revertant 
and WT viruses. The viruses were engineered in collaboration with Dr Bernadette 
Dutia (Edinburgh University) using BAC technology (see Chapter 2.3.1 and Figure 
2.1).  
 
3.3 Results 
3.3.1 Construction of MHV-68 ORF37 mutant and revertant viruses 
To produce an ORF37Stop mutant virus a 17bp sequence, which contained three stop 
codons along with a restriction enzyme cut site for HpaI was inserted at the 
beginning of ORF37 at nt 54157. The 17bp sequence was inserted into a PCR 
product spanning the Hpy991 site at nt 53949 and the SacI site at nt 54270 (Figure 
3.1A). After the ORF37Stop and ORF37StopRev viruses had been produced (see 
chapter 2.3.1) a Southern blot was carried out to check for presence of the mutation 
in the viral genomic DNA using a probe encompassing nt 53949-54270 (Figure 
3.1B).  After RE digest the mutant virus was expected to cut the probed area into two 
fragments for the ORF37Stop virus, but would yield just one fragment from the 
ORF37StopRev virus. Figure 3.1B shows the Southern blot which confirmed that the 
mutation had been inserted into ORF37 and at the correct position. 
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Figure 3.1 Construction of MHV-68 ORF37Stop mutant and revertant viruses.  
A) The ORF37 gene begins at nt 54129, the 17bp sequence was inserted at nt 54157 
which corresponds to the end of ORF36. Arrows indicate position of primers used 
during construction of ORF37Stop and ORF37StopRev viruses. B) Virus stocks were 
pelleted at high speed, before undergoing phenol/chloroform extraction and ethanol 
precipitation. The viral DNA was then cut overnight with the RE HpaI. 20µg of 
gDNA was then ran on a 1% (w/v) TAE gel along with a DNA ladder, the gel was 
imaged to later decipher fragment size before being transferred overnight onto nylon 
membrane. The membrane was then probed with a 340bp radiolabelled probe for the 
area of interest. Southern blot shows ORF37Stop (mutant) and ORF37StopRev 
(revertant), sizes of fragments are indicated on the left-hand side. 
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3.3.2 Diagnostic PCR to verify mutation within ORF37 gene  
A diagnostic PCR was carried out on ORF37Stop (mutant), ORF37StopRev 
(revertant) and WT MHV68. The primers used amplify a 340bp fragment for WT 
and revertant viruses and a 357bp fragment for mutant viruses (Figure 3.2A). After 
PCR was carried out each of the viral PCR products was cut using the restriction 
enzyme HpaI. Because there is no HpaI site in either WT virus or revertant virus, 
then the expected outcome would be a single product of 340bp.  In contrast, the 
presence of the HpaI site within the mutant virus should yield two products of 230 
and 137 bp sizes (Figure 3.2A). Figure 3.2B clearly shows the digestion of PCR 
products from cells infected with WT and revertant viruses with HpaI yielding a 
single PCR product of 340 bp, whereas digestion of PCR products from cells 
infected with ORF37Stop virus yielded two products.  Taken together these data 
clearly show that (1) the insertion (to generate mutant virus) and removal (to obtain 
the revertant virus) within the ORF37 had been successful, and (2) the mutant virus 
did not show any signs of revertion to wild type genotype.  Amplified PCR products 
were also sequenced to confirm that the 17bp fragment contained the three stop 
codons. Figure 3.2C shows the sequencing results from the forward primer for 
ORF37Stop and ORF37StopRev, which confirmed that the three stop codons were 
present in the 17 bp insertion sequence in the ORF37Stop virus, along with the HpaI 
cut site. The diagnostic PCR and RE digest were carried out throughout experiments 
to ensure that the mutation was present and that reversion did not occur due to 
repeated infections.  
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   bp                                      -ve              Mut        Mut (cut)      Rev        Rev (Cut)     WT  
 
 
 
 
 GGATTTTTTTGA~~~~~~~~~~~~~~~~~~~~~AAAGGATGATTTGCTGGAAGT ORF37StopRev 
 GGATTTTTTTGAGCGTAGTTAACGTGTAGAAAGGATGATTTGTTGGAAGT   ORF37Stop 
  
  
Figure 3.2 Diagnostic PCR to identify ORF37 mutant virus. A) Schematic of 
ORF37 gene depicting PCR fragment size and size of RE cut fragments. B) PCR 
amplification of ORF37 from virus stocks.  Amplification was performed with 
primers to yield a 340bp fragment or 357bp fragment if mutation was present. After 
RE digest with HpaI 15µl of PCR product was run on a 2% (w/v) TAE 
electrophoresis gel. Bands correspond to PCR products for ORF37Stop (Mut), 
ORF37StopRev (Rev) and MHV68 (WT), cut and uncut.  C) Sequencing data from 
ORF37StopRev and ORF37Stop from forward primer amplification, ORF37Stop 
contains the 17 bp inserted sequence with three stop codons highlighted in red and 
the HpaI RE site in italics. 
400 
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3.3.3 Growth characteristics of ORF37Stop and revertant viruses in vitro  
Previous work had found that growth of a mutant ORF37 virus was severely 
attenuated in NIH3T3 cells (Dutia and Ebrahimi, pers. Comm.).  One possible 
obstacle to virus growth is inhibition by type I interferons.  Therefore, an attempt 
was made to propagate the mutant viruses in cells which cannot respond to type I 
IFN, and as result, are unable to mount an effective anti-viral response (Dutia et al. 
1999).  
 
To characterise the growth of the ORF37 mutant virus compared to WT and revertant 
MHV-68 viruses in an immuno-compromised cell line, IFNαβRKO cells were 
infected with each virus. After infection, cells were harvested every five hours until 
30 hours post-infection. The virus titre was determined using plaque assays, the 
pfu/ml was calculated and the growth curve for each virus was plotted (Figure 3.3).  
After initially replicating to 3x10
2
 pfu/ml at 5 hours post-infection (hpi) the 
ORF37Stop virus titre raised steadily to 1.4x10
5
 pfu/ml at 30 hpi.  As can be seen 
from Figure 3.3 both MHV-68 and the revertant viruses followed similar infection 
paths to the mutant virus indicating that there was no attenuation of mutant virus 
growth. This can also be seen as there is no significant difference between the end 
titres at 30 hpi of mutant virus (1.4x10
5
) compared to either revertant (1.4x10
5
) or 
WT (2.7x10
5
) (p values > 0.05). Figure 3.3 depicts the results from one experiment, 
however the one step growth curve was conducted twice, showing similar results to 
those seen in figure 3.3. These findings meant that further work could be carried out 
using ORF37Stop in IFNαβRKO cells as it could be compared to WT and revertant 
viruses without bias because of impeded growth.  
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Figure 3.3 Growth characteristics of MHV68 ORF37 mutant and revertant 
viruses in IFNαβRKO cells.  Six-well plates were seeded with 5x105 IFNαβRKO 
cells, the following day the cells were infected with ORF37Stop, ORF37StopRev and 
WT MHV68 at an MOI of 5. At 5 hour intervals cells were harvested until 30 hours 
post-infection. Samples then underwent three freeze-thaw cycles before each sample 
was diluted in media to give five dilutions ranging from 10
-1
 to 10
-5
, to each dilution 
1x10
6
 cells were added and bijoux were incubated at 37ºC for one hour. Following 
incubation each sample was added to 4ml media in 60mm petri dishes and incubated 
at 37ºC. After four days cells were fixed with formalin and stained with toluidine 
blue, plaques were counted and the pfu/ml was calculated. Results are from one 
experiment, values are an average of three replicates +/- SD. 
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3.3.4 Growth characteristics of ORF37Stop and revertant viruses in IFNαβRKO 
mice 
Once it had been established that the mutant virus did not show any attenuated 
growth in vitro (Figure 3.3), the next step was to characterise growth of the ORF37 
mutant virus in vivo. This is an important step as characteristics identified in cells 
may differ in vivo, this is due to the increased complexity of the immune response to 
the virus (reviewed by Randall and Goodbourn 2008). Therefore, IFNαβRKO mice 
were infected with the ORF37Stop virus and the corresponding revertant virus via 
the intra-nasal (respiratory) route.  Lungs were harvested on days three and six post-
infection.   Lungs from each mouse were divided into two equal parts: one half was 
homogenised and viral titres were determined using plaque assays; the other half was 
used to obtain RNA for use in the diagnostic PCR assay to assess the likelihood of 
reversion to wild type genotype with respect to ORF37. 
 
After three days of infection plaques were identified from samples from lungs of 
IFNαβRKO mice infected with all three viruses. Interestingly the mutant ORF37Stop 
virus titre was higher than the WT virus titre although revertant virus titre was the 
highest of the three. Taken together these results pointed to the fact that ORF37Stop 
can cause lytic infection in IFNαβRKO mice, levels of which were similar to virus 
titres from mice infected with revertant and wild type viruses. However a significant 
difference was seen in virus titres from mice infected with ORF37Stop compared to 
mice infected with ORF37StopRev (p=0.02) and WT (p=0.003) at 6 dpi.  This 
difference can best be visualised when comparing how much the virus titre has 
increased from three dpi to six dpi, with the ORF37Stop pfu/ml only increasing by 
1.8-fold compared to a 56-fold increase in revertant virus-infected lungs. These 
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results suggest that once the infection has become established in the lungs the mutant 
virus growth is restricted by other immune response factors. 
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Figure 3.4 Growth characteristics of ORF37 mutant and revertant viruses in 
IFNαβRKO mice lungs IFNαβRKO mice were intranasally infected with 40µl of 
either MHV68, ORF37Stop or ORF37StopRev at 4x10
5
pfu/mouse. At three and six 
days post-infection, the mice were euthanised and their lungs were harvested. Half of 
each mouse lung was homogenised to release virus particles and viral titres were 
determined by plaque assay.  ORF37Stop (3 & 6 dpi) n=4, ORF37StopRev (3 dpi) 
n=4, ORF37StopRev (6 dpi) n=3, MHV-68 (3 & 6 dpi) n=3. Each bar on the graph is 
the average titre of half mouse lungs +/- SD. 
 
 
 
 
 
 
P=0.02 
P=0.003 
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3.4 Discussion 
Investigating the role of ORF37 and its homologues during viral infection has proved 
difficult. This has been due to the inability to produce mutant viruses that could 
replicate to the same levels as WT viruses in immunocompetent cell lines 
(Covarrubias et al. 2009; Feederle et al. 2009). The recent study by Richner et al., 
which used a host shutoff point mutation virus to study ORF37, found unexpected 
results. However the reliability of these results must be brought into question as they 
still saw increased mRNA degradation compared to mock infected cells, suggesting 
that they may have only partially inactivated host shutoff (Richner et al. 2011). This 
chapter has addressed the previously seen problems, through the use of a complete 
ORF37 mutant virus in an immuno-compromised cell line, the results of which 
insinuate a role for ORF37 in innate immune evasion, which was then also seen in 
vivo. 
 
Retrieval of the ORF37Stop BAC virus from immunocompetent MEF cells had 
proved difficult.  These data suggest that lack of function (s) afforded by the ORF37 
product is vital in virus growth and subsequent egress from infected cells. This 
phenotype has also been identified in other studies where the partial or complete 
deletion of the ORF37 gene or its homologues has taken place (Covarrubias et al. 
2009; Feederle et al. 2009). Studies carried out on an ORF37 deletion mutant had 
suggested that the reason for the lack of mutant virus replication was due to ORF37 
playing an essential role in viral DNA replication (Covarrubias et al. 2009). Work 
carried out on the EBV BGLF5 null virus also found that deletion of the ORF37 
homologue led to impaired nucleocapsid maturation, reduced egress and a reduction 
in viral DNA synthesis. Although they did find that despite these impairments 
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morphologically intact BGLF5-null viruses could be identified, suggesting that 
BGLF5 plays a modulatory role, rather than an essential role in viral replication 
(Feederle et al. 2009). How essential ORF37 is in MHV-68 infection has also been 
addressed using signature-tagged mutagenesis, with conflicting results, as it was 
found to be non-essential in BHK-21 cells (Song et al. 2005), but attenuated in Vero 
cells (Moorman et al. 2004), suggesting that the cell type in which the mutant virus is 
grown will have an impact on the ability of these viruses to complete a successful 
cycle of infection. However these results are difficult to explain as Vero cells are 
derived from African green monkey kidney cells and have been found to be defective 
for interferon production (Desmyter et al. 1968). The importance of the innate 
immune response to MHV-68 is well documented (Dutia et al. 1999; Nash et al. 
2001).  This along with the increased susceptibility of HSV-1 vhs mutant viruses to 
IFNα and IFNβ (Suzutani et al. 2000) leads to the possibility that the ORF37 gene 
product may provide a window of opportunity for the virus to grow in the presence 
of type I IFN-mediated antiviral mechanisms, hence a mutation in ORF37 will leave 
the virus susceptible. This led to the hypothesis that the ORF37Stop virus would be 
able to grow in IFNαβRKO cells, which have an impaired innate immune response. 
 
The findings in Figure 3.3 confirmed our hypothesis and are in concordance with 
work carried out on HSV-2 vhs mutant viruses which also showed attenuated growth 
in immunocompetent MEF cells, growth of which was partially or completely 
restored in IFNαβRKO cells (Duerst and Morrison 2004).  Taken together these data 
suggest that the ORF37 product is playing a similar role to HSV-2 vhs. However 
how the host shutoff mechanism interacts with the host immune response is an 
intricate process as differences have been identified with the highly related vhs 
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proteins of HSV-1 and HSV-2, as HSV-2 vhs has been found to interfere with the 
PKR-activated pathway (Duerst and Morrison 2004), a phenotype which has not 
been identified in HSV1 (Pasieka et al. 2008).  
 
The results from the in vitro growth curve also show that the ORF37Stop mutant 
virus is capable of going through all stages of virus entry, uncoating, gene 
expression, encapsidation, and egress similar to ORF37StopRev and WT viruses 
(Figure 3.3). Our observation that MHV-68 ORF37 mutant was capable of forming 
plaques in immunompetent cells is also similar to observations made with HSV-1 AE 
mutants, where it was shown that infection of HSV-1 AE mutants could grow in 
Vero cells (Weller et al. 1990).  This and other studies also showed viral AE is not 
essential for viral DNA synthesis (Weller et al. 1990; Smiley 2004).  This raises the 
issue of how nuclease mutant viruses process their genomic DNA for example in 
resolution of viral DNA intermediates. It was shown that plasmid DNA 
recombination can occur with very high efficiency in cells infected with an AE 
mutant of HSV-1, suggesting a role for cellular nucleases in resolution of Holliday 
junctions, which exist during herpesviral genomic DNA replication (Martinez et al. 
1996).   A number of cellular nucleases have since been shown to share a significant 
amino acid and structural similarities to viral nucleases, for example flap 
endo/exonucleases (Lieber 1997; Tomlinson et al. 2010).  Of relevance here is the 
observation that HSV-1 vhs (but not HSV-1 AE) shares a significant amino acid 
sequence homology to a flap endo/exonucleases, FEN-1 (Smiley 2004). Therefore, in 
some circumstances, cell-derived nucleases can compensate for loss of viral nuclease 
activity, which may explain, at least in part, plaque formation in exonuclease mutant 
viruses.  
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The next step was to investigate the growth characteristics of the mutant virus in 
vivo.  This is an important step as the interplay between a virus and the in vivo 
immune response is a complex one (reviewed by Randall and Goodbourn 2008), 
which may highlight differences between viral growth in cells compared to the 
animal model. An example of this has been seen with the HSV-1 vhs mutant virus, 
which upon infection in cells exhibited no attenuation of growth. In contrast upon in 
vivo infection the mutant vhs virus showed up to a 100-fold loss of replication at sites 
of both lytic and latent infection (Strelow and Leib 1995). The results from the in 
vivo experiment indicated that after initially reaching a similar level in mice lungs 
3dpi the ORF37stop virus infection was restricted by 6dpi when compared to WT 
and revertant titres (Figure 3.4). These findings concord well  to work carried out on 
HSV-2  vhs mutants, which also showed no attenuation of virus growth in 
IFNαβRKO cells (Duerst and Morrison 2004), but  attenuated growth was observed 
in the genital mucosa (site of HSV2 lytic infection) in IFNαβRKO mice after 
reaching similar titres during the first two days post infection (Murphy et al. 2003). 
These findings along with the results from Figure 3.3 & 3.4 imply that in vivo the 
ORF37 (or vhs in HSV-2) mutant viruses may be more susceptible to other immune 
mediators.  
 
The findings in this chapter and by Murphy et al. implicate the importance of host 
shutoff afforded by vhs (for HSV-2) and ORF37 (in -herpesviruses) for evading 
immune responses during lytic infection (Murphy et al. 2003). Paradoxically, the 
study by Richner et al found that growth of a host shutoff mutant of MHV-68 in 
C57BL/6 mice lungs was not attenuated, suggesting that host shutoff does not play 
an important role in lytic infection, whereas it was suggested that virus host shutoff 
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activity played a role in establishment of latency (Richner et al. 2011). One possible 
reason for the discrepancy between our study (and HSV-2 vhs) and Richner et al. is 
that host shutoff mutant virus, by Richner and colleagues, was generated via a point 
mutation, which still showed residual mRNA degradation compared to mock infected 
cells.  It was suggested by Richner et al. that the host shut off activity still present in 
infection with their ORF37 mutant virus may be due to either incomplete inactivation 
of the host shutoff function or other viral genes contributing towards host shutoff 
(Richner et al. 2011). 
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Chapter Four  
Investigating mRNA decay in IFNαβRKO cells infected with 
ORF37Stop 
 
4.1. Introduction 
The global downregulation of cellular genes during lytic MHV68 infection was first 
identified using microarray technology (Ebrahimi et al. 2003). This global 
downregulation of cellular genes or host shutoff was then also identifed in both 
KSHV (Glaunsinger and Ganem 2004b) and EBV (Rowe et al. 2007) and was found 
to be linked to enhanced mRNA turnover (Glaunsinger and Ganem 2004b; Rowe et 
al. 2007; Covarrubias et al. 2009). Understanding how ORF37 (and its homologues) 
cause host shutoff has been hampered by an inability to generate ORF37 mutants of 
these viruses (Covarrubias et al. 2009; Feederle et al. 2009). Therefore, much of our 
understanding of host shutoff in infections with these viruses has come from ORF37 
or BGLF5 gene constructs in transient transfection experiments often using GFP as a 
marker for loss of mRNA. And a number of different methodologies have then been 
employed to monitor the loss of GFP mRNA and protein in the presence or absence 
of ORF37 (Glaunsinger and Ganem 2004b; Rowe et al. 2007a; Covarrubias et al. 
2009).  
 
Microarray technology was originally used to investigate the effect of MHV68 and 
KSHV on cellular genes (Ebrahimi et al. 2003; Glaunsinger and Ganem 2004a). In 
more recent years qPCR and RNAseq have been employed to further study the effect 
of ORF37 on cellular genes (Clyde and Glaunsinger 2011). The study by Clyde and 
Glaunsinger used qPCR to validate their RNAseq results, they selected a number of 
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different genes and compared their results from the two methodologies. Their 
findings showed a good overall conformity between the two methods, although some 
differences could be seen and they suggest that this may be due to both methods 
being less reliable for rare transcripts than more abundant ones (Clyde and 
Glaunsinger 2011).  
 
4.2 Experimental design 
The primary objective of this chapter was to study the effect of ORF37Stop mutant 
virus compared to ORF37StopRev virus and WT MHV68 in IFNαβRKO cells on 
mRNA degradation and loss of protein. A selection of cellular genes, previously 
shown to be degraded because of MHV-68 infection (Ebrahimi et al. 2003), were 
used as markers of host shutoff using qPCR. The cytoskeletal protein β-actin was 
chosen for Western blotting, as it is a highly conserved, abundant cellular protein. 
 
4.3. Results 
4.3.1 Role of MHV-68 ORF37 in mediating loss of mRNA in IFNαβRKO cells. 
To study the role of ORF37 in cellular mRNA degradation during infection the 
immuno-compromised cell line, IFNαβRKO cells were infected at an MOI of 5 with 
either MHV-68, ORF37Stop or ORF37StopRev. At different times post-infection 
RNA was harvested from cells and was subsequently synthesised into cDNA and 
DNase I treated before qPCR was carried out. A selection of genes was chosen to be 
investigated, which had previously shown a loss of mRNA upon MHV-68 infection 
(Ebrahimi et al. 2003). The cellular gene 18s rRNA was chosen for normalisation, as 
it is highly abundant and has been used in other studies for normalisation (Taddeo et 
al. 2003). As MHV-68 infection is known to cause loss of cellular mRNA, firstly the 
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18s rRNA gene which had been chosen for normalisation needed to be tested to 
ensure that its mRNA was not being degraded. The qPCR results for 18s mRNA for 
ORF37Stop and ORF37StopRev looked similar with almost identical average copy 
numbers (data not shown). These results were in accordance with a HSV study which 
investigated the effectiveness of housekeeping genes for RT-qPCR for their study, 
the results of which indicated that 18s rRNA was the best for normalisation (Nystrom 
et al. 2004).   
 
Original experiments looked at comparing mRNA transcript levels in ORF37Stop 
and ORF37StopRev infected cells. The expected result would be to see loss of 
cellular transcripts in ORF37StopRev cells compared to ORF37Stop. However this 
was not seen for eEf_Tu at either 12 or 24 hpi (Figure 4.1) or other cellular genes 
investigated (data not shown), as a clear difference could not be seen, with p-values 
> 0.05. This led onto a different approach, so that instead of comparing the revertant 
and mutant infections together they would be compared to mock infected cells, 
which produced interesting results. A significant loss of ORF37Stop infected mRNA 
transcripts was seen when compared to levels of mock infected transcripts for the 
three cellular genes investigated. Loss of mRNA was also seen for cells infected with 
MHV-68 and ORF37StopRev (Figure 4.2 – Figure 4.4).  Comparing the results seen 
for ORF37Stop and ORF37StopRev indicated that there was no significant 
difference between the transcript levels of the two infections (p > 0.05), suggesting 
that a similar level of mRNA degradation is taking place in ORF37Stop infected cells 
when compared to ORF37StopRev. Taken together these results suggest that loss of 
certain cellular transcripts is seen in the presence or absence of ORF37 in 
IFNαβRKO cells when compared to mock infected cells 
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Figure 4.1 Comparison of ORF37Stop and ORF37StopRev eEf_Tu mRNA copy 
numbers. IFNαβRKO cells were infected with either ORF37Stop or ORF37StopRev 
at an MOI 5. After 12 and 24 hpi cells were harvested and RNA was extracted using 
the Qiagen RNeasy kit, after which cDNA synthesis took place. qPCR was then 
carried out using primers (Table 2.3) for 18s and eEf_Tu. a) Represented is copy 
number of eEf_Tu normalised against 18s, 12 hpi, each bar represents 3 biological 
replicates, of which there were 2 experimental replicates +/- SD. b) Graph depicts the 
average copy number of eEf_Tu normalised against 18s, 24 hpi, each bar represents 
3 biological replicates, of which there were 2 experimental replicates +/-SD.
P > 0.05 
P > 0.05 
          ORF37Stop                ORF37StopRev 
        ORF37Stop                  ORF37StopRev 
 106 
 
           
 
Figure 4.2  Fold change of cyclophilin mRNA in infected cells compared to mock infected mRNA levels. IFNαβRKO cells were infected 
with either ORF37Stop, ORF37StopRev or WT at an MOI 5 or mock infected. After 12 and 24 hpi cells were harvested and RNA was extracted 
using Qiagens RNeasy kit, after which cDNA synthesis took place. qPCR was then carried out using primers (Table 2.3) for 18s and cyclophilin. 
A) Represented is fold loss of abundance of cyclophilin transcript normalised against 18s, 12 hpi, each bar represents 3 biological replicates, of 
which there were 2 experimental replicates +/- SD. B) Graphs depict the fold loss of abundance of cyclophilin transcript normalised against 18s, 
24 hpi, each bar represents 3 biological replicates, of which there were 2 experimental replicate +/- SD (* = p < 0.05 ** = p < 0.01). 
P > 0.05 
** ** 
    Mock                       WT                  ORF37Stop          ORF37StopRev 
    Mock                       WT                  ORF37Stop          ORF37StopRev 
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Figure 4.3 Fold change of β-actin mRNA in infected cells compared to mock infected mRNA levels. IFNαβRKO cells were infected with 
either ORF37Stop, ORF37StopRev or WT at an MOI 5 or mock infected. After 12 and 24 hpi cells were harvested and RNA was extracted using 
Qiagens RNeasy kit, after which cDNA synthesis took place. qPCR was then carried out using primers (Table 2.3) for 18s and β-actin. A) 
Represented is fold loss of abundance of  β-actin transcript normalised against 18s, 12 hpi, each bar represents 3 biological replicates, of which 
there were 2 experimental replicates +/- SD, calculated from ct values using pfaffl equation. B) Graphs depict the fold loss of abundance of β-
actin transcript normalised against 18s, 24 hpi, each bar represents 3 biological replicates, of which there were 2 experimental replicate +/- SD, 
calculated from ct values using pfaffl equation ( * = p < 0.05 ** = p < 0.01).                   
    Mock                       WT                  ORF37Stop          ORF37StopRev     Mock                       WT                  ORF37Stop          ORF37StopRev 
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Figure 4.4  Fold change of c-fos mRNA in infected cells compared to mock infected mRNA levels. IFNαβRKO cells were infected with 
either ORF37Stop, ORF37StopRev or WT at an MOI 5 or mock infected. After 12 and 24 hpi cells were harvested and RNA was extracted using 
Qiagens RNeasy kit, after which cDNA synthesis took place. qPCR was then carried out using primers (Table 2.3) for 18s and cyclophilin. A) 
Represented is fold loss of abundance of c-fos transcript normalised against 18s, 12 hpi, each bar represents 3 biological replicates, of which 
there were 2 experimental replicates +/- SD. B) Graphs depict the fold loss of abundance of c-fos transcript normalised against 18s, 24 hpi, each 
bar represents 3 biological replicates, of which there were 2 experimental replicate +/- SD ( * = p < 0.05 ** = p < 0.01 *** = p < 0.001). 
p > 0.05 
*** 
*** *** 
    Mock                       WT                  ORF37Stop          ORF37StopRev 
    Mock                       WT                  ORF37Stop          ORF37StopRev 
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4.3.2 Role of MHV-68 ORF37 in mediating loss of cellular proteins in IFNαβRKO 
cells. 
To confirm that the loss of mRNA seen in Figures 4.2 – 4.4 was then also seen at the 
protein level an SDS PAGE gel was run with lysates from IFNαβRKO cells, 24 and 48 
hpi (Figure 4.5A).  Infections were carried out using the same method as described in 
section 4.3.1 and at the indicated time point cells were harvested for protein and a 
protein assay was carried out to elucidate protein concentrations. The banding pattern on 
the gel appears to be slightly lighter for MHV68, ORF37Stop and ORF37StopRev 
lysates 24 and 48 hpi compared to mock infected lysates (Figure 4.5A), although this is a 
subjective method. So to further clarify the result in Figure 4.5 A, Western blotting was 
carried out on cell lysates, again 24 and 48 hpi, this time looking specifically for the 
house-keeping gene β-actin (Figure 4.5B & C). After 24 hpi there is no clear difference 
between mock infected and virally infected levels of β-actin (Figure 4.5B). However 
after 48 hpi a loss of β-actin protein can be seen in virally infected lysates compared to 
mock infected, as the bands from virally infected lysates are lighter than that of the 
mock infected lysate (Figure 4.5C). The results suggest loss of cellular protein is seen in 
the presence or absence of ORF37 when compared to levels of mock infected proteins. 
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Figure 4.5 Protein levels from infected cells compared to mock infected cells. 
IFNαβRKO cells were infected with WT, ORF37Stop or ORF37StopRev and cells were 
harvested at 24 and 48 hours using cell lysis buffer. A) 20µg of cell lysates were 
resolved on 10% polyacrylamide gel. The gel was run at 40mA for 45 mins and then 
stained with coomassie blue for 30 mins before destaining B) Western blot for β-actin 
from protein lysates 24 hours post-infection. C) Western blot for β-actin from protein 
lysates 48 hours post-infection.  
 
 
   Mock                                     WT                           ORF37Stop                     ORF37StopRev 
A
) 
B 
C 
       Mock                       WT          ORF37StopRev     ORF37Stop 
                                  24         48         24          48          24      48 
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4.4 Discussion 
Global downregulation of gene expression or host shutoff during MHV-68 infection was 
first identified using microarray technology (Ebrahimi et al. 2003). The gene identified 
as causing host shutoff was found to be the alkaline exonulease, ORF37 (Glaunsinger 
and Ganem 2004b), however the inability to produce ORF37 mutant viruses 
(Covarrubias et al. 2009; Feederle et al. 2009) has led to difficulties in studying the role 
of ORF37 during infection. Recently a partial deletion mutant virus has been produced 
via a point mutation, although some host shutoff was still seen during infection with this 
virus (Richner et al. 2011). As reported in Chapter 3 the ORF37Stop mutant virus was 
found to cause a productive infection in both IFNαβRKO cells and IFNαβRKO mice. So 
to study the effect of ORF37 during infection mRNA and protein levels were 
investigated from infected IFNαβRKO cells. 
 
The results in this chapter led to the conclusion that loss of cellular mRNA and protein 
levels can take place independently of the ORF37 gene product in infected IFNαβRKO 
cells. Loss of cellular transcripts was observed in cells infected with ORF37Stop virus 
when compared to mock-infected cells (Figure 4.2 - 4.4).  Moreover, loss of mRNA was 
also reflected at the protein level (Figure 4.5). These findings indicate that in an 
immuno-compromised cell line host shutoff is taking place regardless of the presence or 
absence of ORF37, suggesting that another host shutoff factor may be causing loss of 
mRNA. However CPE was seen during infections and so it is possible that some of the 
loss of mRNA and protein identified in infected cells when compared to mock infected 
cells may be due to lytic infection. 
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A dual method of host shutoff has been identified in HSV-1 infection, the first is through 
ICP27, which causes a re-distribution of snRNPs, disrupting the splicing machinery 
(Phelan et al. 1993; Hardwicke and Sandri-Goldin 1994) and the second is through the 
RNase activity of vhs protein (Zelus et al. 1996; Everly et al. 2002). These two proteins 
have been found to collaborate to cause loss of cellular mRNA (Smiley 2004) and more 
recently have been found to interact with each other when bound to certain proteins 
(Taddeo et al. 2010). However the complexities of these two proteins are still being 
investigated, as new studies discover more interactions and more functions associated 
with them (Esclatine et al. 2004b; Strand and Leib 2004; Taddeo et al. 2009; Taddeo et 
al. 2010). 
 
A similar activity has also been identified in EBV linked to the ICP27 homologue, SM 
protein, which has been found to enhance intron-less gene expression and inhibit intron-
containing gene expression (Ruvolo et al. 1998). ICP27 is conserved between all 
members of the herpesvirus family, although they differ in size and the overall sequence 
homolgy is low, as even the closest members of the family only share roughly 30% 
homology in their amino acid residues (reviewed by Majerciak and Zheng 2009). 
However EBV SM protein has been found to be able to compensate for ICP27 defects 
during viral infection, suggesting that they are linked to common pathways or have 
distinct activities which share a common phenotype (Boyer et al. 2002). The KSHV 
homologue of ICP27 is ORF57, a viral gene regulator, which has not been found to 
inhibit splicing of intron-containing genes. This difference in function is probably due to 
KSHV containing more than 30 intron-containing genes that require active splicing 
compared to just four in HSV-1 and in EBV just the latent genes contain introns 
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suggesting a role for SM in the lytic-latent switch (Ruvolo et al. 1998; Smiley 2004; 
Majerciak and Zheng 2009). Whether the MHV-68 ICP27 homologue, ORF57 is acting 
towards host shutoff has not been determined. 
 
The fact that host shutoff has not, as yet, been linked to any other proteins in γ-
herpesvirus infections may be due to the inability to produce mutant ORF37  viruses. 
The original study that lead to the discovery of ORF37 used a transfection method to 
screen each KSHV gene individually for its ability to cause host shutoff and their results 
indicated that ORF37 was the only gene linked to a significant decrease in GFP 
expression (Glaunsinger and Ganem 2004b), however other genes may cause host 
shutoff to a lesser degree and it may be that this can best be seen in an immuno-
compromised cell line.  
 
Taken together the results from this chapter suggest that more than one viral protein may 
cause host shutoff, as seen in HSV-1 (Smiley 2004).  When infection studies have been 
carried out on MHV-68 with a deleted ORF37 gene there have been indications that an 
additional host shutoff factor may be at work. This was first suggested by Corruvbias et 
al. when they compared two different transfection experiments, as they saw a much 
decreased half-life of GFP in mRNA decay assays when cells were transfected with a 
deleted ORF37 BAC virus compared to a plasmid transfection in the absence of ORF37. 
They suggest that this difference may be due to GFP sequence differences and the fact 
that the transcripts were under the control of different promoters. However they also 
suggest that it may indicate additional viral host shutoff factors contributing to the 
instability of the BAC GFP (Covarrubias et al. 2009). This has also eluded to in the 
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recent paper by Richner et al. who produced an ORF37 point mutation virus and found 
that they still saw some mRNA degradation, which they suggest may be due to 
incomplete deactivation of ORF37 gene or other viral genes contributing to host shutoff 
(Richner et al. 2011).  
 
The results from this chapter are in accordance with other MHV-68 ORF37 deletion 
studies and would back-up the suggestions that additional host shutoff factor (viral 
and/or cellular) may be involved. Identification of this other viral factor will however 
require much further work to be done to pinpoint where in the mRNA biogenesis 
process it is acting and how, as these are questions which are still being addressed for 
the already discovered ORF37. 
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Chapter Five  
Investigating cellular mRNA decay in transfected cells with MHV-68 
ORF37 
 
5.1 Introduction 
Global mRNA loss because of infection with MHV-68 and KSHV has been well-
documented (Ebrahimi et al. 2003; Glaunsinger and Ganem 2004b).  Moreover, it is 
now widely accepted that ORF37 homologues in the γ-herpesviruses play a key role in 
mediating host shutoff (Glaunsinger and Ganem 2004b; Rowe et al. 2007a; Covarrubias 
et al. 2009).  Global loss of cellular mRNA upon infection of cells with MHV-68 was 
first identified using microarray technology (Ebrahimi et al. 2003). Gene expression 
microarrays have also been used to investigate further loss of cellular mRNA upon 
KSHV infection (Glaunsinger and Ganem 2004a). However the microarray studies that 
have been carried out have investigated host shutoff in the context of virus infection, 
which will have additional viral factors present that may influence mRNA levels. In 
order to investigate mRNA levels independent of lytic viral infection transfection, assays 
needed to be executed to examine the role ORF37 and its homologues. 
 
Previous studies have employed a number of methodologies to investigate mRNA loss, 
the majority of which have used GFP as a marker for mRNA decay (Glaunsinger and 
Ganem 2004b; Rowe et al. 2007; Covarrubias et al. 2009). The first study that 
investigated possible host shutoff genes in KSHV used a GFP expressing cell line, 
which was individually transfected with each viral gene. Following this flow, cytometry 
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was used to identify genes that decreased GFP levels, the results of which implicated 
ORF37 in host shutoff (Glaunsinger and Ganem 2004b). The GFP protein was then used 
to investigate host shutoff in EBV infection.  In the latter case, BGLF5 was co-
transfected with a GFP expression vector and GFP levels were visualised using Northern 
blotting (Rowe et al. 2007). Covarrubias et al. employed similar methodologies to 
investigate host shutoff linked to MHV-68 ORF37, using Northern blotting of 
transfected cells to determine the GFP half-life in cells co-transfected with ORF37 
(Covarrubias et al. 2009). However GFP is not a natural cellular protein, so it would 
appear that the next step would be to investigate loss of cellular mRNA in the presence 
or absence of ORF37.  
 
The effect of MHV-68 ORF37 on cellular genes during transfection has been examined 
using Northern blotting to determine levels of the cellular genes (Covarrubias et al. 
2009). However this is an area which requires further investigation as the effect of 
ORF37 on cellular genes may indicate possible host shutoff mechanisms, as the 
structures of both BGLF5 and SOX have been elucidated, both of which suggest that the 
nuclease may be interacting with other cellular proteins to cause mRNA degradation 
(Buisson et al. 2009; Dahlroth et al. 2009; Bagneris et al. 2011). Examining the direct 
effect of ORF37 on cellular genes may indicate elements that can protect mRNA 
degradation, such as AREs (Chandriani and Ganem 2007), which may point to possible 
decay mechanisms. 
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5.2 Experimental design 
To assess whether MHV-68 ORF37 can directly (i.e. not in the context of a virus 
infection cycle) mediate mRNA degradation, murine NIH3T3 cells were transiently 
transfected with either the empty vector, pcDNA3.1 or pcDNA3.1 containing the ORF37 
gene (FLORF37pcDNA3.1). Following transfection, cells were harvested at set time 
points and quantitative real-time PCR (qPCR) and Western blotting assays were carried 
out to analyse cellular mRNA and protein levels. The pcDNA3.1 construct is a 5.4 kb 
vector under the control of the immediate-early CMV promoter, containing myc and 
His-tagged epitopes. Cells were also transfected with pEGFP-N1, a GFP containing 
vector also under the control of the CMV promoter, GFP was used to check for 
transfection efficiency. 
 
5.3 Results 
5.3.1 Cellular mRNA decay in ORF37 transfected cells using qPCR 
A selection of cellular genes which showed the greatest loss of mRNA upon MHV68 
infection (Ebrahimi et al. 2003) was chosen to investigate loss of mRNA in cells 
transfected with ORF37. NIH3T3 cells were transfected with either an empty vector 
(pcDNA3.1) or a plasmid containing the ORF37 gene (FLORF37pcDNA3.1). Total 
RNA was harvested from cells, synthesized into cDNA and then used in qPCR assays. 
Figure 5.1 shows the results for eukaryotic elongation factor Tu (eEf_Tu) at 12, 24 and 
36 hours post-transfection.  The transcript copy number for eEf_Tu was comparable 
between cells transfected with empty vector and cells transfected with ORF37-
containing plasmid. At 24 and 36 hours post-transfection, however, a greater loss of 
eEf_Tu mRNA was observed in the presence of ORF37, but, this was not statistically 
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significant (p< 0.05). Similar results were also seen for the cellular genes cfos and 
cyclophilin with no significant differences seen between cells transfected with either 
empty vector or cells transfected with FLORF37pcDNA3.1 (Figure 5.2). 
 
A possible explanation for lack of mRNA loss in cells transfected with 
FLORF37pcDNA3.1 (compared to control cells transfected with pcDNA3.1) is lack of 
ORF37 protein expression from FLORF37pcDNA3.1 plasmid.  To ascertain that indeed 
ORF37 was being expressed from FLORF37pcDNA3.1 plasmid, total RNA was isolated 
from transfected cells, DNase I-treated and synthesised into cDNA.  A diagnostic PCR 
was then performed with primers to amplify a 416bp fragment within the ORF37 
transcript.  The same process was used to amplify the cellular β-actin transcript, which 
was used as an internal control.  As can be seen in Figure 5.3A, the control transcript, β-
actin, was detected in all samples indicating that comparable levels and quality of RNA 
were isolated from control and ORF37-transfected cells. In contrast, ORF37 transcript 
was only detected in cells transfected with FLORF37pcDNA3.1 and not in cells 
transfected with empty vector (Figure 5.2B). These results show that the ORF37 gene 
was transcribed from the expression vector in these cells. It is, however plausible to 
suggest that ORF37 transcript was not translated into protein. 
 
 
 
 
 
 119 
 
 
 
 
Figure 5.1 qPCR for cellular gene, eEf_Tu, in transiently transfected cells. NIH3T3 
cells were transfected with either pCDNA3.1 or FLORF37pCDNA3.1 and cells were 
harvested for RNA, which was subsequently synthesised into cDNA. qPCR was then 
carried out using primers (table 2.3) for 18s and eEf_Tu. Graphs depict the average copy 
number of eEf_Tu normalised against 18s, each bar represents 3 biological replicates, of 
which there were 2 experimental replicates +/- SD A) 12 hours post-transfection B) 24 
hours post-transfection C) 36 hours post-transfection. 
 
A 
B 
C 
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Figure 5.2 qPCR for cellular genes, c-fos and cyclophilin, 24 hours post-
transfection. NIH3T3 cells were transfected with either pCDNA3.1 or 
FLORF37pCDNA3.1 and cells were harvested for RNA, which was subsequently 
synthesised into cDNA. qPCR was then carried out using primers (Table 2.3) for 18s 
and either c-fos or cyclophilin. Graphs depict the average copy number normalised 
against 18s, each bar represents 3 biological replicates, of which there were 2 
experimental replicates +/- SD A) c-fos transript B) cyclophilin transcript. 
A 
B 
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Figure 5.3 Diagnostic PCR for presence of ORF37 in transiently transfected cells. 
NIH3T3 cells were transfected with either pCDNA3.1 or FLORF37pCDNA3.1, 12, 24 
and 36 hours post-transfection cells were harvested for RNA, which was subsequently 
synthesised into cDNA. A diagnostic PCR was then carried out using primers in table 
2.2, PCR products were then run on a 2% (w/v) TAE electrophoresis gel. A) 897bp PCR 
products corresponding to β-actin. B) 461bp PCR products corresponding to ORF37. 
 
 
 
 
900 bp 
800 bp 
 
500 bp   
                pcDNA3.1                                 FLORF37pcDNA3.1                   -ve 
  12               24                36               12              24              36 
      pcDNA3.1                                   FLORF37pcDNA3.1                -ve 
  12               24                36                   12              24              36 
500 bp 
400 bp 
300 bp   
A 
B 
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5.3.2 Detection of epitope-tagged FLORF37 and β-actin using Western blotting 
The presence of ORF37 transcript in transfected cells confirmed that the transfection 
experiment had been successful.  As stated above, it is, plausible to suggest that ORF37 
transcript was either expressed at very low levels or not translated.  The pcDNA3.1 
vector used in these transfection experiments contains both myc and His-tagged 
epitopes. Therefore, the expressed protein of interest (ORF37) could also be detected at 
the protein level. Western blotting for the myc tag using the ABC-alkaline phosphatase 
detection method was unsuccessful, as although bands could be seen they were around 
70kDa, rather than the expected 56kDa and were also seen in the empty vector samples 
which should not contain the myc-tagged protein (Figure 5.4B). Western blotting for β-
actin (Figure 5.4A) had been successful with clear bands seen at the expected size 
(43kDa), which indicated that the Western blotting method was working well.  This 
leads to the conclusion that unspecific binding may be taking place in the Western 
blotting experiments for the myc-tagged protein due to the increased development time 
that was used in order to identify a band relating to the myc-tagged ORF37 protein. A 
number of underlying causes may explain these findings, one of which was lack of a 
positive control. We were able to obtain a His-tagged protein (M4) (courtesy of Dr 
Bernadette Dutia, Edinburgh University) to use as a positive control (Figure 5.4C). 
Original experiments used the ABC detection method for the His-tag. The ABC method 
uses the binding of the glycoprotein avidin to the small molecular weight vitamin, biotin. 
This process is used because of the extraordinarily high affinity that these two molecules 
have for each other, which is over one million times higher than that of an antibody for 
most antigens (Diamandis and Christopoulos 1991). These macromolecular complexes 
formed between avidin and biotinylated antibodies can then be visualised using alkaline 
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phosphatase or horseradish peroxidase. However experiments carried out using the ABC 
method gave weak results with unclear bands for both ORF37 and the 52kDa His-tagged 
M4 protein (the positive control) (Figure 5.5A). So to try to improve detection of the 
bands a similar method to ABC was used which uses a Streptavidin-AP conjugate 
(Roche) instead of avidin. Figure 5.5B shows the results from a Western blot for the His-
tag developed using the Streptavidin method, which did show bands at the correct size 
for ORF37, but on this blot the positive control (M4) did not have a strong band. Extra 
bands were also seen in the FLORF37pcDNA3.1 lanes, which again may be due to 
unspecific binding of the secondary antibody due to long development times. Attempts 
were made to improve the detection limits included loading high quantities of total 
protein (40µg of protein/lane).  However, the high viscosity of samples at high protein 
concentration levels gave poor results (data not shown). 
 
To improve detection of ORF37, another antibody detection method, ECL, was used.  
ECL is a light emitting method that detects horseradish peroxidise-linked antibodies and 
is thought to be at least 10 times more sensitive than colourimetric assays (Amersham). 
As can be seen in Figure 5.6 B, -actin was readily detected in all samples.  With respect 
to ORF37, faint bands corresponding to the expected ORF37 protein were detected by 
this method. Taken together it appears that it is not possible to improve the intensity of 
the ORF37 protein from the samples described in this chapter. 
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Figure 5.4 Detection of myc-tagged ORF37 protein and His-tagged M4 protein. 
NIH3T3 cells were transfected with either pCDNA3.1 or FLORF37pCDNA3.1, 24 & 48 
hours post-transfection cells were harvested for protein. Protein concentration was 
calculated using Bio-Rad’s protein assay and 20µg of protein was loaded into each well 
and samples were run using SDS-PAGE before blotting and staining of the membrane. 
Asterisks indicate bands of interest, M4 control is 52kDa, β-actin is 43kDa and myc-
tagged ORF37 is 56kDa. A) Membrane stained with 1/2000 dilution of primary ab: 
rabbit α actin and a 1/2000 dilution of secondary ab: biotinylated goat α rabbit B) 
Membrane stained with 1/2000 dilution of primary ab: rabbit α myc and a 1/2000 
dilution of secondary ab: biotinylated goat α rabbit C) Membrane stained with 1/500 
dilution of primary ab: mouse penta His and a 1/2000 dilution of secondary ab: 
biotinylated rabbit α mouse. All bands visualised using ABC-alkaline phophatase 
staining. 
                                              FLORF37pcDNA3.1                     pcDNA3.1                                  
                                              24                    48                        24              48 
                         FLORF37pcDNA3.1                     pcDNA3.1                                  
                              24                  48                   24                48 
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Figure 5.5 Detection of His-tagged ORF37 protein. NIH3T3 cells were transfected 
with either pCDNA3.1 or FLORF37pCDNA3.1, 24 and 48 hours post-transfection total 
cellular protein was harvested for protein assays. Protein concentration was measured 
using Bio-Rad’s Bradford protein assay and 20µg of total cellular protein was loaded 
into each well and samples were run using SDS-PAGE before blotting and staining of 
the membrane. Asterisks indicate bands of interest, +ve control is 52kDa and His-tagged 
ORF37 is 56kDa. A) Membrane stained with 1/500 dilution of primary ab: mouse penta 
His and a 1/4000 dilution of secondary ab: biotinylated rabbit α mouse, bands visualised 
using ABC-alkaline phophatase followed by BCIP/NBT B) Membrane stained with 
1/500 dilution of primary ab: mouse penta His and a 1/2000 dilution of secondary ab: 
biotinylated rabbit α mouse, bands visualised using streptavidin followed by BCIP/NBT. 
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Figure 5.6 Detection of His-tagged ORF37 protein using ECL detection method. 
NIH3T3 cells were transfected with either pCDNA3.1 or FLORF37pCDNA3.1, 24 
and 48 hours post-transfection cells were harvested for protein. Protein concentration 
was calculated using Bio-rad protein assay and 20µg of protein was loaded into each 
well and samples were run using SDS-PAGE before membrane transfer and 
visualization of bands using ECL chemiluminescence. A)  Membrane stained with 
1/500 dilution of primary ab: mouse α penta His and 1/10,000 dilution of secondary 
ab: α mouse-HRP-linked. Astrix points to bands of interest; His-tagged ORF37 is 
56kDa. B) Membrane stained with 1/2000 dilution of primary ab: rabbit α actin and  
1/20,000 dilution of secondary ab: α-rabbit-HRP-linked. Bands correspond to 43 kDa 
β-actin. 
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5.4 Discussion 
Previous studies have focussed on the use of GFP levels as a marker for mRNA loss 
during co-transfection experiments with ORF37/ BGLF5 plasmids (Glaunsinger and 
Ganem 2004b; Rowe et al. 2007; Covarrubias et al. 2009). Glaunsinger et al 
investigated mRNA loss in the presence of ORF37 from KSHV using a plasmid 
containing a destabilised GFP gene with a reduced half life of 3 hours, the results of 
which indicated a clear loss of GFP mRNA when ORF37 was co-expressed 
(Glaunsinger and Ganem 2004b). This loss of GFP has also been seen in co-
transfection experiments with MHV-68 ORF37 and EBV BGLF5 when mRNA 
decay assays have been conducted post-actinomycin D treatment (Rowe et al. 2007; 
Covarrubias et al. 2009). However these studies only examined loss of cellular 
mRNA in the context of viral infection. As a number of viral genes are expressed 
during lytic infection, to determine the effect of ORF37 on cellular mRNA, 
transfection experiments which focussed on cellular mRNA levels were required. 
 
The qPCR method is a relatively simple method for the quantification of mRNA. The 
indications from previous viral infection studies (Ebrahimi et al. 2003; Glaunsinger 
and Ganem 2004b; Rowe et al. 2007) and GFP transfection experiments 
(Glaunsinger and Ganem 2004b; Rowe et al. 2007a; Covarrubias et al. 2009) led to 
the hypothesis that loss of cellular mRNA ought be seen in the presence of ORF37 
alone. However as Figure 5.1 shows this was not seen for the cellular genes 
examined in this study, some loss was identified 24 and 36 hours post-transfection, 
but this was not statistically significant (Figure 5.1B & C). Similarly other cellular 
genes tested also did not exhibit a significant loss of mRNA and in the case of c-fos 
the mRNA level is actually higher in ORF37 transfected cells (Figure 5.2). This led 
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to the possibility that the ORF37 gene was not adequately expressed from the vector 
used in transient transfection studies.  The FLORF37pcDNA3.1 plasmid was 
sequenced, which confirmed that the presence of ORF37 DNA sequence in the 
vector (data not shown). A diagnostic PCR was then conducted on cDNA 
synthesised from RNA to confirm that the ORF37 gene was being transcribed, the 
results of which clearly shows the presence of ORF37 mRNA (Figure 5.3).  
 
The next logical step was to confirm that ORF37 transcript was translated into 
protein.  This was facilitated by the presence of myc and His tags in the expression 
vectors used in this study. Initially, antibodies against the the myc tag were to detect 
ORF37 protein, but this gave very poor results (Figure 5.4B). The His-tag was then 
tested for the presence of ORF37 protein. Bands were visible at the expected size, 
but expressed at the level of detection with this approach (Figure 5.5 & 5.6). A 
number of different methods were used to improve the detection of ORF37 protein, 
and with varying antibody concentrations. These attempts, however, did not improve 
the quality of ORF37 protein detection.  Taken together, these results show that the 
ORF37 gene was transcribed and translated at very low levels compared to the 
housekeeping gene β-actin.  This observation correlates well with expression 
profiling of all MHV-68 genes by DNA microarrays, which showed low abundance 
of ORF37 compared to structural genes of MHV-68 (Ebrahimi et al. 2003; Martinez-
Guzman et al. 2003). For example, 24 hours post MHV-68 infection there is 
approximately an 18-fold decrease in ORF37 expression compared to gp150 
(Martinez-Guzman et al. 2003). This is expected, since ORF37 is an enzyme, and 
unlike structural genes, relatively minute quantities of this protein are required 
during the virus infection. 
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Furthermore, it is also plausible that not all cells were transfected leaving a number 
of harvested cells untransfected. Therefore, host shutoff effect of ORF37 on cellular 
mRNA would be masked with greater quantities of intact mRNA from untransfected 
cells. One way to circumnavigate this problem is to identify transfected cells using a 
marker. This method was used by Clyde and Glaunsinger.  Therefore, only cells 
which harboured ORF37 (as green cells) were isolated by means of flow cytometry. 
This study focussed on the use of RNAseq for deep sequencing and used qPCR to 
validate the results. They compared mRNA levels for the housekeeping gene 
GAPDH for sorted and unsorted cells transfected with ORF37 compared to control 
cells and found that as expected a greater loss of mRNA was seen in the sorted cells, 
although some loss was still seen in unsorted cells (Clyde and Glaunsinger 2011). 
These results concord well with our findings as the cells in this study were in effect 
unsorted and did exhibit some loss of cellular mRNA, but not to a significant level 
(Figure 5.1). The findings from Clyde and Glaunsinger were in agreement with 
previous studies as they found a reduction in the levels of most cellular mRNAs in 
cells expressing ORF37. They did not detect any obvious similarities between 
cellular mRNAs that escape host shutoff, but they did notice that in the majority of 
cases the more abundant mRNAs experience a higher level of downregulation 
compared to rare mRNAs (Clyde and Glaunsinger 2011). 
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Chapter Six 
 Examining the mechanism of mRNA degradation in MHV68 
infected cells 
 
6.1 Introduction 
The discovery of host shutoff within the γ-herpesvirus family has led to the question 
of how the multi-functional DNA exonuclease could be causing mRNA degradation.  
The first and most obvious answer would be that ORF37 (and homologues of 
ORF37) has direct RNase similar to HSV vhs (Everly et al. 2002).  However, in vitro 
studies have not found this to be the case (Glaunsinger and Ganem 2004b; Rowe et 
al. 2007), leading to the possibility that the DNA exonuclease interacts with the host 
mRNA degradation pathways indirectly. The crystal structures of KSHV ORF37 and 
EBV BGLF5 have recently been elucidated and in vitro asays with these 
recombinant proteins suggest that ORF37 and BGLF5 possess a degree of RNase 
activity under in vitro conditions (Buisson et al. 2009; Bagneris et al. 2011). 
However SOX exhibited a low affinity for binding RNA.  This, along with site-
directed mutagenesis studies looking at residues required for SOX mediated host 
shutoff, suggest that SOX may interact with cellular mRNA decay pathways to 
degrade RNA (Bagneris et al. 2011).  
 
Studies investigating the mRNA degradation activity of ORF37 have so far identified 
two phenotypes, both of which are linked to the 3’ end of mRNA. The first 
phenotype is hyperadenylation, which was seen as an increase in poly(A) tail length, 
using RNase H and Northern blotting methods (Covarrubias et al. 2009; Lee and 
Glaunsinger 2009; Kumar and Glaunsinger 2010). The second phenotype was a 
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relocalisation of the cytoplasmic poly(A) binding protein (PABPC) to the nucleus, 
which was visualised using immunofluorescence assays (Covarrubias et al. 2009; 
Lee and Glaunsinger 2009; Kumar and Glaunsinger 2010). PABPC is a nuclear-
cytoplasmic shuttling protein (Afonina et al. 1998) that plays a role in mRNA 
stability and translation (Tarun and Sachs 1995), hence its relocation may prevent 
export of nuclear mRNA and destabilise mRNA in the cytoplasm. However, no 
direct binding of ORF37 with PABPC was identified in these studies (Covarrubias et 
al. 2009; Lee and Glaunsinger 2009), suggesting that ORF37 is interacting with other 
cellular factors to cause these phenotypes. As can be seen from these studies host 
shutoff by ORF37 is a complex process which still needs further investigation. 
 
6.2 Experimental design 
Due to previous studies in KSHV and MHV-68 suggesting a link between mRNA 
decay and an increase in poly(A) tail length (Covarrubias et al. 2009; Lee and 
Glaunsinger 2009; Kumar and Glaunsinger 2010), the 3’ end of cellular mRNA was 
investigated. Previous studies had used transfected cells and probes for GFP as the 
reporter mRNA. In this chapter the effect of ORF37 in the context of a lytic infection 
with MHV-68 on cellular poly(A) tail length mRNA was investigated. Total RNA 
was isolated from mock-infected, MHV-68-infected and ORF37Stop virus-infected 
cells.  The poly(A) tail was radiolabelled followed by enzymatic  digestions to 
remove mRNA.  The labelled poly(A) tails were then resolved by PAGE and 
visualised using a PhosphorImager (Temme et al. 2004). Infections were carried out 
in immunocompetent NIH3T3 and IFNαβRKO cells. 
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6.3 Results 
 
6.3.1 Poly(A) tail length in MHV-68 infected cells 
To investigate the effect of MHV-68 infection on the 3’ cellular mRNA  poly(A) tail 
lengths, total cellular RNA was examined that was harvested from either mock-
infected cells or cells infected with MHV-68 viruses of interest. NIH3T3 cells were 
either mock-infected or virus-infected and 24 hours post-infection total RNA was 
harvested from cells and DNase I treated. Poly(A) tails were labelled with [-32P] 
dATP, digested to remove mRNA and resolved on 10% polyacrylamide/urea gels. 
Figure 6.1 shows a representation of the banding pattern seen with the poly(A) tail 
assay of RNA from mock-infected and MHV-68-infected cells.  Initial visual 
inspection of lanes corresponding to mock-infected and virus-infected samples did 
not show any apparent difference in the overall size distribution of poly(A) tail 
lengths, although MHV-68 infected profiles did appear to be slightly lighter near to 
the top of the lane in the region of higher molecular weight RNA.  To quantify any 
possible difference in bulk  poly(A) tail distribution between mock and virus-infected 
samples, images were analysed using the ImageQuant software that measures the 
intensity of bands. The relative intensity profiles of poly(A) tail lengths in samples 
from mock and virus-infected cells were found to be similar (Figure 6.2). 
 
Previous studies had suggested that ORF37 causes hyperadenylation (Covarrubias et 
al. 2009; Lee and Glaunsinger 2009; Kumar and Glaunsinger 2010).  Therefore, the 
gel region where higher molecular weight poly(A) tail fragments are expected to 
resolve were investigated using the poly(A) tail assay. Based on empirical 
observations, samples which were resolved over a two hour run period were chosen 
to investigate the impact of MHV-68 on lengthening on poly(A) tails.  As Figure 6.1 
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shows, no apparent difference was observed in the population of mRNA with longer 
poly(A) tails between mock-infected and virus-infected samples . ImageQuant was 
then used to assess the band intensities of poly(A) tail fragments between the two 
samples.  Again no obvious difference could be identified between the two profiles 
(Figure 6.3).  
 
However, when the two poly(A) tail profiles from mock and WT MHV-68-infected 
mRNA for both shorter poly(A) tails (75-200 nt) and longer poly(A) tails (200-775 
nt) were compared there were areas on both graphs that showed some difference 
(Figure 6.4). Statistical analysis of the data indicated that although some regions 
exhibited no difference in intensities other regions were significantly different (p< 
0.001). For shorter poly(A) tails, there appeared to be a greater intensity of poly(A) 
tails in the regions of 80-100 nt and 130-155 nt in length in MHV-68 infected cells 
when compared to mock-infected cells with an average 10% increase in relative 
intensity in the regions highlighted (Figure 6.4A). In terms of the longer poly(A) 
tails, there was a decrease in poly(A) tail intensity at approximately 225-450 nt in 
MHV-68 infected cells compared to mock infected with an average 12% decrease in 
intensity (Figure 6.4B). Taken together, these results suggest a shortening of some 
poly(A) tails in MHV-68 infected cells. 
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Figure 6.1 Poly(A) tail profile from mock and WT infected NIH3T3 cells. Five 
g of total RNA was labelled with [-32P]dATP, the RNA was then purified by 
phenol/chloroform extraction and ethanol precipitation and re-suspend in 20 l of 
Sigma water. Labelled RNA (10
6
 counts) was digested with RNase A/T1, after 30 
minutes the reaction was stopped and the remaining RNA was ethanol precipitated 
and separated on a 10% polyacrylamide/urea gel. Gels were analyzed on a 
PhosphorImager and data were analysed using the ImageQuant program.   
Representative banding pattern of poly(A) tail profiles of mock and WT MHV-68 
infected NIH3T3 cells seen on 4 gels, with on average 3 RNA samples per infection 
ran in duplicate (approximate sizes are indicated). 
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Figure 6.2 Comparison of poly(A) tail profile from mock- and WT-infected 
NIH3T3 cells. Total RNA was harvested and poly(A) tails labelled and resolved as 
described in figure legend 6.1. Gels were analyzed on a PhosphorImager and data 
were analysed using the ImageQuant program. Relative intensity of bands from 
mock and WT MHV-68 RNA covering 75-200 nt in length, information pooled from 
two gels +/-SD.  
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Figure 6.3 Analysis of longer poly(A) tail profile from mock and WT infected 
NIH3T3 cells. Total RNA was harvested and poly(A) tails labelled and resolved as 
described in figure legend 6.1. Gels were analyzed on a PhosphorImager and data 
were analysed using the ImageQuant program. Relative intensity of bands from 
mock and WT RNA covering 200-775 nt in length, information pooled from two gel 
+/-SD. 
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Figure 6.4 Analysis of longer poly(A) tail profile from mock and WT infected 
NIH3T3 cells. Total RNA was harvested and poly(A) tails labelled and resolved as 
described in figure legend 6.1. Gels were analyzed on a PhosphorImager and data 
were analysed using the ImageQuant program. A) Graph comparing relative intensity 
of Poly(A) tails in the region of 75-200 nt from mock and WT (MHV-68) infected 
cells +/- SD  B) Graph comparing relative intensity of Poly(A) tails in the region of 
200-775 nt from mock and WT (MHV-68) infected cells +/- SD. *** = p>0.001  
 
 
A 
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6.3.2 Characterisation of poly(A) tail lengths in αβRKO cells infected with 
MHV-68, ORF37Stop and ORF37StopRev 
As described in previous chapters, the ORF37Stop virus was found to cause mRNA 
degradation in IFNαβRKO cells in stark contrast to infection in immunocompetent 
cells thus suggesting host shutoff can still procced in an immune-compromised 
cellular enviroment and absence of ORF37. This led to the question of whether 
poly(A) tail distribution was similar or different in IFNαβRKO cells infected with 
MHV-68 or ORF37Stop mutant virus.  To address this question, poly(A) tail 
distribution was assayed from mock-infected IFNαβRKO  cells and IFNαβRKO  
cells infected with wild type MHV-68 and ORF37Stop mutant virus as described 
previously for NIH3T3 infections (Section 6.3.1).  
 
The results from the gels showed comparable bulk poly(A) tail distributions (Figure 
6.5).  This was corroborated when images were analysed using the ImageQuant 
where the profiles for 75-200 nt in length were very similar between the groups 
(Figure 6.6).  Similarly, when the bands from the top of the gel were analysed they 
also exhibited very similar poly(A) profiles for mock, MHV-68, and ORF37Stop 
infected cells (Figure 6.7).  However, when the three profiles from Mock, MHV-68 
and ORF37Stop infected cells were plotted on the same graph for both shorter 
poly(A) tails (Figure 6.8A) and longer poly(A) tails (Figure 6.8B) some areas 
appeared to show some differences. Figure 6.8A had two regions where a significant 
difference was identified (P>0.001); the first is at approximately 75-85 nt and in this 
region both MHV-68 and ORF37Stop infected cells exhibited a lower intensity of 
poly(A) tails compared to mock-infected samples. The second region is at 
approximately 140-170 nt and in this region the ORF37Stop infected cells show a 
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higher intensity of poly(A) tails when compared to MHV-68 and mock infected. 
Figure 6.8B had one area of significant difference in the region of 225-300 nt within 
this area the MHV-68 and ORF37Stop infected cells exhibited a lower intensity of 
poly(A) tails when compared to mock infected, similar to the result seen in NIH3T3 
cells for wildtype virus (Figure 6.4B). Overall there was no obvious shift in poly(A) 
tail length distribution. 
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Figure 6.5 Poly(A) tail profiles in  IFNαβRKO cells infected with wild type 
MHV-68 and ORF37Stop mutant virus. Total RNA was harvested and poly(A) 
tails labelled and resolved as described in figure legend 6.1. Representative banding 
patterns of poly(A) tail profiles from gels showing mock, WT MHV-68 and 
ORF37Stop infected αβRKO cells seen on 4 gels, with on average 3 RNA samples 
per infection ran in duplicate (approximate sizes are indicated).  
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Figure 6.6 Comparison of poly(A) tail profiles from MHV-68 and ORF37Stop 
mRNA from IFNαβRKO cells. Total RNA was harvested and poly(A) tails labelled 
and resolved as described in figure legend 6.1. Gels were analyzed on a 
PhosphorImager and data were analysed using the ImageQuant program. Relative 
intensity of poly(A) tail bands from cells either mock-infected, infected with wild 
type virus or with ORF37Stop mutant virus covering 75-200 nt in length.  Band 
intensities were obtained from two separate gels +/-SD. 
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Figure 6.7 Comparison of poly(A) tail profiles from MHV-68 and ORF37Stop 
mRNA from IFNαβRKO cells. Total RNA was harvested and poly(A) tails labelled 
and resolved as described in figure legend 6.1. Gels were analyzed on a 
PhosphorImager and data were analysed using the ImageQuant program. Relative 
intensity of poly(A) tail bands from cells either mock-infected, infected with wild 
type virus or with ORF37Stop mutant virus covering 200-775 nt in length.  Band 
intensities were obtained from two separate gels +/-SD. 
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Figure 6.8 Comparison of poly(A) tail profiles from MHV-68 and ORF37Stop 
mRNA from IFNαβRKO cells. Total RNA was harvested and poly(A) tails labelled 
and resolved as described in figure legend 6.1. Gels were analyzed on a 
PhosphorImager and data were analysed using the ImageQuant program. Relative 
intensity of poly(A) tail bands from cells either A) Graph comparing relative 
intensity of Poly(A) tails in the region of 75-200 nt from mock, WT (MHV-68) or 
ORF37Stop infected cells +/- SD  B) Graph comparing relative intensity of Poly(A) 
tails in the region of 200-775 nt from mock, WT (MHV-68) and ORF37Stop infected 
cells +/- SD. *** = p>0.001 
 
 
A 
B 
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6.4 Discussion 
The method of radio labelling 3’ RNA, digestion with RNases and visualisation 
using gel sequencing methods was first described by Ahlquist and Kaesburg in 1979, 
who used the method to examine the length distribution of viral RNAs (Ahlquist and 
Kaesberg 1979). Since then the method has been refined and updated and used in a 
number of studies to analyse poly(A) tail length in both fungi (Morozov et al. 2010) 
and flies (Temme et al. 2004). This method was employed in this chapter as a tool to 
investigate the bulk cellular poly(A) tail length distribution in both mock and MHV-
68 infected cell, as previous studies have focused on GFP mRNA in transfected cell 
lines (Covarrubias et al. 2009; Lee and Glaunsinger 2009; Kumar and Glaunsinger 
2010).  
 
The results from Figures 6.1 and 6.2 suggest that there is little difference between 
bulk poly(A) tail lengths of mock and MHV-68 infected transcripts as the poly(A) 
profiles follow a similar trend for poly(A) tails ranging from 75-200 nt in length. The 
results from the NIH3T3 infections suggested that infection with MHV-68 was not 
affecting the poly(A) tail length (Figure 6.1 & 6.2). However previous studies using 
RNase H assays to look at the poly(A) tail length of GFP mRNA have suggested that 
ORF37 causes hyperadenylation (Covarrubias et al. 2009; Lee and Glaunsinger 
2009; Kumar and Glaunsinger 2010).  Therefore, the gel regions corresponding to 
higher molecular weight poly(A) tails were investigated further.  The poly(A) tail 
distributions from these regions suggested that the mock infected poly(A) tails were 
slightly longer when compared to a similar region for poly(A) tail population in cells 
infected with WT-MHV-68, suggesting a decrease in poly(A) tails rather than 
hyperadenylation (Figure 6.1). Image analysis of the bands revealed that the relative 
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intensities were very similar (Figure 6.3). Further analysis of the data through 
plotting the data on the same graphs to highlight areas of difference along with 
looking for areas exhibiting significant differences did indicate that some changes 
may occur to poly(A) tail length in MHV-68 infected cells, as the poly(A) tails were 
shorter in virus-infected cells when compared to mock-infected controls (Figure 6.4).  
 
As mRNA degradation had also been indentified in ORF37Stop infected immuno-
compromised cells (Chapter 4), the next objective was to see if any variation could 
be identified in IFNαβRKO cells infected with ORF37Stop mutant when compared 
to cells infected with the wild type virus. This may indicate a difference in the 
mechanism of host shutoff employed in an ORF37 mutant virus in cells lacking a 
response to type I IFN (in IFNαβRKO cells) when compared to infection in 
immunocompetent cells. Therefore, IFNαβRKO cells were infected with these 
viruses and total RNA harvested for use in poly(A) tail assays. The results showed 
comparable band intensities and size distribution between the samples (Figure 6.5); 
very similar poly(A) tail profiles in the region of 75-200 nt (Figure 6.6) and in 200-
775 nt regions (Figure 6.7). The findings from the comparison of intensity profiles 
did highlight some areas where a significant difference could be identified (Figure 
6.8). However, the differences did not point to either a lengthening or shortening of 
poly(A) tails in infected cells and so would need to be investigated further. Also the 
poly(A) tails from ORF37Stop infected cells were very similar to MHV-68  infected 
cells with only one region showing a significant difference suggesting that the 
mutant virus is acting in a similar way to the WT virus. 
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The results described in this chapter were not as expected, as hyperadenylation was 
not seen in MHV-68 infected NIH3T3 or IFNαβRKO cells as was reported 
previously (Covarrubias et al. 2009; Lee and Glaunsinger 2009; Kumar and 
Glaunsinger 2010). One possible explanation is that their experiments focused on the 
use of transfection experiments using GFP as a marker, whereas our study used virus 
infections and their impact on global cellular mRNA. Another key observation 
identified in previous studies is the relocalisation of PABPC from the cytoplasm to 
the nucleus (Covarrubias et al. 2009; Lee and Glaunsinger 2009; Kumar and 
Glaunsinger 2010), which has also been seen upon infection with MHV-68 (Richner 
et al. 2011). The relocalisation of PABP is a feature seen in a number of viral 
infections (reviewed by Smith and Gray 2010) and so far in the γ-herpesviruses it has 
been linked to mRNA turnover, but not hyperadenylation (Lee and Glaunsinger 
2009).   A way forward will be the use of other assays such as the ligation-mediated 
poly(A) test (LM-PAT), which uses cDNA synthesis from an oligo(dT) primer 
followed by PCR amplification. Following PCR amplification samples are visualized 
on polyacrylamide gels with short tails producing a compact band and long tails 
appearing as a smear. Alternatively, the more direct method of RNase H assays can 
be conducted, which involves the removal of the poly(A) tail followed by the direct 
comparion of deadenylated mRNA with polyadenylated mRNA using Northen 
blotting (reviewed by Murray and Schoenberg 2008).  
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Chapter Seven 
Final discussion 
 
The γ-herpesviruses are double-stranded DNA viruses that are of medical and 
veterinary importance due to their ability to cause lymphoproliferative diseases, as 
well as lymphomas and non-lymphoid cancers in their respective hosts. The species 
specificity of γ-herpesviruses has limited the study of human γ-herpesviruses in 
animal models.  Over the years, murine gammaherpesvirus 68 (MHV-68) has been 
developed as an amenable model to study γ-herpesviruses within their natural hosts 
(reviewed by Barton et al. 2011). Differences can be identified between MHV-68 
and EBV and KSHV for example, MHV-68 is distantly related to the human γ-
herpesviruses (McGeoch et al. 2005) and genome analysis has revealed that the γ-
herpesviruses, including MHV-68 contain virus-specific genes (Virgin et al. 1997). 
However the MHV-68 genome also contains large blocks of conserved -herpesvirus 
genes (Virgin et al. 1997) and in terms of pathogenesis all -herpesviruses have 
conserved the ability to cause lymphoproliferative diseases. Therefore some aspects 
of γ-herpesvirus pathogenesis may be different, but the core pathogenic strategies 
appear to be conserved (reviewed by Barton et al. 2011). These observations and the 
relative ease of constructing gene deletion mutant MHV-68 viruses (Adler et al. 
2000; Adler et al. 2003) have made MHV-68 a powerful model for the study of γ-
herpesvirus pathogenesis.  
 
A feature of infection with a number of lytic viruses is loss of cellular proteins, a 
phenomenon termed host shutoff (Tables 1.4 & 1.5). More recently host shutoff was 
identified in γ-herpesviruses linked to viral DNA exonuclease, encoded by ORF37 
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(in KSHV and MHV-68) and BGLF5 (in EBV) (Glaunsinger and Ganem 2004b; 
Rowe et al. 2007; Covarrubias et al. 2009). Furthermore, in γ-herpesviruses, ORF37 
(and BGLF5)-mediated host shutoff is now believed to be post-transcriptional and at 
the level of mRNA (Glaunsinger and Ganem 2004b; Rowe et al. 2007).  The 
significant loss of cellular mRNA is a key component of disease pathogenesis as a 
result of infection with these viruses and therefore an important area of 
herpesvirology research worldwide. 
 
At the onset of this study, the role of ORF37 (and BGLF5) in mediating host shutoff 
was not entirely clear.  This was because ORF37 and BGLF5 are primarily alkaline 
DNA exonucleases believed to play a role in viral genomic DNA encapsidation 
(Martinez et al. 1996; Goldstein and Weller 1998).  This function had made deletion 
of these viral genes in their respective genomes difficult (Covarrubias et al. 2009; 
Feederle et al. 2009).  Therefore, the primary purpose of this study was to generate a 
mutant of MHV-68 ORF37 to investigate the role of viral DNA exonuclease in host 
shutoff in vitro and in vivo.  Initially, an ORF37 mutant virus (ORF37Stop) was 
constructed using the BAC technology in collaboration with Dr Bernadette Dutia 
(University of Edinburgh), which generates premature stop codons in all possible 
reading frames at the beginning of the ORF37 gene. Previously conducted 
experiments had indicated that retrieval of the ORF37Stop BAC virus from 
immunocompetent MEF cells was difficult.  This suggested that lack of function (s) 
afforded by the ORF37 product is vital in virus growth and subsequent egress from 
infected cells. This phenotype has also been identified in other studies where the 
partial or complete deletion of the ORF37 gene or its homologues had taken place 
(Covarrubias et al. 2009; Feederle et al. 2009). Studies carried out on an ORF37 
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deletion mutant had suggested that ORF37 plays an essential role in viral DNA 
replication (Covarrubias et al. 2009). Furthermore, work carried out on the EBV 
BGLF5 null virus had found that maturation, egress and viral DNA synthesis were 
impaired in this mutant virus but BGLF5-null virus was morphologically intact, 
suggesting that BGLF5 plays a modulatory role, rather than an essential role in EBV 
replication (Feederle et al. 2009).  
 
The observation that MHV-68 ORF37 mutant was severely restricted in forming 
plaques in immunocompetent cells is also similar to observations made with HSV-1 
AE mutants, where it was shown that infection of HSV-1 AE mutants could grow, 
albeit in a significantly restricted manner in Vero cells (Weller et al. 1990).  This and 
other studies also showed viral AE is not essential for viral DNA synthesis (Weller et 
al. 1990; Smiley 2004).  This raises the issue of how nuclease mutant viruses process 
their genomic DNA for example in resolution of viral DNA intermediates. It was 
shown that plasmid DNA recombination can occur with very high efficiency in cells 
infected with an AE mutant of HSV-1, suggesting a role for cellular nucleases in 
resolution of Holliday junctions, which exist during herpesviral genomic DNA 
replication (Martinez et al. 1996).   A number of cellular nucleases have since been 
shown to share amino acid and structural similarities to viral nucleases, for example 
flap endo/exonucleases (Lieber 1997; Tomlinson et al. 2010).  Of relevance here is 
the observation that HSV-1 vhs (but not HSV-1 AE) shares amino acid sequence 
homology to a flap endo/exonucleases, FEN-1 (Smiley 2004). Therefore, in some 
circumstances, cell-derived nucleases can compensate for loss of viral nuclease 
activity, which may explain, at least in part, plaque formation in exonuclease mutant 
viruses. Studies carried out using signature-tagged mutagenesis to identify essential 
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and attenuated genes in MHV-68 infection, had found ORF37 to be non-essential in 
BHK-21 cells (Song et al. 2005), but attenuated in Vero cells (Moorman et al. 2004), 
suggesting that the cell type in which the mutant virus is grown will have an impact 
on the ability of these viruses to complete a successful cycle of infection. These 
observations prompted attempts to grow MHV68 ORF37Stop virus in other cell 
types.   
 
Type I interferons are the most potent anti-viral cytokines known to-date.  The 
importance of the innate immune response to MHV-68 is well documented (Dutia et 
al. 1999; Nash et al. 2001).  This along with the increased susceptibility of HSV1 
vhs mutant viruses to IFNα and IFNβ highlights the importance of the Type I 
interferons (Suzutani et al. 2000). Therefore, attempts were made to propagate the 
MHV-68 ORF37Stop virus in cells defective in type I IFN receptor knockout cells.   
 
As shown in chapter three, the ORF37Stop virus was able to grow in IFNαβRKO 
cells, which was in concordance with work carried out on HSV-2 vhs mutant viruses 
which also showed attenuated growth in immunocompetent MEF cells, growth of 
which was partially or completely restored in IFNαβRKO cells (Duerst and Morrison 
2004).  Replication of the ORF37Stop virus was then investigated in lungs (site of 
lytic infection) of IFNαβRKO mice. When compared to WT and ORF37StopRev the 
viral titres were similar three days post infection, but were attenuated six days post 
infection (Figure 3.4). These results accord well  with work carried out on HSV-2  
vhs mutants, which also showed no attenuation of virus growth in IFNαβRKO cells 
(Duerst and Morrison 2004), but attenuated growth was observed in the genital 
mucosa (site of HSV-2 lytic infection) in IFNαβRKO mice after reaching similar 
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titres for first two days post infection (Murphy et al. 2003). These findings along 
with the results from this study imply that in vivo the ORF37 (or vhs in HSV-2) 
mutant viruses may be more susceptible to other immune mediators.  
 
The findings in chapter three and data from Murphy et al. implicate the importance 
of host shutoff afforded by vhs (for HSV-2) and ORF37 (in -herpesviruses) for 
evading immune responses during lytic infection (Murphy et al. 2003). 
Paradoxically, the study by Richner et al found that growth of a host shutoff mutant 
of MHV-68 in C57BL/6 mice lungs was not attenuated, suggesting that host shutoff 
does not play an important role in lytic infection, whereas it was suggested that virus 
host shutoff activity played a role in establishment of latency (Richner et al. 2011). 
One possible reason for the discrepancy between our study (and HSV-2 vhs) and 
Richner et al. is that the host shutoff mutant virus constructed by Richner and 
colleagues, was generated via a point mutation, which still showed residual mRNA 
degradation compared to mock infected cells.  It was suggested by Richner et al. that 
the host shutoff activity still present in infection with their ORF37 mutant virus may 
be due to either incomplete inactivation of the host shutoff function or other viral 
genes contributing towards host shutoff (Richner et al. 2011).  
 
To study further the effect of ORF37 during infection mRNA and protein levels were 
investigated from IFNαβRKO infected cells. Loss of cellular transcripts was 
observed in cells infected with ORF37Stop virus when compared to mock-infected 
IFNαβRKO cells (Figures 4.2-4.4).  Moreover, loss of mRNA was also reflected at 
the protein level (Figure 4.5). These findings led to the conclusion that in immune-
compromised cells host shutoff is taking place regardless of the presence or absence 
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of ORF37, suggesting that another host shutoff factor (cellular/viral) may be causing 
loss of mRNA. Host shutoff has not, as yet, been linked to any other proteins in γ -
herpesvirus infections. The original study that led to the discovery of ORF37 used a 
transfection method to screen each KSHV gene individually for its ability to cause 
host shutoff and their results indicated that ORF37 was the only gene linked to a 
significant decrease in GFP expression (Glaunsinger and Ganem 2004b). However, 
other genes may cause host shutoff to a lesser degree and it may be that this can best 
be seen in an immune-compromised cell line.  
 
A dual method of host shutoff has been well characterised  in HSV-1 infection, the 
first is through ICP27, which causes a re-distribution of snRNPs, disrupting the 
splicing machinery (Phelan et al. 1993; Hardwicke and Sandri-Goldin 1994) and the 
second is through the RNase activity of vhs protein (Zelus et al. 1996; Everly et al. 
2002). These two proteins have been found to cause loss of cellular mRNA 
(reviewed by Smiley 2004) and more recently have been found to interact with each 
other when bound to other proteins (Taddeo et al. 2010). ICP27 is conserved 
between all members of the herpesvirus family, although they differ in size and the 
overall sequence homology is low, as even the closest members of the family only 
share 30% homology in their amino acid residues (reviewed by Majerciak and Zheng 
2009). The EBV ICP27 homologue, SM protein, displays similar properties to ICP27 
as it has been found to enhance intron-less gene expression and inhibit intron-
containing gene expression (Ruvolo et al. 1998). The KSHV homologue of ICP27 is 
ORF57, a viral gene regulator, which has not been found to inhibit splicing of intron-
containing genes. This difference in function is probably due to KSHV containing 
more than 30 intron-containing genes that require active splicing compared to just 
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four in HSV-1; in EBV only latent genes contain introns suggesting a role for SM in 
the lytic-latent switch (Ruvolo et al. 1998; Smiley 2004a; Majerciak and Zheng 
2009). Whether the MHV-68 ICP27 homolog, ORF57, is acting towards host shutoff 
has not been determined. 
 
Although no obvious link has been made between γ-herpesviruses and a dual host 
shutoff system infection studies have been carried out on MHV-68 with a deleted 
ORF37 gene that have indicated that an additional host shutoff factor may be at 
work. This was first suggested by Covarrubias et al. when they compared two 
different transfection experiments, as they saw a much decreased half-life of GFP in 
mRNA decay assays when cells were transfected with a deleted ORF37 BAC virus 
compared to a plasmid transfection in the absence of ORF37. They suggest that this 
difference may be due to GFP sequence differences and the fact that the transcripts 
were under the control of different promoters. However they also suggested that it 
may indicate additional viral host shutoff factors contributing to the instability of the 
BAC GFP (Covarrubias et al. 2009). As discussed previously, a recent paper by 
Richner et al. produced an ORF37 point mutation virus and found that they still 
observed some mRNA degradation, which they suggest may be due to incomplete 
deactivation of ORF37 gene or other viral genes contributing to host shutoff (Richner  
et al. 2011).  
 
To gain further insight into the direct effect of MHV-68 ORF37 on mRNA 
degradation, transient transfections of immunocompetant cells were carried out with 
an empty vector and a plasmid containing the ORF37 gene and mRNA and protein 
levels were analysed. Previous studies had used co-transfection of ORF37/BGLF5 
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plasmids along with GFP as a marker for mRNA loss in mRNA decay assays 
(Glaunsinger and Ganem 2004b; Rowe et al. 2007; Covarrubias et al. 2009). 
However these studies only examined the effect of ORF37/BGLF5 on GFP and not 
on cellular mRNA. Therefore, the effect of ORF37 on cellular mRNA was 
investigated in cells transfected with an ORF37 expression vector 
(FLORF37pcDNA3.1) in transient transfection experiments. 
 
The indications from previous viral infection studies (Ebrahimi et al. 2003; 
Glaunsinger and Ganem 2004b; Rowe et al. 2007) and GFP transfection experiments 
(Glaunsinger and Ganem 2004b; Rowe et al. 2007; Covarrubias et al. 2009) led to 
the hypothesis that loss of cellular mRNA ought to be seen in the presence of ORF37 
alone. However the qPCR results seen in chapter five were equivocal. Expression of 
ORF37 at both mRNA and protein levels were confirmed in these experiments 
(Figures 5.3 & 5.6).  One possible explanation is that since transfection efficiency is 
usually in the order of 20%, the host shutoff activity of ORF37 would have been 
masked by the majority of the cell population which is untransfected. A recent study 
by Clyde and Glaunsinger used a marker method to overcome this problem, 
therefore, only cells which harboured ORF37 (as green cells) were isolated by means 
of flow cytometry. They found a reduction of most cellular mRNAs in sorted cells, 
although some loss was still seen in unsorted cells (Clyde and Glaunsinger 2011). 
These results are in accordance with our findings as the cells were in effect unsorted 
and did exhibit a degree of loss of cellular mRNA, but not at a significant level. In 
searching for patterns in mRNA degradation, Clyde and Glaunsinger did notice that 
in the majority of cases the more abundant mRNAs experience a higher level of 
downregulation compared to rare mRNAs (Clyde and Glaunsinger 2011). However 
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this correlation is imperfect as increasing the abundance of some cellular genes did 
not make them susceptible to SOX, suggesting that some cellular genes can escape 
host shutoff (Glaunsinger and Ganem 2004a; Clyde and Glaunsinger 2011). In 
contrast to a previous study which had suggested that the presence of AREs in their 
3’ UTR of mRNAs may lead to stabilisation of mRNA (Chandriani and Ganem 
2007) no correlation was identified between the presence of AREs and their loss 
when compared to transcripts lacking ARE motifs (Clyde and Glaunsinger 2011). 
These findings have led to the conclusion that other viral factors such as KSHV 
kaposin B may stabilise ARE containing mRNAs (McCormick and Ganem 2005). 
Taken together the results from Clyde and Glaunsinger suggest that multiple 
mechanisms may influence SOX-mediated decay (Clyde and Glaunsinger 2011).   
 
Another important question to be addressed is how MHV-68 ORF37 is causing 
mRNA degradation. The original studies which identified DNA exonucleases 
SOX/BGLF5 as the causative agent of mRNA degradation failed to find a direct 
RNase activity linked to these proteins (Glaunsinger and Ganem 2004b; Rowe et al. 
2007). Subsequently, protein structure studies demonstrated that SOX and BGLF5 
were able to mediate RNA degradation in vitro, but only in the presence of high 
levels of metal ions (Mg
2+
 and Mn
2+
) (Buisson et al. 2009; Bagneris et al. 2011). 
Nucleases utilise metal ions as cofactors for cleavage, although the types and 
concentrations of metals required vary magnesium and manganese are the most 
commonly required metals for catalysis (reviewed by Nishino and Morikawa 2002). 
Whether metal ions at such high concentrations would be found within cells is 
questionable. In addition SOX exhibits a lower affinity for binding RNA than DNA.  
Furthermore RNase activity was still seen following mutation of residues which had 
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previously been found to play an essential role in host shutoff (Bagneris et al. 2011). 
These findings led to the conclusion that other factors such as cellular mRNA decay 
machinery may be required for host shutoff. 
 
Previous studies using RNase H assays to look at the poly(A) tail length of GFP 
mRNA have suggested that ORF37 causes hyperadenylation (Covarrubias et al. 
2009; Lee and Glaunsinger 2009; Kumar and Glaunsinger 2010). In our current 
study, a method of radio-labelling all poly(A) tails was used to analyse poly(A) tail 
length distribution in infected cells (Ahlquist and Kaesberg 1979; Temme et al. 
2004; Morozov et al. 2010).  The results from chapter six did indicate that some 
changes may occur in poly(A) tail lengths in MHV-68-infected cells in NIH3T3 
cells, as poly(A) tails appeared to be shorter in virus-infected cells  when compared 
to mock-infected cells (Figure 6.4). As mRNA degradation had also been identified 
in ORF37Stop infected immune-compromised cells (Chapter 4), the next objective 
was to see if any variation could be observed in poly(A) tail lengths in IFNαβRKO 
cells infected with ORF37Stop mutant when compared to cells infected with the wild 
type virus. Comparison of poly(A) tail intensity profiles highlights an apparent 
difference in these samples (Figure 6.8). However, the apparent differences in band 
intensities did not point to either lengthening or shortening of poly(A) tails in 
infected cells. Also the poly(A) tails from ORF37Stop infected cells were very 
similar to MHV-68  infected cells with only one region showing a significant 
difference suggesting that the mutant virus is acting in a similar way to the wild type 
virus.  Further detailed analysis of poly(A) tail length distribution are warranted.   
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In contrast to a previous report, no obvious hyperadenylation was seen in either 
MHV-68-infected NIH3T3 or IFNαβRKO cells (Covarrubias et al. 2009; Lee and 
Glaunsinger 2009; Kumar and Glaunsinger 2010). One possible explanation for this 
discrepancy may be that previous experiments used transfected GFP mRNA as a 
marker.  This is in contrast to the approach in this study, where impact of MHV-68 
infection was investigated on cellular transcripts and on a global scale. Furthermore, 
Lee and Glaunsinger found that hyperadenylation was linked to newly transcribed 
nuclear transcripts rather than the bulk of transcripts located in the cytoplasm.  
Taking this into consideration, this may explain the discrepancy between the two 
studies; bulk poly(A) tail more than likely does not represent newly transcribed 
cellular mRNA.  Even so, this does not explain how poly(A) tail lengthening could 
explain loss of mRNA in virus-infected cells, since almost 50% of cellular mRNA 
are lost as a result of MHV-68 infection.  Therefore, one would expect to detect a 
significant population of transcripts with lengthened poly(A) tail.  The latter was not 
the case in this study. Interestingly, hyperadenylation was found to be necessary, but 
not sufficient for host shutoff as inhibition of hyperadenylation resulted in only a 
partial reduction in mRNA turnover (Lee and Glaunsinger 2009). Another key 
observation identified in previous studies is the relocalisation of poly A binding 
protein (cytoplasmic), PABPC, from cytoplasm to nucleus (Covarrubias et al. 2009; 
Lee and Glaunsinger 2009; Kumar and Glaunsinger 2010), which has also been seen 
upon infection with MHV-68 (Richner et al. 2011). The relocalisation of PABPC is a 
feature seen in a number of other viral infections (reviewed by Smith and Gray 
2010). In KSHV, knockdown of PABPN (nuclear) and PABPC (cytoplasmic) leads 
to a strong inhibition of SOX-induced mRNA degradation highlighting their 
importance in host shutoff (Lee and Glaunsinger 2009). In contrast to the study by 
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Lee and Glaunsinger, which found that the poly(A) tail participates in targeting of 
mRNAs for turnover by SOX in KSHV and MHV-68, a more recent study has 
suggested a different mRNA degradation process is occurring which is not linked to 
poly(A) tail (Lee and Glaunsinger 2009; Covarrubias et al. 2011). The process that 
they describe is a two-step mechanism that involves initial removal of the 5’ 
sequences of mRNA via endonucleolytic cleavage followed by exonucleolytic 
degradation of the fragments by the cellular Xrn1 enzyme. They found that this 
process occurred during early stages of translation and bypassed the regulatory 
decapping and deadenylation pathways (Covarrubias et al. 2011). Although these 
studies suggest different mechanisms of SOX-induced mRNA degradation and are in 
contrast to our findings they also suggest that multiple mechanisms govern SOX-
induced host shutoff in the γ-herpesviruses (Figure 7.1). Additionally, the discovery 
of the relocalisation of PABPC may be in agreement with our findings as it may lead 
to a destabilization of mRNA leading to deadenylation. Conversely, our results may 
also indicate that a viral factor other than SOX is causing the differences in poly(A) 
tail length as no obvious difference was identified between wild type MHV-68 and 
mutant ORF37Stop infected IFNαβRKO cells, although this will require further 
investigation.  
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Figure 7.1 Possible mRNA degradation mechanisms employed by ORF37/SOX. 
ORF37 may induce different mechanisms to induce host shutoff. One such 
mechanism is via direct endonuclease activity, which in turns leads to the recruitment 
of the cellular exonuclease Xrn1. Another mechanism is hyperadenylation of newly 
transcribed transcripts via PABPN and PAP activity, which are then retained in the 
nucleus and degraded by deadenylases. The other possible process that could be 
occurring is the relocalisation of PABPC from the cytoplasm to the nucleus, which 
may destabilize the mRNA leading to degradation via host factors. Additionally 
another viral or cellular factor may initiate shortening of poly(A) tails, as MHV-68 
and ORF37 mutant viruses appear to cause similar effects in IFNαβRKO cells 
(Information from Lee and Glaunsinger 2009; Covarrubias et al. 2011). 
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In conclusion, the results from this study have shown that an ORF37 mutant can 
grow in IFNαβRKO cells to a similar level seen in wild-type MHV-68, suggesting 
the importance of host shutoff in the evasion of the type I IFN response during lytic 
MHV-68 infection. Furthermore, an ORF37 mutant virus can also be propagated in 
vivo, however, ORF37 does afford a degree of robustness in vivo. Interestingly, host 
shutoff can proceed in IFNαβRKO cells even in the absence of ORF37, suggesting 
that additional viral/cellular factors may lead to host shutoff in immunocompromised 
cells. Future investigation into the effect of ORF37 in transfection experiments 
would require the use of a reporter system, to remove the effect of untransfected 
cells. The mechanism behind ORF37-induced mRNA degradation appears to be 
more complex and may involve shortening of cellular poly(A) tails. 
 
7.1 Future work 
There are two main areas which require further investigation: (1) the link between 
the ORF37Stop virus and the Type I IFN system; and (2) mRNA degradation 
pathways linked to ORF37. One approach would be to conduct in vivo experiments 
to examine the effect of ORF37 mutation during the latent phase of infection. The 
study by Richner et al. found that an ORF37 point mutation virus caused little defect 
during lytic infection, but decreased latency establishment in immunocompetant 
mice (Richner et al. 2011). It would be interesting to examine latent infection in 
immunocompromised mice to see if any parallels can be drawn between the ORF37 
deletion and point mutation viruses. In addition, it would be interesting to conduct 
RNA profiling experiments using microarrays or RNAseq on ORF37Stop infected 
IFNαβRKO cells compared to MHV-68-infected and also compared to MHV-68 
infection in an immunocompetant cell line to gauge if differences can be seen in 
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mRNAs that are down regulated. In addition, mutational analysis of the MHV-68 
genome, similar to those carried out by Glaunsinger and Ganem in KSHV 
(Glaunsinger and Ganem 2004b) could also be executed to try to decipher if another 
viral factor is causing additional host shutoff in IFNαβRKO cells.  
 
The mRNA degradation mechanism employed by MHV-68 requires further 
investigation. Although the findings in chapter six are in contrast to previous studies 
(Lee and Glaunsinger 2009; Covarrubias et al. 2011) they do warrant further 
examination as they may suggest a shortening of some transcripts. A way forward 
will be the use of other assays such as the LM-PAT assay and the more direct 
method of RNase H (Murray and Schoenberg 2008). 
 
Other possible mRNA degradation pathways require further investigation such as 
those described by Covarrubias et al. 2011, to see if a link can be made between 
ORF37 and the cellular degradation machinery. For example co-immunoprecipitation 
could be used to try to identify protein-protein interactions between ORF37 and 
cellular mRNA degradation proteins or alternatively biomolecular fluorescence 
complementation (BiFC) could also be used to identify protein-protein interactions. 
Overall the findings from this study have highlighted the importance of MHV-68 
ORF37 in innate immune avoidance and in addition have also suggested that another 
factor may cause host shutoff in the absence of ORF37 in an immunocompromised 
environment. Furthermore, this study has used a global cellular poly(A) tail assay to 
investigate mRNA degradation, which suggests that ORF37 may cause poly(A) tail 
shortening, which along with previously published work points to the highly 
complex nature of mRNA degradation by ORF37. 
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Appendix A 
Vector maps 
 
 
 
       
 
 
pcDNA3.1 with myc and His-tagged epitope vector circle map. 
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pEGFP-N1 vector circle map. 
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Appendix B 
Molecular biology kits, reagents and chemicals 
Kits  Manufacturer Cat. No. 
ABC (Vectastain) kit 
BCIP/NBT kit 
Qiagen Endofree Maxi Prep kit   
Qiashredders 
Qiaquick Gel extraction kit 
Ready-to-go DNA labelling beads 
RNase-free DNase kit     
RNeasy mini kit  
Vector labs 
Vector labs 
Qiagen 
Qiagen 
Qiagen 
Amersham 
Qiagen 
Qiagen 
AK-5000 
SK-5400 
12362 
79656 
28704 
27-9240-01 
79254 
74104 
 
Biological Reagent  Manufacturer Cat. No. 
10X SuRE/Cut Buffer A  
10X SuRE/Cut Buffer H  
α-32P dATP 
α-32P dCTP 
Anti-mouse biotin conjugate 
Anti-mouse-HP-linked 
Biotin-anti-rabbit 
Bovine serum 
DMEM 
dNTP set (dATP, dCTP, dGTP, dTTP) 
ECL anti-rabbit 
EcoR I   
Fungizone-ampotericin B 
Generuler DNA ladder 
HpaI 
Immobilon Western HRP substrate 
L-Glutamine 
Lipofectamine  
Low-molecular weight DNA ladder 
Roche 
Roche 
Perkin-Elmer 
Perkin-Elmer 
Sigma-Aldrich 
GE Healthcare 
Vector labs 
Gibco 
Sigma-Aldrich 
Invitrogen 
GE Healthcare 
Roche 
Gibco  
Fermentas  
Roche 
Millipore 
Sigma-Aldrich 
Invitrogen 
NEB 
11417959001 
11417991001 
B BLU012H250uc 
BLU013A250uc 
BA8520 
NA9310 
BA-1000 
26170-026 
D6546 
10297-018 
NA934 
10703737001 
15290-018 
SM0333 
10567647001 
WBKLSO500 
G7513 
2000 11668 
N3233L 
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Opti-MEM 
Penicillin-Streptomycin  
Phosphate buffered saline (10x) 
Platinum Taq DNA Polymerase   
Precision plus Dual colour marker 
Protease inhibitor cocktail 
Rabbit anti-βactin 
RNase cocktail 
Strevtavidin-AP conjugate 
Superscript II 
Trypsin 
Versene-EDTA 
XL-10 Gold supercompetent cells 
Yeast poly(A) polymerase  
Gibco  
Gibco 
Q biogene 
Invitrogen 
Bio-Rad 
Sigma-Aldrich 
Abcam 
Ambion 
Roche 
Invitrogen 
Gibco 
Gibco 
Agilent 
Affymetrix 
51985-026 
15140-122 
PBS10X02 
10966 
161-0374 
P2714 
Ab8227 
AM2286 
11-089-161-001 
18064-014 
25300-054 
15040-033 
200159 
742252 
 
Chemical Manufacturer Cat. No. 
6X loading dye 
Acetic acid 
Acrylamide 
Agar 
Agarose 
Ammonium acetate (7.5M) 
β-mercaptoethanol 
Bradford reagent 
Cell extraction buffer  
Chloroform 
Coomassie blue (R250) 
Dithiothreitol (DTT) 
EDTA 
Ethanol 
Ethidium bromide 
Gel loading buffer II 
Luria Broth 
Fermentas 
BDH 
Geneflow 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Bio-Rad 
Invitrogen 
Sigma-Aldrich 
Geneflow 
Melford 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Ambion 
Sigma-Aldrich 
R0611 
100015N 
EC-890 
05040 
A9539 
A2706 
M7154 
500-0006 
FNN0011 
C2432 
H8-604 
MB1015 
E9884 
E7023 
E1510 
AM8547 
L3022 
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Methanol 
Microsieve low melt agarose 
PAGE/urea (6%) 
Phenol 
PMSF 
Sigmacoat 
Sodium acetate 
Sodium Chloride 
Sodium Citrate 
Sodium Hydroxide 
SYBR green 
TEMED 
Toluidine blue 
Transfer buffer (10x) 
Triton X-100 
Trypan blue (0.4%) 
Tween 20 
Ultrahyb 
Sigma-Aldrich 
Flowgen 
Ambion 
Sigma-Aldrich 
FLUKA 
Sigma-Aldrich 
Sigma-Aldrich  
Fisher Scientific  
BDM 
Sigma-Aldrich 
Molecular probes 
Bio-Rad 
Sigma-Aldrich 
Bio-Rad  
Sigma 
Gibco 
Sigma-Aldrich 
Ambion 
322415 
GG25LM-SVE 
AM9030 
P1037 
GA19056 
SL2 
S-7899 
S/3160/65 
27833-294 
S8045 
S-7563 
161-0800 
T3260 
161-0734 
T-8787 
15250-061 
P9416 
AM8670 
 
Consumable Manufacturer Cat. No. 
Amersham hyperfilm ECL 
Hybond ECL membrane 
Hybond-P 
Nunc multidish six-well plate 
Hybond-N 
GE healthcare 
GE healthcare 
GE Healthcare 
Fisher Scientific 
GE Healthcare 
28-9068-40 
8549057 
RPN2020F 
140675 
RPN119N 
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Appendix C 
Buffers and reagents 
General buffers and biological reagents 
Ethanol 70%: 7ml of ethanol and 3ml of Sigma water were mixed thoroughly. 
Luria Broth medium / LB agar:  consisted of the following, 1l deionised H2O, 10g 
tryptone, 5g yeast, 10g NaCl, 1% agar. 
50X TAE Buffer : 242g Tris (hydroxymethyl) methylamine, 100ml 0.5M EDTA 
and 57.1ml acetic acid in a total volume of litre. The buffer was diluted 1/50 to give 
1x TAE working solution. 
 
Southern blot buffers 
Lysis buffer: 20mM Tris HCl pH 7.5; 2mM EDTA; 1.2% SDS containing 
proteinase-K to a final concentration of 1mg/ml 
Denaturing solution: 1.5M NaCl, 0.5M NaOH 
Neutralisation solution: 1.5M NaCl, 1M Tris-HCl (pH 7) 
20X SSC: solution was made which consisted of 1.5M NaCl together with 150mM 
Na3citrate.2H20 (the pH of the solution was brought to pH7 using 1N HCL). 20x 
SSC buffer was diluted with Millipore water to give lower SSC concentrations. 
Wash buffer 1: 2xSSC, 0.1% SDS 
Wash buffer 2: 0.1xSSC, 0.1% SDS 
 
Western blot buffers and gels 
APS 10%: Ammonium Persulphate 10% (w/v), 1g APS in 10ml Sigma water. 
Aliquoted 500µl volumes into microfuge tubes and stored at -20
o
C. 
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Resolving gel: Gel mix was prepared in a glass universal by adding 5.9ml RO water, 
5ml 30% acrylamide, 3.8ml 1.5M Tris (pH8.8), 150µl 10% SDS, 150µl 10% APS 
and finally 6µl Temed. 
            Stacking gel: Gel mix was prepared in a glass universal by adding 4.1ml RO water, 
1ml 30% acrylamide, 750µl 1M Tris (pH6.8), 60µl 10% SDS, 60µl 10% APS and 
finally 6µl Temed. 
Sample buffer 2x: 100mM Tris-HCL (pH6.8), 4% SDS, 20% glycerol, 0.05% 
bromophenol blue and 100mM DTT. 
SDS-PAGE running buffer 1x: 25mM Tris, 250 mM glycine, and 0.1% SDS (pH 
8.3), (50ml 10x Tris-Glycine buffer, 5ml 10% SDS solution in a total volume of 
500ml RO water). 
Transfer buffer: 140ml RO water, plus 20ml 10x transfer buffer, plus 40ml 
methanol. 
Blocking buffer: 100ml of 1 x TBS plus 5g milk powder, plus 100µl of Tween 20. 
Antibody dilution buffer: 100ml 1 x TBS, plus 3g dried milk, plus 100µl of Tween 
20. 
Wash buffer: 200ml 1x TBS plus 200µl of Tween 20. 
Coomasie blue: 1.25g Coomasie blue (R250), 250 ml methanol, 200ml RO water 
plus 50ml of glacial acetic acid. Solution was mixed well and then filtered through 
Whatman filter paper. 
Destain: 250 ml methanol, 200ml RO water plus 50ml of glacial acetic acid. 
 
Poly(A) tail gel electrophoresis 
Gel: Gel mix was prepared in a volumetric flask by adding 64ml 6% PAGE/urea 
acrylamide to 16ml 0.5x TBE buffer plus 500µl 10% APS. 
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5x TBE buffer: 54g Tris base, 27.5g boric acid along with 20ml of 0.5M EDTA (pH 
8.0) made up to 1L with RO water. The buffer was diluted 1/10 to make a 0.5X 
solution. 
Stop solution: 200mM Tris–HCl (pH 7.9), 300mM NaCl, 25mM EDTA, 2% SDS 
containing 20 µg proteinase K, 1 µg rRNA and 1 µg glycogen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
